Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Colon Carcinoma	21/2091	4.606718411811365E-20	9.098268863327446E-17	0	0	181.67536231884057	8088.947641234293	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;CREBBP;HDAC3;JUND;UBE2I;XRCC5;FOS;HIF1A;PIAS1;NCOR2;MAPK8;CDK6;KAT5;CTNNB1;MAPK1;UBA52;MAPK3
Malignant tumor of colon	20/2001	1.754755499937414E-18	1.7328210561881963E-15	0	0	90.84805653710248	3714.2503077575375	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;CREBBP;HDAC3;JUND;UBE2I;XRCC5;FOS;HIF1A;NCOR2;MAPK8;CDK6;KAT5;CTNNB1;MAPK1;UBA52;MAPK3
Non-Small Cell Lung Carcinoma	19/2243	9.086570906859055E-16	5.981992513682211E-13	0	0	50.55845323741007	1751.0699787728574	SMAD2;GSK3B;XRCC6;SMAD4;CREBBP;HDAC3;JUND;UBE2I;XRCC5;FOS;HIF1A;PIAS1;MAPK8;CDK6;KAT5;CTNNB1;MAPK1;PGR;MAPK3
Stomach Carcinoma	19/2378	2.711407983076193E-15	1.0437312888909213E-12	0	0	47.3026706231454	1586.593460865038	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;HDAC3;JUND;UBE2I;XRCC5;FOS;HIF1A;PIAS1;MAPK8;CDK6;CTNNB1;MAPK1;PGR;UBA52;MAPK3
Mammary Neoplasms	19/2387	2.909761153750714E-15	1.0437312888909213E-12	0	0	47.098817567567565	1576.430647249592	SMAD2;XRCC6;SMAD4;CREBBP;HDAC3;JUND;UBE2I;XRCC5;FOS;HIF1A;PIAS1;NCOR2;MAPK8;CDK6;KAT5;CTNNB1;MAPK1;PGR;MAPK3
Malignant neoplasm of stomach	19/2398	3.1708292320736846E-15	1.0437312888909213E-12	0	0	46.85175844192238	1564.135800644124	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;HDAC3;JUND;UBE2I;XRCC5;FOS;HIF1A;PIAS1;MAPK8;CDK6;CTNNB1;MAPK1;PGR;UBA52;MAPK3
melanoma	19/2454	4.8804145867190296E-15	1.3621420300932675E-12	0	0	45.62861054072553	1503.624526515831	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;CREBBP;HDAC3;JUND;UBE2I;XRCC5;FOS;HIF1A;MAPK8;CDK6;KAT5;CTNNB1;MAPK1;PGR;MAPK3
Multiple Myeloma	16/1312	5.517537337086654E-15	1.3621420300932675E-12	0	0	38.440329218106996	1262.028481419511	SMAD2;XRCC6;HDAC2;CREBBP;HDAC3;JUND;UBE2I;XRCC5;FOS;HIF1A;NCOR2;MAPK8;CDK6;CTNNB1;MAPK1;MAPK3
Colorectal Neoplasms	15/1073	9.551602728301137E-15	2.096046154266083E-12	0	0	38.32028085336214	1237.0578904273802	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;CREBBP;HDAC3;FOS;HIF1A;NCOR2;MAPK8;CTNNB1;MAPK1;PGR;MAPK3
Glioma	18/2211	2.695429082970346E-14	5.323472438866434E-12	0	0	36.49452804377565	1140.2581679266348	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;CREBBP;HDAC3;JUND;UBE2I;XRCC5;FOS;HIF1A;MAPK8;CDK6;KAT5;CTNNB1;MAPK1;MAPK3
Adenocarcinoma of lung (disorder)	15/1187	4.215449875352373E-14	7.568648639837215E-12	0	0	34.38444661140907	1058.9527589813574	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;CREBBP;JUND;UBE2I;XRCC5;FOS;HIF1A;CDK6;CTNNB1;MAPK1;PGR
Bladder Neoplasm	15/1217	6.07962314948995E-14	1.0006046433535542E-11	0	0	33.47278345614452	1018.6185943481962	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;CREBBP;JUND;XRCC5;FOS;HIF1A;MAPK8;CDK6;KAT5;CTNNB1;MAPK3
Leukemogenesis	13/730	6.745492653126998E-14	1.0247959992250631E-11	0	0	38.80257244692391	1176.7779062894313	GSK3B;SMAD4;HDAC2;CREBBP;JUND;FOS;HIF1A;NCOR2;CDK6;KAT5;CTNNB1;MAPK1;MAPK3
Malignant neoplasm of lung	18/2449	1.624781493266736E-13	2.2921024637155742E-11	0	0	32.48107774578363	956.5103412570386	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;HDAC3;JUND;UBE2I;XRCC5;FOS;HIF1A;MAPK8;CDK6;KAT5;CTNNB1;MAPK1;PGR;MAPK3
Tumor Progression	17/2090	3.1345153453405154E-13	4.012151669537014E-11	0	0	29.366618427399903	845.4981770112148	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;CREBBP;JUND;XRCC5;FOS;HIF1A;NCOR2;MAPK8;KAT5;CTNNB1;MAPK1;PGR;MAPK3
Leukemia, Myelocytic, Acute	16/1703	3.2503507196249225E-13	4.012151669537014E-11	0	0	28.91286307053942	831.3848470828124	GSK3B;SMAD4;HDAC2;CREBBP;HDAC3;JUND;UBE2I;FOS;HIF1A;NCOR2;MAPK8;CDK6;KAT5;CTNNB1;MAPK1;MAPK3
Prostate carcinoma	19/3145	4.932644823739261E-13	5.730572662873553E-11	0	0	34.14246107912135	967.5198739590855	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;CREBBP;JUND;XRCC5;FOS;HIF1A;PIAS1;NCOR2;MAPK8;CDK6;KAT5;CTNNB1;MAPK1;PGR;MAPK3
Malignant neoplasm of urinary bladder	14/1144	7.714263006272214E-13	8.464260798548679E-11	0	0	29.18938053097345	814.107446772166	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;CREBBP;JUND;XRCC5;FOS;HIF1A;CDK6;KAT5;CTNNB1;MAPK3
Malignant neoplasm of prostate	19/3239	8.510189295973684E-13	8.846117820814751E-11	0	0	32.96086956521739	916.0597603201306	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;CREBBP;JUND;XRCC5;FOS;HIF1A;PIAS1;NCOR2;MAPK8;CDK6;KAT5;CTNNB1;MAPK1;PGR;MAPK3
Carcinoma of bladder	14/1162	9.542856784431883E-13	9.423571074626484E-11	0	0	28.704268292682926	794.4713791484037	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;JUND;XRCC5;FOS;HIF1A;MAPK8;CDK6;KAT5;CTNNB1;MAPK3
Malignant neoplasm of pancreas	16/1846	1.1363152649992762E-12	1.0686774516064622E-10	0	0	26.445173041894353	727.3276848152274	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;CREBBP;HDAC3;JUND;FOS;HIF1A;MAPK8;CDK6;CTNNB1;MAPK1;PGR;MAPK3
Pancreatic carcinoma	16/1869	1.3765965407715757E-12	1.2358082581926644E-10	0	0	26.083828026623493	712.3860417314371	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;CREBBP;HDAC3;JUND;FOS;HIF1A;MAPK8;CDK6;CTNNB1;MAPK1;PGR;MAPK3
Tumor Angiogenesis	11/511	1.4892933413366294E-12	1.278849717017323E-10	0	0	38.956	1060.8778160126606	SMAD2;SMAD4;HDAC2;CREBBP;MAPK8;JUND;CDK6;MAPK1;FOS;HIF1A;MAPK3
Squamous cell carcinoma of the head and neck	13/934	1.5565074870450038E-12	1.2808759528807845E-10	0	0	29.887923754373265	812.610104257134	SMAD2;XRCC6;SMAD4;CREBBP;JUND;XRCC5;FOS;HIF1A;NCOR2;MAPK8;CTNNB1;MAPK1;MAPK3
Carcinogenesis	20/4065	2.098304065207307E-12	1.636149030703867E-10	0	0	39.389369592089	1059.1758818902406	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;CREBBP;HDAC3;JUND;UBE2I;XRCC5;FOS;HIF1A;PIAS1;MAPK8;CDK6;KAT5;CTNNB1;MAPK1;PGR;MAPK3
Prostatic Neoplasms	15/1554	2.1539177113063562E-12	1.636149030703867E-10	0	0	25.673906989696462	689.6969757797744	SMAD2;GSK3B;SMAD4;HDAC2;CREBBP;JUND;FOS;HIF1A;NCOR2;MAPK8;CDK6;CTNNB1;MAPK1;PGR;MAPK3
Breast Carcinoma	21/4963	3.165656305547461E-12	2.3156189642430502E-10	0	0	63.892351274787536	1691.7838918999983	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;CREBBP;HDAC3;JUND;UBE2I;XRCC5;FOS;HIF1A;PIAS1;NCOR2;MAPK8;CDK6;KAT5;CTNNB1;MAPK1;PGR;MAPK3
Adenoma	13/1000	3.694435722416196E-12	2.5560484488032976E-10	0	0	27.792750197005518	731.6217281637098	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;HDAC3;XRCC5;FOS;HIF1A;CTNNB1;MAPK1;PGR;MAPK3
Colorectal Carcinoma	18/2931	3.753185064065602E-12	2.5560484488032976E-10	0	0	26.361997940267766	693.5424159438371	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;CREBBP;JUND;UBE2I;XRCC5;FOS;HIF1A;MAPK8;KAT5;CTNNB1;MAPK1;PGR;UBA52;MAPK3
Malignant neoplasm of breast	21/5054	4.61350444920449E-12	3.037223762392956E-10	0	0	62.357440890125176	1627.6560025768035	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;CREBBP;HDAC3;JUND;UBE2I;XRCC5;FOS;HIF1A;PIAS1;NCOR2;MAPK8;CDK6;KAT5;CTNNB1;MAPK1;PGR;MAPK3
Central neuroblastoma	15/1655	5.36675228798664E-12	3.4191405705721336E-10	0	0	23.96080139372822	621.8019211625714	GSK3B;XRCC6;SMAD4;HDAC2;CREBBP;HDAC3;JUND;FOS;HIF1A;NCOR2;MAPK8;CDK6;CTNNB1;MAPK1;MAPK3
Neuroblastoma	15/1698	7.778139042021812E-12	4.800570189997837E-10	0	0	23.293862999745354	595.8501206440092	GSK3B;XRCC6;SMAD4;HDAC2;CREBBP;HDAC3;JUND;FOS;HIF1A;NCOR2;MAPK8;CDK6;CTNNB1;MAPK1;MAPK3
Ovarian Carcinoma	16/2203	1.739217668644703E-11	1.0408954229009965E-9	0	0	21.693034598384394	537.4449457664612	SMAD2;GSK3B;SMAD4;HDAC2;HDAC3;JUND;UBE2I;FOS;HIF1A;MAPK8;CDK6;KAT5;CTNNB1;MAPK1;PGR;MAPK3
Primary malignant neoplasm of lung	16/2268	2.717739198145706E-11	1.5786867400993438E-9	0	0	20.989934872705742	510.65647815849366	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;HDAC3;UBE2I;XRCC5;HIF1A;MAPK8;CDK6;KAT5;CTNNB1;MAPK1;PGR;MAPK3
Squamous cell carcinoma	15/1876	3.27533213648745E-11	1.8482231341607755E-9	0	0	20.860904275735013	503.62430030450895	SMAD2;GSK3B;SMAD4;HDAC2;CREBBP;JUND;XRCC5;FOS;HIF1A;MAPK8;CDK6;CTNNB1;MAPK1;PGR;MAPK3
Malignant neoplasm of mouth	10/492	3.676868371933833E-11	2.0171708429359225E-9	0	0	33.706777316735824	809.851659008924	XRCC6;SMAD4;MAPK8;JUND;XRCC5;CTNNB1;MAPK1;FOS;HIF1A;MAPK3
Malignant neoplasm of thyroid	10/505	4.749348208064407E-11	2.5351250570073524E-9	0	0	32.7996632996633	779.6620556726663	GSK3B;SMAD4;CREBBP;JUND;KAT5;CTNNB1;MAPK1;FOS;HIF1A;MAPK3
Glioblastoma	15/1937	5.187498535234765E-11	2.696134107128595E-9	0	0	20.13081611416679	476.74169973561413	SMAD2;GSK3B;XRCC6;CREBBP;JUND;FOS;HIF1A;NCOR2;MAPK8;CDK6;KAT5;CTNNB1;MAPK1;PGR;MAPK3
leukemia	15/1941	5.343431885173038E-11	2.705968711081218E-9	0	0	20.084557187360925	475.0513526408658	SMAD2;GSK3B;SMAD4;HDAC2;CREBBP;JUND;FOS;HIF1A;PIAS1;MAPK8;CDK6;KAT5;CTNNB1;MAPK1;MAPK3
Thyroid carcinoma	11/721	6.084453687309401E-11	3.0041990081090167E-9	0	0	27.138028169014085	638.3596702647445	GSK3B;SMAD4;CREBBP;MAPK8;JUND;KAT5;CTNNB1;MAPK1;FOS;HIF1A;MAPK3
Malignant neoplasm of ovary	15/2026	9.878802293102278E-11	4.758691348506586E-9	0	0	19.145059316615757	441.0647331611508	SMAD2;GSK3B;SMAD4;HDAC2;CREBBP;HDAC3;JUND;FOS;HIF1A;MAPK8;CDK6;CTNNB1;MAPK1;PGR;MAPK3
Carcinoma of lung	16/2476	1.0404870503319014E-10	4.8927664866797745E-9	0	0	18.98970189701897	436.5003643034445	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;HDAC3;UBE2I;XRCC5;HIF1A;MAPK8;CDK6;KAT5;CTNNB1;MAPK1;PGR;MAPK3
Liver carcinoma	18/3593	1.277157914058206E-10	5.866016000616179E-9	0	0	20.647132867132868	470.36674614564953	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;CREBBP;HDAC3;JUND;UBE2I;XRCC5;FOS;HIF1A;MAPK8;CDK6;KAT5;CTNNB1;MAPK1;MAPK3
Epithelial ovarian cancer	13/1329	1.3148651461243932E-10	5.901951508171992E-9	0	0	20.483451536643027	466.0418822394352	SMAD2;SMAD4;HDAC3;UBE2I;FOS;HIF1A;MAPK8;CDK6;KAT5;CTNNB1;MAPK1;PGR;MAPK3
FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)	8/249	1.4187167365844332E-10	6.2265901216761225E-9	0	0	46.797866034380554	1061.1930045081135	GSK3B;XRCC6;SMAD4;MAPK8;KAT5;XRCC5;MAPK1;HIF1A
Trigeminal Neuralgia	5/33	2.298292352612048E-10	9.867668253062597E-9	0	0	209.55882352941177	4650.8824215971745	MAPK8;CTNNB1;MAPK1;FOS;MAPK3
Stomach Neoplasms	11/835	2.9123419900462506E-10	1.22380328305135E-8	0	0	23.24514563106796	510.39118387211636	GSK3B;XRCC6;SMAD4;HDAC2;MAPK8;HDAC3;CTNNB1;MAPK1;FOS;HIF1A;MAPK3
Glioblastoma Multiforme	11/854	3.6987545690694045E-10	1.5218833903983487E-8	0	0	22.698695136417555	492.96696443913316	SMAD2;XRCC6;CREBBP;MAPK8;JUND;CDK6;CTNNB1;MAPK1;FOS;HIF1A;MAPK3
Fanconi Anemia	8/290	4.757035818888515E-10	1.9136815825023698E-8	0	0	39.91084093211753	856.7351385944459	GSK3B;XRCC6;SMAD4;MAPK8;KAT5;XRCC5;MAPK1;HIF1A
Myeloid Leukemia, Chronic	11/876	4.844763500006E-10	1.9136815825023698E-8	0	0	22.095953757225434	473.912966605014	GSK3B;XRCC6;CREBBP;MAPK8;CDK6;XRCC5;CTNNB1;MAPK1;FOS;HIF1A;MAPK3
Secondary Trigeminal Neuralgia	4/13	7.795335079871747E-10	2.960728227451289E-8	0	0	493.0617283950617	10340.651030817968	MAPK8;MAPK1;FOS;MAPK3
Trigeminal Neuralgia, Idiopathic	4/13	7.795335079871747E-10	2.960728227451289E-8	0	0	493.0617283950617	10340.651030817968	MAPK8;MAPK1;FOS;MAPK3
Acute Promyelocytic Leukemia	9/475	8.427379663330592E-10	3.140391478316588E-8	0	0	28.9877847474414	605.6813562419122	SMAD2;NCOR2;GSK3B;MAPK8;UBE2I;MAPK1;HIF1A;PIAS1;MAPK3
Agenesis of corpus callosum	8/317	9.613514920202069E-10	3.516054068036868E-8	0	0	36.373555247341656	755.212525065919	SMAD4;CREBBP;MAPK8;JUND;CDK6;CTNNB1;PGR;FOS
Obesity	14/1961	1.0866558045471323E-9	3.902082207237429E-8	0	0	16.206599897277865	334.5068299447533	SMAD2;CREBBP;JUND;UBE2I;FOS;HIF1A;PIAS1;NCOR2;MAPK8;KAT5;CTNNB1;MAPK1;PGR;MAPK3
Aplasia Cutis Congenita	7/199	1.3052475476991784E-9	4.603328404831924E-8	0	0	48.09097222222222	983.7909170846635	SMAD4;CREBBP;MAPK8;JUND;CTNNB1;PGR;FOS
Myeloid Leukemia	9/501	1.3458124018295052E-9	4.663121918619776E-8	0	0	27.419324577861165	560.0744719323743	SMAD2;XRCC6;HDAC2;MAPK8;JUND;XRCC5;MAPK1;FOS;HIF1A
Tumor Promotion	6/108	1.4983281681743103E-9	5.1020657450763145E-8	0	0	73.07352941176471	1484.7748989967454	JUND;KAT5;MAPK1;FOS;HIF1A;MAPK3
Pneumonitis	8/339	1.6312398452408854E-9	5.4605062616114387E-8	0	0	33.91799741044454	686.2942316951512	CREBBP;MAPK8;JUND;MAPK1;FOS;HIF1A;PIAS1;MAPK3
Neurodegenerative Disorders	10/745	2.0871090972453955E-9	6.870067445099426E-8	0	0	21.817460317460316	436.07618124451125	GSK3B;CREBBP;MAPK8;JUND;CDK6;KAT5;CTNNB1;MAPK1;FOS;HIF1A
Endometriosis	10/749	2.197680062212427E-9	7.115439545687775E-8	0	0	21.69485791610284	432.50572715537714	SMAD2;HDAC2;MAPK8;CDK6;CTNNB1;MAPK1;PGR;FOS;HIF1A;MAPK3
Adenocarcinoma	13/1712	3.018695144891212E-9	9.616004695419587E-8	0	0	15.540317834020012	304.87681119226914	SMAD2;GSK3B;XRCC6;SMAD4;UBE2I;XRCC5;FOS;HIF1A;CDK6;CTNNB1;MAPK1;PGR;MAPK3
Gallbladder Carcinoma	7/233	3.9109467601501015E-9	1.2260507700470555E-7	0	0	40.7858407079646	789.5929266269096	SMAD4;MAPK8;CTNNB1;MAPK1;PGR;HIF1A;MAPK3
Malignant neoplasm of endometrium	9/577	4.6286883925908196E-9	1.4283843086510733E-7	0	0	23.657908992416036	454.018749154219	SMAD2;SMAD4;CREBBP;CTNNB1;MAPK1;PGR;FOS;HIF1A;MAPK3
Uterine Corpus Cancer	9/579	4.770427983689172E-9	1.4494761950440174E-7	0	0	23.57246963562753	451.6680789374396	SMAD2;SMAD4;CREBBP;CTNNB1;MAPK1;PGR;FOS;HIF1A;MAPK3
Cervix carcinoma	11/1105	5.5984709730060934E-9	1.6649034025705101E-7	0	0	17.26142595978062	327.9804245289295	SMAD2;XRCC6;SMAD4;MAPK8;JUND;CTNNB1;MAPK1;PGR;FOS;HIF1A;MAPK3
Cholestasis, Extrahepatic	5/61	5.648026732770844E-9	1.6649034025705101E-7	0	0	104.63235294117646	1987.1734202913035	SMAD4;MAPK8;MAPK1;FOS;MAPK3
Hepatitis B	10/839	6.539596912687445E-9	1.8993682209643682E-7	0	0	19.24909529553679	362.7567139110843	GSK3B;SMAD4;CREBBP;MAPK8;HDAC3;KAT5;XRCC5;CTNNB1;MAPK1;HIF1A
Colorectal Cancer	16/3298	7.911027298919154E-9	2.2643882486036708E-7	0	0	13.565711964249441	253.0684677984054	SMAD2;GSK3B;XRCC6;SMAD4;HDAC2;CREBBP;JUND;UBE2I;FOS;HIF1A;MAPK8;KAT5;CTNNB1;MAPK1;PGR;MAPK3
Neoplasm Metastasis	17/3920	8.6006503715447E-9	2.4266120691143976E-7	0	0	14.00333077120164	260.06184934486924	SMAD2;GSK3B;SMAD4;HDAC2;HDAC3;JUND;UBE2I;FOS;HIF1A;NCOR2;MAPK8;CDK6;KAT5;CTNNB1;MAPK1;PGR;MAPK3
Malignant neoplasm of gastrointestinal tract	7/263	9.044944722339184E-9	2.516023355861956E-7	0	0	35.9515625	665.8610400273396	SMAD2;GSK3B;SMAD4;MAPK8;MAPK1;HIF1A;MAPK3
Adenocarcinoma of colon	7/267	1.0038588644508116E-8	2.7536406351254903E-7	0	0	35.391282051282055	651.7952004526047	GSK3B;SMAD4;JUND;MAPK1;FOS;HIF1A;MAPK3
Lung Neoplasms	11/1177	1.082407179160201E-8	2.928430381974516E-7	0	0	16.133790737564322	295.9178149339367	SMAD2;SMAD4;CREBBP;MAPK8;JUND;XRCC5;CTNNB1;MAPK1;FOS;HIF1A;MAPK3
Meningioma	8/438	1.2128060031094955E-8	3.23688088667737E-7	0	0	25.977408637873754	473.5095559481303	SMAD2;SMAD4;UBE2I;CTNNB1;PGR;FOS;HIF1A;MAPK3
Acute lymphocytic leukemia	10/907	1.377390871412863E-8	3.6271292947205393E-7	0	0	17.726681531029357	320.86161659610434	HDAC2;CREBBP;HDAC3;JUND;CDK6;XRCC5;CTNNB1;MAPK1;FOS;HIF1A
Aortic Aneurysm, Abdominal	7/288	1.6917304882188662E-8	4.3962733082003433E-7	0	0	32.71150652431791	585.3700795842619	CREBBP;MAPK8;JUND;PGR;FOS;HIF1A;MAPK3
Alzheimer's Disease	13/1982	1.8028689632852602E-8	4.6242418214134916E-7	0	0	13.211274758760792	235.5742231508987	SMAD2;GSK3B;HDAC2;CREBBP;HDAC3;JUND;FOS;HIF1A;MAPK8;KAT5;CTNNB1;MAPK1;MAPK3
ovarian neoplasm	10/938	1.897132002620938E-8	4.803635519456863E-7	0	0	17.106681034482758	304.1625617930627	SMAD2;GSK3B;SMAD4;HDAC3;UBE2I;CTNNB1;MAPK1;PGR;HIF1A;MAPK3
MYELODYSPLASTIC SYNDROME	9/683	2.001212905935334E-8	5.003032264838335E-7	0	0	19.828349691851177	351.4957133522722	GSK3B;XRCC6;CREBBP;MAPK8;UBE2I;XRCC5;MAPK1;FOS;MAPK3
Transitional cell carcinoma of bladder	6/167	2.068520672208337E-8	5.106660409514332E-7	0	0	46.15760869565217	816.7056681438405	CREBBP;MAPK8;CTNNB1;MAPK1;HIF1A;MAPK3
Malignant Head and Neck Neoplasm	8/470	2.0984495923277622E-8	5.116590055367075E-7	0	0	24.138528138528137	426.756672796488	XRCC6;SMAD4;MAPK8;JUND;MAPK1;FOS;HIF1A;MAPK3
Lip and Oral Cavity Carcinoma	8/473	2.204680469717811E-8	5.310053570356923E-7	0	0	23.97910906298003	422.754046503666	XRCC6;SMAD4;MAPK8;XRCC5;CTNNB1;MAPK1;HIF1A;MAPK3
Pancreatic Ductal Adenocarcinoma	9/701	2.505307194173977E-8	5.961423745173017E-7	0	0	19.2945753668297	337.69885573036044	SMAD2;SMAD4;HDAC2;CREBBP;CDK6;XRCC5;MAPK1;HIF1A;MAPK3
Degenerative polyarthritis	10/976	2.7670342924819095E-8	6.505824675775919E-7	0	0	16.40096618357488	285.42445065807885	SMAD2;NCOR2;HDAC2;MAPK8;JUND;CTNNB1;MAPK1;FOS;HIF1A;MAPK3
Fibroid Tumor	7/310	2.805841154588603E-8	6.519454447426459E-7	0	0	30.302530253025303	526.9300129167202	SMAD2;NCOR2;SMAD4;CTNNB1;MAPK1;PGR;FOS
Lymphoma	11/1307	3.212671727917981E-8	7.345247092354566E-7	0	0	14.415123456790123	248.71245462050177	SMAD2;XRCC6;CREBBP;MAPK8;JUND;CDK6;KAT5;MAPK1;FOS;HIF1A;MAPK3
Pneumonia	8/497	3.2356278330878344E-8	7.345247092354566E-7	0	0	22.77417470055507	392.7738419848456	CREBBP;MAPK8;JUND;MAPK1;FOS;HIF1A;PIAS1;MAPK3
Renal carcinoma	8/500	3.389923626175512E-8	7.608067229200722E-7	0	0	22.631823461091752	389.2644972548209	SMAD4;MAPK8;XRCC5;CTNNB1;MAPK1;HIF1A;UBA52;MAPK3
Liver neoplasms	11/1321	3.586861480777313E-8	7.959608342174374E-7	0	0	14.250381679389314	244.30003835868087	SMAD2;GSK3B;SMAD4;MAPK8;JUND;KAT5;CTNNB1;MAPK1;FOS;HIF1A;MAPK3
Squamous cell carcinoma of esophagus	10/1023	4.321046980593244E-8	9.482297540746285E-7	0	0	15.601349128002633	264.55493243573267	SMAD2;SMAD4;CREBBP;MAPK8;CDK6;XRCC5;CTNNB1;MAPK1;HIF1A;MAPK3
Hepatocarcinogenesis	8/527	5.0902137461345086E-8	1.1039254998906875E-6	0	0	21.424717864024224	359.79301971954743	SMAD2;CREBBP;MAPK8;JUND;CTNNB1;MAPK1;FOS;HIF1A
Osteosarcoma of bone	10/1042	5.1423365058199115E-8	1.1039254998906875E-6	0	0	15.298772609819121	256.7619503762481	SMAD2;GSK3B;SMAD4;MAPK8;CDK6;CTNNB1;MAPK1;FOS;HIF1A;MAPK3
Retinoblastoma	8/539	6.055806236079908E-8	1.2860448727158944E-6	0	0	20.927629808985742	347.81015949544854	SMAD2;SMAD4;MAPK8;CDK6;CTNNB1;MAPK1;FOS;HIF1A
Colonic Neoplasms	9/778	6.141746750362452E-8	1.2904201948899834E-6	0	0	17.293287986395917	287.1649310831646	GSK3B;SMAD4;HDAC2;MAPK8;HDAC3;CTNNB1;MAPK1;HIF1A;MAPK3
Central Serous Chorioretinopathy	5/98	6.28045273801065E-8	1.2992644500490045E-6	0	0	62.88741302972802	1042.8769798643375	SMAD2;GSK3B;HDAC2;MAPK1;MAPK3
Uterine Fibroids	7/349	6.31541201036478E-8	1.2992644500490045E-6	0	0	26.793762183235867	444.17862304503564	SMAD2;NCOR2;SMAD4;CTNNB1;MAPK1;PGR;FOS
Malignant neoplasm of gallbladder	6/203	6.61638570524418E-8	1.3471506977172427E-6	0	0	37.65418781725889	622.4663299213324	SMAD4;MAPK8;MAPK1;PGR;HIF1A;MAPK3
Systemic Scleroderma	8/562	8.354873828049925E-8	1.6837628377957759E-6	0	0	20.035069623517277	326.5282726293525	SMAD2;GSK3B;SMAD4;JUND;MAPK1;FOS;HIF1A;MAPK3
Osteosarcoma	10/1103	8.793607357522717E-8	1.7379104294753265E-6	0	0	14.398444647758463	233.92657314019038	SMAD2;GSK3B;SMAD4;MAPK8;CDK6;CTNNB1;MAPK1;FOS;HIF1A;MAPK3
Carcinoid Tumor	6/213	8.799546478356083E-8	1.7379104294753265E-6	0	0	35.81702898550725	581.8827566279251	SMAD4;JUND;CDK6;CTNNB1;FOS;MAPK3
Papillary thyroid carcinoma	8/571	9.44057120742101E-8	1.846052290560049E-6	0	0	19.705658462319207	318.75211523707065	SMAD4;KAT5;CTNNB1;MAPK1;PGR;FOS;HIF1A;MAPK3
Chronic Lymphocytic Leukemia	10/1120	1.0154143920478293E-7	1.966121004210258E-6	0	0	14.165165165165165	228.09880538488412	GSK3B;XRCC6;MAPK8;JUND;XRCC5;CTNNB1;MAPK1;FOS;HIF1A;MAPK3
Endometrial Carcinoma	9/840	1.1836250697727124E-7	2.2598810555833018E-6	0	0	15.951402388225493	254.41711297797676	SMAD2;SMAD4;CREBBP;CTNNB1;MAPK1;PGR;FOS;HIF1A;MAPK3
Mesothelioma	7/383	1.190013315345131E-7	2.2598810555833018E-6	0	0	24.32872340425532	387.9003567797748	XRCC6;HDAC2;CTNNB1;MAPK1;PGR;HIF1A;MAPK3
Medulloblastoma	8/590	1.2138649737555781E-7	2.2677853654361808E-6	0	0	19.043691703485518	303.25719677683577	GSK3B;CREBBP;MAPK8;CDK6;CTNNB1;MAPK1;HIF1A;MAPK3
Pulmonary Emphysema	6/225	1.2171404999303048E-7	2.2677853654361808E-6	0	0	33.83390410958904	538.6895965592896	XRCC6;HDAC2;JUND;FOS;HIF1A;MAPK3
CEROID LIPOFUSCINOSIS, NEURONAL, 6	3/10	1.379143686230442E-7	2.4794815921551454E-6	0	0	450.4736842105263	7115.967403292334	GSK3B;MAPK1;MAPK3
Perihilar Cholangiocarcinoma	3/10	1.379143686230442E-7	2.4794815921551454E-6	0	0	450.4736842105263	7115.967403292334	JUND;FOS;HIF1A
Diabetes Mellitus	11/1507	1.3898034515923216E-7	2.4794815921551454E-6	0	0	12.35427807486631	195.06087268577656	SMAD2;GSK3B;HDAC2;CREBBP;MAPK8;HDAC3;CTNNB1;MAPK1;FOS;HIF1A;MAPK3
Adenomatous Polyposis Coli	7/392	1.393531426477069E-7	2.4794815921551454E-6	0	0	23.74909090909091	374.90919397272734	GSK3B;SMAD4;HDAC2;CTNNB1;FOS;HIF1A;MAPK3
Carcinoma breast stage IV	7/392	1.393531426477069E-7	2.4794815921551454E-6	0	0	23.74909090909091	374.90919397272734	SMAD2;HDAC3;CDK6;KAT5;MAPK1;PGR;HIF1A
Liver and Intrahepatic Biliary Tract Carcinoma	8/607	1.5092045563901093E-7	2.6613205347057733E-6	0	0	18.487002146434534	290.36633811640706	HDAC2;MAPK8;HDAC3;XRCC5;CTNNB1;MAPK1;HIF1A;MAPK3
Virus Diseases	9/875	1.6761794811160788E-7	2.9296057302692524E-6	0	0	15.278735121691241	238.37238638498442	GSK3B;CREBBP;MAPK8;HDAC3;JUND;CTNNB1;MAPK1;FOS;MAPK3
Malignant tumor of cervix	9/884	1.828660937061626E-7	3.1680748690322025E-6	0	0	15.114461538461539	234.49349008036756	SMAD2;XRCC6;SMAD4;MAPK8;CTNNB1;MAPK1;PGR;HIF1A;MAPK3
Malignant neoplasm of kidney	7/421	2.2611466573164275E-7	3.8832736071303866E-6	0	0	22.052818035426732	337.45715249667177	SMAD4;MAPK8;CTNNB1;MAPK1;HIF1A;UBA52;MAPK3
Radiation Injuries, Experimental	3/12	2.524850480879744E-7	4.298775603221978E-6	0	0	350.3333333333333	5322.233803185608	MAPK1;HIF1A;MAPK3
Pulmonary Fibrosis	7/432	2.6922578679766966E-7	4.5446233241486975E-6	0	0	21.469960784313727	324.7914575382163	SMAD2;SMAD4;CREBBP;KAT5;FOS;HIF1A;MAPK3
Pancreatic Neoplasm	8/665	3.03055578314543E-7	5.072328535349343E-6	0	0	16.80452272233094	252.22495676151965	SMAD2;GSK3B;SMAD4;MAPK8;CTNNB1;MAPK1;HIF1A;MAPK3
Chronic Obstructive Airway Disease	8/669	3.172195793941752E-7	5.264778733642824E-6	0	0	16.699373244002594	249.88393753957862	SMAD2;SMAD4;HDAC2;CREBBP;HDAC3;XRCC5;MAPK1;HIF1A
Secondary malignant neoplasm of lymph node	10/1271	3.314288095410627E-7	5.4509887312101555E-6	0	0	12.369151467089612	184.54591918573632	SMAD4;MAPK8;HDAC3;XRCC5;CTNNB1;MAPK1;PGR;FOS;HIF1A;MAPK3
Precancerous Conditions	7/446	3.339593096083184E-7	5.4509887312101555E-6	0	0	20.77038724373576	309.7331381951001	SMAD4;MAPK8;JUND;CTNNB1;FOS;HIF1A;MAPK3
Cytomegalovirus Infections	6/270	3.563110961107496E-7	5.7681509411371345E-6	0	0	28.00284090909091	415.77110571066044	JUND;CTNNB1;MAPK1;PGR;FOS;MAPK3
cervical cancer	9/965	3.845461778856577E-7	6.174623588001415E-6	0	0	13.775185065980045	203.47604060022937	SMAD2;XRCC6;SMAD4;MAPK8;CTNNB1;MAPK1;PGR;HIF1A;MAPK3
Glucocorticoid Receptor Deficiency	4/56	3.882626530146595E-7	6.184022094386714E-6	0	0	85.15384615384616	1257.0056346647941	HDAC2;MAPK8;JUND;FOS
Cerebral Ischemia	6/275	3.968137172724535E-7	6.2696567329047655E-6	0	0	27.475371747211895	404.9814540476719	JUND;KAT5;MAPK1;FOS;HIF1A;MAPK3
Asthma	10/1313	4.4830265425940665E-7	7.026966207637524E-6	0	0	11.94359171143515	174.5890022546625	SMAD2;HDAC2;CREBBP;MAPK8;JUND;KAT5;MAPK1;FOS;HIF1A;MAPK3
Septicemia	7/468	4.620324076391034E-7	7.185149646356136E-6	0	0	19.756905278380334	288.20643998951346	CREBBP;JUND;KAT5;MAPK1;FOS;HIF1A;MAPK3
Hyperactive behavior	8/709	4.932445997114387E-7	7.61061003461009E-6	0	0	15.713878133278989	228.2010339242777	SMAD2;SMAD4;CREBBP;CDK6;MAPK1;FOS;HIF1A;MAPK3
Noninfiltrating Intraductal Carcinoma	6/287	5.096620775279826E-7	7.802965915641593E-6	0	0	26.28603202846975	380.87193222530647	NCOR2;SMAD4;CREBBP;CTNNB1;PGR;HIF1A
Primary Effusion Lymphoma	5/153	5.816998642112977E-7	8.837363321671638E-6	0	0	39.40779014308426	565.7899075555854	GSK3B;CDK6;XRCC5;CTNNB1;HIF1A
B-Cell Lymphomas	8/730	6.153786294265914E-7	9.27765490929403E-6	0	0	15.240205777601899	217.95061109012744	NCOR2;CREBBP;MAPK8;HDAC3;CDK6;MAPK1;PGR;MAPK3
Fibrosarcoma	6/298	6.350866164458305E-7	9.502242935458449E-6	0	0	25.28167808219178	360.75701773307776	SMAD2;MAPK8;JUND;MAPK1;FOS;HIF1A
Cocaine Dependence	5/157	6.610631699366942E-7	9.81653955357121E-6	0	0	38.36300309597523	545.8831467281321	NCOR2;JUND;MAPK1;FOS;MAPK3
Cutaneous Melanoma	6/301	6.733697877632384E-7	9.924666648002955E-6	0	0	25.020762711864407	355.5693382113243	CREBBP;CDK6;CTNNB1;MAPK1;HIF1A;MAPK3
Intestinal Neoplasms	5/158	6.821815114372231E-7	9.980062852507523E-6	0	0	38.11034217608612	541.0894975244082	HDAC2;CTNNB1;MAPK1;HIF1A;MAPK3
Cardiomegaly	5/159	7.038298262358565E-7	1.0221058138351591E-5	0	0	37.86096256684492	536.3660052270824	GSK3B;HDAC2;MAPK1;HIF1A;MAPK3
Malignant neoplasm of skin	6/307	7.55631754599376E-7	1.0893231498786626E-5	0	0	24.51453488372093	345.54981560511754	SMAD2;SMAD4;JUND;MAPK1;FOS;HIF1A
invasive cancer	5/166	8.710337910606499E-7	1.2465882154672344E-5	0	0	36.20204603580563	505.1483288927141	SMAD4;KAT5;CTNNB1;PGR;HIF1A
Aneurysmal disease	3/18	9.325101688170238E-7	1.3249694844702317E-5	0	0	210.13684210526316	2917.831119346567	SMAD2;JUND;FOS
Stromal Neoplasm	4/70	9.595295562668952E-7	1.3536220525907985E-5	0	0	67.04377104377105	929.0136497098683	SMAD2;CTNNB1;PGR;HIF1A
Malignant Neoplasms	10/1438	1.03857053303945E-6	1.4547353211013572E-5	0	0	10.82516339869281	149.1454778841121	SMAD4;CREBBP;MAPK8;HDAC3;CDK6;CTNNB1;MAPK1;FOS;HIF1A;MAPK3
Sepsis	7/529	1.051294848231693E-6	1.4621882572236576E-5	0	0	17.393614303959133	239.43158836474862	CREBBP;JUND;KAT5;MAPK1;FOS;HIF1A;MAPK3
Lymphoma, Non-Hodgkin	7/539	1.1914509977341687E-6	1.64553546889859E-5	0	0	17.057894736842105	232.67546117000157	NCOR2;CREBBP;MAPK8;CDK6;MAPK1;HIF1A;MAPK3
Endometrial Hyperplasia	4/75	1.267394639232359E-6	1.7382669531138258E-5	0	0	62.30672926447574	846.034866052178	NCOR2;CREBBP;CDK6;PGR
Malignant neoplasm of liver	8/805	1.2871539862548153E-6	1.75319249851949E-5	0	0	13.75228535579853	186.52330505632554	HDAC2;MAPK8;HDAC3;XRCC5;CTNNB1;MAPK1;HIF1A;MAPK3
Peyronie Disease	3/20	1.3009213387008683E-6	1.7598079752974075E-5	0	0	185.39628482972137	2512.5716226669324	SMAD2;HDAC2;HIF1A
Recurrent tumor	6/347	1.5413571377432013E-6	2.0708709843828725E-5	0	0	21.594941348973606	289.0018019069456	NCOR2;XRCC6;MAPK8;HDAC3;XRCC5;MAPK3
Hyperalgesia, Secondary	4/84	1.998959801360051E-6	2.649627924621544E-5	0	0	55.272222222222226	725.3309392000863	MAPK8;MAPK1;FOS;MAPK3
Allodynia	4/84	1.998959801360051E-6	2.649627924621544E-5	0	0	55.272222222222226	725.3309392000863	MAPK8;MAPK1;FOS;MAPK3
Hyperalgesia, Primary	4/85	2.0961630959571405E-6	2.7599480763435682E-5	0	0	54.58710562414266	713.7483490464186	MAPK8;MAPK1;FOS;MAPK3
Cystic Fibrosis	7/594	2.2753981886784167E-6	2.9703025161980725E-5	0	0	15.415900056785917	200.30426968062798	CREBBP;MAPK8;JUND;MAPK1;FOS;HIF1A;PIAS1
Renal fibrosis	5/202	2.2901938869546804E-6	2.9703025161980725E-5	0	0	29.53269632726187	383.5374083620332	SMAD2;SMAD4;MAPK8;MAPK1;HIF1A
Hemangiosarcoma	4/87	2.3010444809028106E-6	2.9703025161980725E-5	0	0	53.26639892904953	691.5122432153075	SMAD2;CTNNB1;MAPK1;HIF1A
Melanocytic nevus	5/203	2.346356871969575E-6	3.0091265078830587E-5	0	0	29.382055852644086	380.86920933640084	CREBBP;CDK6;MAPK1;FOS;HIF1A
Tactile Allodynia	4/89	2.520424172956849E-6	3.2115082203805015E-5	0	0	52.0078431372549	670.437440632254	MAPK8;MAPK1;FOS;MAPK3
Adenoid Cystic Carcinoma	5/208	2.6436696687898784E-6	3.34695358708975E-5	0	0	28.651115618661258	367.9760931879697	CREBBP;CTNNB1;MAPK1;HIF1A;MAPK3
Gastric Adenocarcinoma	6/383	2.7293836632049606E-6	3.4334603406559216E-5	0	0	19.497015915119363	249.78474699496843	SMAD2;SMAD4;CREBBP;CTNNB1;PGR;HIF1A
Aortic Valve Insufficiency	5/214	3.0387758858129057E-6	3.785794772606217E-5	0	0	27.82015198423867	353.42876297137684	JUND;PGR;FOS;HIF1A;MAPK3
Neoplasms	9/1236	3.0478043992120943E-6	3.785794772606217E-5	0	0	10.57983825465488	134.37546829031794	SMAD4;CREBBP;MAPK8;KAT5;CTNNB1;MAPK1;PGR;HIF1A;MAPK3
Traditional Serrated Adenoma	4/94	3.1365956918574518E-6	3.871735307136542E-5	0	0	49.10617283950617	622.2917152907637	HDAC2;CREBBP;MAPK8;JUND
Lung diseases	6/393	3.167027410278996E-6	3.885018096460259E-5	0	0	18.983527131782946	240.3830343034527	XRCC6;HDAC3;JUND;FOS;HIF1A;MAPK3
synovial sarcoma	5/217	3.253011631785577E-6	3.944711778548249E-5	0	0	27.422308546059934	346.50635298424976	GSK3B;MAPK8;CTNNB1;MAPK1;MAPK3
Huntington Disease	7/627	3.2556355438145044E-6	3.944711778548249E-5	0	0	14.570537634408602	184.10053591259546	GSK3B;XRCC6;HDAC2;CREBBP;MAPK8;HDAC3;MAPK1
Triple Negative Breast Neoplasms	7/632	3.4311717227761316E-6	4.132051312489549E-5	0	0	14.45024	181.82171619110417	SMAD2;MAPK8;HDAC3;MAPK1;PGR;HIF1A;MAPK3
Adult Hepatocellular Carcinoma	4/97	3.5561004954459454E-6	4.256544532427722E-5	0	0	47.51493428912784	596.1625622707741	SMAD2;SMAD4;CTNNB1;HIF1A
Esophageal Neoplasms	7/637	3.614571095006676E-6	4.300468622071196E-5	0	0	14.331851851851852	179.58580500040506	GSK3B;XRCC6;SMAD4;CTNNB1;MAPK1;HIF1A;MAPK3
Scrub Typhus	3/29	4.143191672683946E-6	4.870716400923091E-5	0	0	121.16599190283401	1501.7366509066526	JUND;MAPK1;FOS
Paget Disease Extramammary	3/29	4.143191672683946E-6	4.870716400923091E-5	0	0	121.16599190283401	1501.7366509066526	CTNNB1;MAPK1;MAPK3
Ductal Carcinoma	5/230	4.322682077294825E-6	5.051655090329752E-5	0	0	25.82091503267974	318.9305048651352	SMAD4;CREBBP;MAPK8;PGR;HIF1A
Metastatic melanoma	6/417	4.454944773734222E-6	5.1709963675819965E-5	0	0	17.853102189781023	219.9769253191675	JUND;CDK6;KAT5;MAPK1;FOS;HIF1A
Sarcoma	7/658	4.477166475222893E-6	5.1709963675819965E-5	0	0	13.854480286738351	170.6389862407425	SMAD2;SMAD4;CTNNB1;MAPK1;FOS;HIF1A;MAPK3
Bone necrosis	3/30	4.600272051318671E-6	5.282289128694404E-5	0	0	116.67251461988305	1433.8346311808384	CREBBP;CTNNB1;HIF1A
Carcinoid tumor no ICD-O subtype	4/104	4.695487347735517E-6	5.311183645611897E-5	0	0	44.17333333333333	541.9585913998206	SMAD4;JUND;FOS;MAPK3
Tumor Initiation	5/234	4.702008441900869E-6	5.311183645611897E-5	0	0	25.364757256614435	311.16268754858646	SMAD4;MAPK1;PGR;HIF1A;MAPK3
Metabolic Diseases	6/421	4.706112091048516E-6	5.311183645611897E-5	0	0	17.677409638554217	216.84256952847497	NCOR2;GSK3B;MAPK8;KAT5;CTNNB1;HIF1A
Cognition Disorders	5/237	5.003293520401909E-6	5.6005698509390374E-5	0	0	25.03296146044625	305.53766223351147	GSK3B;SMAD4;CREBBP;HDAC3;MAPK1
Myocardial Infarction	8/966	5.019244879069415E-6	5.6005698509390374E-5	0	0	11.345064121682075	138.43509378140018	SMAD2;NCOR2;GSK3B;SMAD4;MAPK8;MAPK1;HIF1A;MAPK3
Endometrial Neoplasms	5/238	5.107021960251803E-6	5.666499085110849E-5	0	0	24.92426155011361	303.6994877650149	CDK6;CTNNB1;PGR;FOS;HIF1A
Mechanical Allodynia	4/108	5.456813501652542E-6	6.0207858467954026E-5	0	0	42.465811965811966	514.6281230507192	MAPK8;MAPK1;FOS;MAPK3
Hyperalgesia, Thermal	4/109	5.660610305750462E-6	6.210947418809534E-5	0	0	42.05925925925926	508.1590805516886	MAPK8;MAPK1;FOS;MAPK3
Esophageal carcinoma	7/685	5.833544127593662E-6	6.365331299446124E-5	0	0	13.28416912487709	160.0992896420453	GSK3B;XRCC6;SMAD4;CREBBP;CTNNB1;MAPK1;HIF1A
Kidney Neoplasm	5/246	5.9990814105953625E-6	6.509992190069144E-5	0	0	24.08713692946058	289.62142686058746	CTNNB1;MAPK1;PGR;HIF1A;MAPK3
Renal Cell Carcinoma	9/1348	6.224696338765041E-6	6.717909983093418E-5	0	0	9.636985120928362	115.51840474115016	SMAD2;GSK3B;XRCC6;SMAD4;XRCC5;CTNNB1;MAPK1;HIF1A;MAPK3
Cocaine-Related Disorders	4/113	6.5325572748584185E-6	7.011848161872486E-5	0	0	40.50764525993884	483.60911346955226	JUND;MAPK1;FOS;MAPK3
Female infertility	3/34	6.761030305692242E-6	7.179050996635581E-5	0	0	101.59762308998302	1209.4521676379877	MAPK1;PGR;MAPK3
Parkinson Disease, Familial, Type 1	3/34	6.761030305692242E-6	7.179050996635581E-5	0	0	101.59762308998302	1209.4521676379877	GSK3B;MAPK8;MAPK1
Neuroendocrine Tumors	5/257	7.420553005897505E-6	7.837215073073567E-5	0	0	23.022875816993466	271.9291025657158	SMAD4;CTNNB1;MAPK1;PGR;HIF1A
Hyperalgesia	4/119	8.021680393248588E-6	8.427031264184022E-5	0	0	38.38260869565217	450.3570666147468	MAPK8;MAPK1;FOS;MAPK3
Memory impairment	5/267	8.930433050062168E-6	9.332066282472372E-5	0	0	22.132914234396047	257.31827170821674	CREBBP;MAPK8;KAT5;MAPK1;MAPK3
Rheumatoid Arthritis	10/1833	9.400452385169654E-6	9.713255037052561E-5	0	0	8.299049186322911	96.05944234002732	MAPK8;HDAC3;JUND;CDK6;KAT5;MAPK1;PGR;FOS;HIF1A;MAPK3
Uterine Cervical Neoplasm	4/124	9.442759327159957E-6	9.713255037052561E-5	0	0	36.77407407407407	425.4856835721647	SMAD2;SMAD4;CTNNB1;HIF1A
Polycystic Kidney Diseases	4/124	9.442759327159957E-6	9.713255037052561E-5	0	0	36.77407407407407	425.4856835721647	GSK3B;JUND;MAPK1;FOS
Thin upper lip vermilion	4/125	9.74788564748789E-6	9.975167955330873E-5	0	0	36.46831955922865	420.7882520861079	SMAD4;CDK6;CTNNB1;MAPK1
Rectal Carcinoma	5/276	1.0486054942304926E-5	1.067523634590321E-4	0	0	21.388105057521162	245.2245546446048	SMAD2;SMAD4;CTNNB1;HIF1A;MAPK3
Hereditary Nonpolyposis Colorectal Cancer	4/128	1.07070194488557E-5	1.0788960924229596E-4	0	0	35.58064516129032	407.2066432963179	SMAD2;SMAD4;HDAC2;CTNNB1
Cocaine Abuse	4/128	1.07070194488557E-5	1.0788960924229596E-4	0	0	35.58064516129032	407.2066432963179	JUND;MAPK1;FOS;MAPK3
Endometrial adenocarcinoma	4/129	1.1041679356833353E-5	1.106970392372887E-4	0	0	35.294222222222224	402.84237288685455	MAPK1;PGR;HIF1A;MAPK3
Infection	6/492	1.147045941799171E-5	1.144149361138062E-4	0	0	15.040123456790123	171.09246744094156	HDAC3;CTNNB1;MAPK1;FOS;HIF1A;MAPK3
Experimental Organism Basal Cell Carcinoma	5/282	1.1635717209307804E-5	1.1548010798182368E-4	0	0	20.918454024208962	237.66357454781468	CREBBP;MAPK1;FOS;HIF1A;MAPK3
Arteriosclerosis	8/1087	1.1969806014058087E-5	1.1820183438882361E-4	0	0	10.008738249702105	113.43026410617445	SMAD2;GSK3B;HDAC3;KAT5;MAPK1;FOS;HIF1A;MAPK3
polyps	5/285	1.2246356493024312E-5	1.2033111479464187E-4	0	0	20.691176470588236	234.02304274643836	SMAD2;SMAD4;HDAC2;CTNNB1;MAPK3
Adult T-Cell Lymphoma/Leukemia	6/500	1.2572051728577316E-5	1.2291981269277327E-4	0	0	14.790485829959515	166.89634978057296	CREBBP;JUND;CDK6;KAT5;MAPK1;FOS
Anoxia	5/288	1.288179914002145E-5	1.2486108694655294E-4	0	0	20.468717522344626	230.47151966398582	HDAC2;MAPK1;FOS;HIF1A;MAPK3
Clear Cell Sarcoma of Soft Tissue	3/42	1.2897043917517367E-5	1.2486108694655294E-4	0	0	80.7246963562753	908.8399970555669	CREBBP;FOS;HIF1A
Nasopharyngeal carcinoma	7/782	1.3863159303193701E-5	1.335597054819881E-4	0	0	11.563096774193548	129.3479878400975	GSK3B;HDAC2;CREBBP;MAPK8;MAPK1;HIF1A;MAPK3
Ureteral obstruction	4/138	1.4411689024065703E-5	1.3750878192794833E-4	0	0	32.908789386401324	366.8497734502965	SMAD2;MAPK8;HIF1A;MAPK3
Schizophrenia	10/1923	1.4412312840043191E-5	1.3750878192794833E-4	0	0	7.869402334901551	87.72359324316	GSK3B;HDAC2;CREBBP;MAPK8;HDAC3;KAT5;CTNNB1;MAPK1;HIF1A;MAPK3
Major Depressive Disorder	6/513	1.454431541444333E-5	1.3810107184387296E-4	0	0	14.40162721893491	160.40979327695615	GSK3B;JUND;MAPK1;FOS;HIF1A;MAPK3
Idiopathic pulmonary arterial hypertension	5/297	1.4944137991952262E-5	1.4121852887131925E-4	0	0	19.828767123287673	220.32122757725645	SMAD2;SMAD4;MAPK1;HIF1A;MAPK3
Hereditary Diffuse Gastric Cancer	5/300	1.5686044016383605E-5	1.4752350920170296E-4	0	0	19.624127617148556	217.0966050138463	SMAD4;MAPK8;CTNNB1;MAPK1;MAPK3
Enteritis	3/45	1.5907544914060914E-5	1.488976360439351E-4	0	0	74.94736842105263	828.0722664562938	JUND;MAPK1;FOS
Lymphatic Metastasis	4/142	1.6130209096747068E-5	1.502696366324314E-4	0	0	31.948470209339774	352.5455126914373	SMAD4;PGR;HIF1A;MAPK3
Lichen disease	2/6	1.7278715595310902E-5	1.6021344272647433E-4	0	0	499.35	5475.88964033087	SMAD2;SMAD4
Fibrosis, Liver	6/545	2.0485179639088264E-5	1.8905714853831459E-4	0	0	13.52435064935065	146.0063048054548	SMAD2;SMAD4;HDAC2;JUND;CTNNB1;MAPK1
Bipolar Disorder	7/837	2.153529532994385E-5	1.9782422454250745E-4	0	0	10.765943775100402	115.68886514491814	NCOR2;GSK3B;CREBBP;KAT5;MAPK1;HIF1A;MAPK3
Solid Neoplasm	7/840	2.2038752851380207E-5	2.0151174482164775E-4	0	0	10.72549019607843	115.0063012559062	SMAD2;SMAD4;HDAC2;MAPK8;XRCC5;MAPK1;HIF1A
Kaposi Sarcoma	5/323	2.2378700387437966E-5	2.03677111821152E-4	0	0	18.183499815020348	194.69802277605396	MAPK8;CDK6;CTNNB1;MAPK1;HIF1A
Hypertrophic Cardiomyopathy	5/328	2.4090664241735154E-5	2.1701802199227261E-4	0	0	17.897468584957203	190.3160641408515	HDAC2;MAPK1;FOS;HIF1A;MAPK3
Diabetic Nephropathy	6/561	2.411782905296255E-5	2.1701802199227261E-4	0	0	13.123648648648649	139.53797112757144	GSK3B;MAPK8;CTNNB1;MAPK1;HIF1A;MAPK3
Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive	2/7	2.417415941179746E-5	2.1701802199227261E-4	0	0	399.46	4246.350193084194	MAPK8;MAPK1
granulosa cell tumor	3/53	2.6112306795911263E-5	2.3335658788201243E-4	0	0	62.93052631578947	664.1123782883907	CTNNB1;PGR;MAPK3
Non-alcoholic Fatty Liver Disease	5/334	2.6277994557514543E-5	2.3377945608599648E-4	0	0	17.565707133917396	185.26162546147222	GSK3B;JUND;FOS;HIF1A;MAPK3
Polycystic Kidney, Autosomal Dominant	4/161	2.6426386137727987E-5	2.3404534808077476E-4	0	0	28.0552016985138	295.7340212673969	SMAD2;JUND;MAPK1;FOS
Malignant mesothelioma	5/335	2.6657112848875426E-5	2.3503481194879004E-4	0	0	17.511586452762923	184.4399883126387	SMAD2;CDK6;CTNNB1;MAPK1;MAPK3
Rotavirus Infections	3/54	2.76286456378592E-5	2.410763299474998E-4	0	0	61.693498452012385	647.57551940516	MAPK8;MAPK1;MAPK3
Drug Withdrawal Symptoms	3/54	2.76286456378592E-5	2.410763299474998E-4	0	0	61.693498452012385	647.57551940516	MAPK1;FOS;MAPK3
Mental Depression	6/575	2.770851994839618E-5	2.410763299474998E-4	0	0	12.791520210896309	134.23127888085327	GSK3B;HDAC2;MAPK8;MAPK1;HIF1A;MAPK3
HER2 gene amplification	3/56	3.0832776538449746E-5	2.6708216519051863E-4	0	0	59.35948361469712	616.5629353234951	CTNNB1;MAPK1;PGR
Shprintzen-Goldberg syndrome	2/8	3.2210818955169004E-5	2.7780073116357546E-4	0	0	332.8666666666667	3442.9092260043108	SMAD2;SMAD4
Peutz-Jeghers Syndrome	3/57	3.252254285840293E-5	2.7926966150150343E-4	0	0	58.25730994152047	602.006402909338	SMAD2;SMAD4;CTNNB1
Ewings sarcoma	5/352	3.3780292292519756E-5	2.8881418734946545E-4	0	0	16.639260891676557	171.31172342869723	CREBBP;MAPK8;CDK6;MAPK1;HIF1A
Substance Withdrawal Syndrome	3/58	3.42720876283805E-5	2.917559183881529E-4	0	0	57.19521531100479	588.0342641064299	MAPK1;FOS;MAPK3
Adenocarcinoma of pancreas	5/354	3.4706953812942984E-5	2.941898445517699E-4	0	0	16.542221473116467	169.86496730786132	SMAD4;HDAC2;CTNNB1;MAPK1;HIF1A
Diabetes	8/1268	3.661800533987737E-5	3.090622245566573E-4	0	0	8.488888888888889	86.71374948734821	SMAD2;GSK3B;HDAC2;CREBBP;MAPK8;HDAC3;CTNNB1;HIF1A
Multiple malignancy	4/176	3.745275364886765E-5	3.1476250407027066E-4	0	0	25.589147286821706	260.815600721079	SMAD4;MAPK8;HIF1A;PIAS1
MYELOPROLIFERATIVE SYNDROME, TRANSIENT	3/61	3.9889174519359884E-5	3.338183037107448E-4	0	0	54.22867513611615	549.304244855207	CREBBP;CTNNB1;MAPK3
insulinoma	4/181	4.178254837990243E-5	3.475966817911161E-4	0	0	24.86001255492781	250.66429735068107	GSK3B;SMAD4;MAPK8;CTNNB1
Pemphigus Vulgaris	3/62	4.1887600134828165E-5	3.475966817911161E-4	0	0	53.30686886708296	537.3609958311199	HDAC2;MAPK8;MAPK1
Neoplasm Invasiveness	4/183	4.361316372150724E-5	3.6040166673630467E-4	0	0	24.579764121663562	246.7845564259148	CTNNB1;MAPK1;HIF1A;MAPK3
Hashimoto Disease	4/186	4.646836845517247E-5	3.823959487456901E-4	0	0	24.17094017094017	241.14715482599343	MAPK1;PGR;HIF1A;MAPK3
Malignant Peripheral Nerve Sheath Tumor	4/188	4.844635990332033E-5	3.970189245189114E-4	0	0	23.905797101449274	237.50536965951488	MAPK8;MAPK1;HIF1A;MAPK3
Medullary Neoplasms	2/10	5.1698634856081705E-5	4.219206770279395E-4	0	0	249.625	2463.8185157826147	SMAD4;CDK6
Cervical Adenocarcinoma	3/67	5.286868851405455E-5	4.296940733138179E-4	0	0	49.129934210526315	483.81681843371445	CTNNB1;PGR;HIF1A
Mucoepidermoid Carcinoma	3/69	5.7740525992608545E-5	4.673669624401716E-4	0	0	47.63636363636363	464.90953342059345	CTNNB1;MAPK1;MAPK3
Ataxia Telangiectasia	5/396	5.9177602869406665E-5	4.7704394149827823E-4	0	0	14.733714457650068	143.43223018497105	NCOR2;XRCC5;MAPK1;HIF1A;MAPK3
Rhabdomyosarcoma	5/397	5.988960047854268E-5	4.791072859490842E-4	0	0	14.695378151260504	142.88327466387554	SMAD4;MAPK8;MAPK1;HIF1A;MAPK3
Amyotrophic Lateral Sclerosis	6/660	5.991873398958166E-5	4.791072859490842E-4	0	0	11.080275229357799	107.72821245164857	HDAC2;CREBBP;MAPK8;MAPK1;HIF1A;MAPK3
Anemia, Diamond-Blackfan	3/70	6.0282980376351684E-5	4.80076154206833E-4	0	0	46.923016496465046	455.9256477413351	SMAD4;MAPK8;MAPK1
Vascular Diseases	5/401	6.280425320630068E-5	4.981461850700556E-4	0	0	14.543969102792632	140.71999504415592	SMAD2;SMAD4;JUND;FOS;HIF1A
Hypothalamic hamartomas	2/11	6.314522336867865E-5	4.988472646125613E-4	0	0	221.87777777777777	2145.5743861743645	MAPK8;MAPK3
Impaired cognition	6/671	6.568356591820867E-5	5.168328393962635E-4	0	0	10.89078947368421	104.88551017777668	GSK3B;CREBBP;MAPK8;HDAC3;MAPK1;HIF1A
Small cell carcinoma of lung	6/673	6.677802819145169E-5	5.212909315340596E-4	0	0	10.857008995502248	104.38076593050768	CREBBP;MAPK8;XRCC5;MAPK1;HIF1A;MAPK3
Malignant neoplasm of esophagus	6/673	6.677802819145169E-5	5.212909315340596E-4	0	0	10.857008995502248	104.38076593050768	SMAD2;GSK3B;XRCC6;SMAD4;CTNNB1;MAPK1
Withdrawal Symptoms	3/73	6.83478096678561E-5	5.293604866431992E-4	0	0	44.90526315789474	430.68193517339813	MAPK1;FOS;MAPK3
Dysplastic Nevus	3/73	6.83478096678561E-5	5.293604866431992E-4	0	0	44.90526315789474	430.68193517339813	CDK6;KAT5;MAPK1
Addictive Behavior	4/208	7.177327960740459E-5	5.515650864771365E-4	0	0	21.540305010893245	205.5375538275179	CREBBP;JUND;FOS;MAPK3
Constipation	4/208	7.177327960740459E-5	5.515650864771365E-4	0	0	21.540305010893245	205.5375538275179	SMAD4;CREBBP;PGR;FOS
Secondary malignant neoplasm of lung	6/683	7.24723566689383E-5	5.526366966067689E-4	0	0	10.691100443131463	101.91083401706206	SMAD2;MAPK8;CTNNB1;MAPK1;HIF1A;MAPK3
Liver Cirrhosis	6/683	7.24723566689383E-5	5.526366966067689E-4	0	0	10.691100443131463	101.91083401706206	GSK3B;HDAC2;JUND;XRCC5;CTNNB1;HIF1A
Lymphoma, Lymphocytic, Intermediate	2/12	7.572389207798609E-5	5.752103340539328E-4	0	0	199.68	1894.6470730177257	GSK3B;CTNNB1
Varicosity	3/76	7.708851726284747E-5	5.833326497859147E-4	0	0	43.05335255948089	407.7391959396414	JUND;FOS;HIF1A
Blast Phase	4/214	8.013804366875406E-5	6.040940314724782E-4	0	0	20.918518518518518	197.29844338723638	GSK3B;CREBBP;MAPK8;CDK6
Adenocarcinoma of prostate	4/216	8.307791846540345E-5	6.231989176544167E-4	0	0	20.71907756813417	194.67089211675597	SMAD4;HDAC2;CTNNB1;HIF1A
Cardiac Hypertrophy	3/78	8.330355152443848E-5	6.231989176544167E-4	0	0	41.90105263157895	393.5773991742032	GSK3B;HDAC2;HIF1A
Invasive Ductal Breast Carcinoma	4/218	8.60956915167529E-5	6.416565688512716E-4	0	0	20.523364485981308	192.0997421436609	SMAD4;MAPK8;PGR;HIF1A
Spinocerebellar Ataxia Type 1	3/79	8.653020976556561E-5	6.42470542432301E-4	0	0	41.34764542936288	386.8079242127714	CREBBP;HDAC3;KAT5
Parkinson Disease	7/1064	9.958300668048739E-5	7.366158733856276E-4	0	0	8.35364238410596	76.97479666459526	GSK3B;HDAC2;MAPK8;CDK6;MAPK1;HIF1A;MAPK3
Childhood Acute Lymphoblastic Leukemia	5/443	1.0052553930044476E-4	7.408132093969344E-4	0	0	13.121138866505506	120.78137885210971	HDAC2;CREBBP;CDK6;XRCC5;HIF1A
Endometrioma	4/229	1.0414265338284374E-4	7.646161354316595E-4	0	0	19.509135802469135	178.8938771802758	HDAC2;CTNNB1;PGR;FOS
Anemia, Sickle Cell	4/231	1.0769784851891115E-4	7.87789817869813E-4	0	0	19.33529123837494	176.65071948660037	MAPK8;JUND;FOS;HIF1A
Promyelocytic leukemia	4/233	1.1134057489222706E-4	8.114303889747175E-4	0	0	19.16448326055313	174.4526968625005	NCOR2;MAPK8;KAT5;MAPK1
Actinic keratosis	3/87	1.1532352298026509E-4	8.373674922280278E-4	0	0	37.39473684210526	339.08684058782666	SMAD4;MAPK1;MAPK3
Uveal melanoma	4/236	1.1697165597350876E-4	8.462235184896696E-4	0	0	18.913793103448278	171.23751833344528	CDK6;MAPK1;HIF1A;MAPK3
Undifferentiated carcinoma	4/237	1.188938732368467E-4	8.537493965917892E-4	0	0	18.831664282308058	170.18700950741876	UBE2I;CTNNB1;PGR;HIF1A
IGA Glomerulonephritis	4/237	1.188938732368467E-4	8.537493965917892E-4	0	0	18.831664282308058	170.18700950741876	SMAD2;SMAD4;MAPK1;MAPK3
Chordoma	3/88	1.1930877643510573E-4	8.537493965917892E-4	0	0	36.95294117647059	333.8253198264229	MAPK1;PGR;HIF1A
Medullary carcinoma of thyroid	4/239	1.2280708631551762E-4	8.756100919608206E-4	0	0	18.66950354609929	168.11693477538495	JUND;MAPK1;FOS;HIF1A
Meningioma, benign, no ICD-O subtype	4/241	1.2681311278951837E-4	8.957741980290319E-4	0	0	18.510079699953117	166.08717109312593	SMAD4;PGR;FOS;MAPK3
Chondrosarcoma	4/241	1.2681311278951837E-4	8.957741980290319E-4	0	0	18.510079699953117	166.08717109312593	MAPK8;MAPK1;HIF1A;MAPK3
Multiple Sclerosis	7/1106	1.2699583566993868E-4	8.957741980290319E-4	0	0	8.01656050955414	71.91942032744133	SMAD4;MAPK8;HDAC3;XRCC5;MAPK1;PGR;HIF1A
Embryonal Rhabdomyosarcoma	3/91	1.3180083507914405E-4	9.252703076847545E-4	0	0	35.6877990430622	318.84259800212004	SMAD4;MAPK8;MAPK1
Lupus Erythematosus, Systemic	7/1113	1.3211454519853203E-4	9.252703076847545E-4	0	0	7.962869198312236	71.12308353413815	XRCC6;CREBBP;JUND;CDK6;XRCC5;MAPK1;FOS
Premature aging syndrome	3/92	1.3614657811150416E-4	9.501395468912392E-4	0	0	35.28503843879361	314.09959557171976	NCOR2;HDAC2;CREBBP
Reoviridae Infections	2/16	1.3731388963879662E-4	9.515611650407836E-4	0	0	142.6	1268.176179092661	MAPK1;MAPK3
Osteoblastoma	2/16	1.3731388963879662E-4	9.515611650407836E-4	0	0	142.6	1268.176179092661	SMAD2;CTNNB1
Mucinous Adenocarcinoma	3/93	1.4058465454737417E-4	9.708206039547692E-4	0	0	34.89122807017544	309.47475098574995	MAPK1;PGR;HIF1A
AMYOTROPHIC LATERAL SCLEROSIS 1	3/94	1.451159432223752E-4	9.986201667741847E-4	0	0	34.506072874493924	304.96389659703544	CREBBP;JUND;FOS
Atherosclerosis	7/1134	1.48494999108759E-4	0.0010183250806937467	0	0	7.805797101449276	68.80778356852221	GSK3B;HDAC3;KAT5;MAPK1;FOS;HIF1A;MAPK3
Limb ischemia	3/95	1.4974132016917394E-4	0.0010233187104986801	0	0	34.12929061784897	300.56305460415405	CTNNB1;HIF1A;MAPK3
Cardiac fibrosis	3/96	1.5446165860092987E-4	0.0010518828175822348	0	0	33.76061120543294	296.26842648702603	SMAD2;HIF1A;MAPK3
Atypical Endometrial Hyperplasia	2/17	1.5551887733367725E-4	0.0010518828175822348	0	0	133.08666666666667	1167.0028347616174	CTNNB1;PGR
Multiple congenital anomalies	2/17	1.5551887733367725E-4	0.0010518828175822348	0	0	133.08666666666667	1167.0028347616174	GSK3B;CTNNB1
Hyperglycemia	5/488	1.5822630979900348E-4	0.0010665425319216105	0	0	11.871270247229326	103.89123411246723	MAPK8;JUND;MAPK1;FOS;HIF1A
Ductal Breast Carcinoma	3/97	1.5927782905655647E-4	0.0010699786135602008	0	0	33.399776035834265	292.07638310086037	SMAD4;PGR;HIF1A
Aortic Aneurysm, Thoracic	3/99	1.6920113392375336E-4	0.0011327872525403826	0	0	32.70065789473684	283.9863262145943	SMAD2;SMAD4;HIF1A
Hemangioma	3/101	1.7951814323168664E-4	0.0011969041553200725	0	0	32.03007518796993	276.2669024588286	MAPK1;FOS;HIF1A
Brain Ischemia	4/264	1.7999014386332229E-4	0.0011969041553200725	0	0	16.852991452991454	145.3167467612513	MAPK8;MAPK1;HIF1A;MAPK3
Herpes Simplex Infections	5/503	1.8223043756903143E-4	0.0012077352825464332	0	0	11.504842901015827	99.05944164262915	XRCC6;SMAD4;XRCC5;MAPK1;FOS
Malignant Glioma	5/504	1.8392459861106382E-4	0.0012132924579003935	0	0	11.481197689496641	98.74960537225948	MAPK8;XRCC5;MAPK1;FOS;HIF1A
Seizures	7/1174	1.8429758854183193E-4	0.0012132924579003935	0	0	7.52225078548986	64.68352442063872	SMAD4;CREBBP;CTNNB1;MAPK1;PGR;FOS;MAPK3
Genetic Diseases, Inborn	5/507	1.8907970224552105E-4	0.0012406392423086514	0	0	11.410827279118818	97.82892393147908	SMAD2;SMAD4;CREBBP;CTNNB1;MAPK1
Sunken eyes	3/103	1.9023572137031317E-4	0.0012435546421247473	0	0	31.386315789473684	268.894307735104	SMAD4;CREBBP;MAPK1
Secondary malignant neoplasm of liver	5/508	1.9082247277015101E-4	0.0012435546421247473	0	0	11.387557010875922	97.52494023727908	SMAD4;CTNNB1;MAPK1;HIF1A;MAPK3
Heart failure	6/815	1.914129676992016E-4	0.0012435546421247473	0	0	8.885506798516687	76.06951081315306	GSK3B;XRCC6;MAPK8;MAPK1;FOS;HIF1A
Psoriasis	6/818	1.9528109421193537E-4	0.001255194942371339	0	0	8.851293103448276	75.59951866584275	SMAD2;MAPK8;JUND;MAPK1;FOS;MAPK3
Skeletal muscle hypertrophy	2/19	1.9528200357975852E-4	0.001255194942371339	0	0	117.41764705882353	1002.8718580525142	SMAD4;FOS
Hypertrophy	2/19	1.9528200357975852E-4	0.001255194942371339	0	0	117.41764705882353	1002.8718580525142	MAPK1;MAPK3
Enophthalmos	3/104	1.957468568356316E-4	0.001255194942371339	0	0	31.07399687337155	265.3311729233719	SMAD4;CREBBP;MAPK1
Head and Neck Neoplasms	3/107	2.1289982214951257E-4	0.0013607674716675964	0	0	30.173076923076923	255.10397616987294	MAPK1;HIF1A;MAPK3
Congenital Heart Defects	4/277	2.1634219639501587E-4	0.0013770108363893167	0	0	16.03988603988604	135.35497087781638	SMAD2;CREBBP;HIF1A;MAPK3
Tonsillar Carcinoma	2/20	2.1683563043902658E-4	0.0013770108363893167	0	0	110.88888888888889	935.4998014387867	XRCC5;HIF1A
Polycystic Ovary Syndrome	5/526	2.2435343964057375E-4	0.0014201860361863243	0	0	10.983967483346506	92.2904570142592	GSK3B;HDAC3;PGR;FOS;MAPK3
Reperfusion Injury	3/110	2.3099980022731238E-4	0.0014575865988784088	0	0	29.322675848499753	245.5215127737022	MAPK8;FOS;HIF1A
Cerebral Infarction	4/283	2.347938009040821E-4	0.001476808142629179	0	0	15.690163281561132	131.11960157286944	JUND;KAT5;FOS;HIF1A
Lupus Vulgaris	4/284	2.3797601690032444E-4	0.0014920718519940976	0	0	15.633333333333333	130.434225630959	XRCC6;CREBBP;XRCC5;MAPK1
Pseudomyxoma Peritonei	2/21	2.3950096406846579E-4	0.0014968810254279111	0	0	105.04736842105264	875.7749854627358	MAPK1;HIF1A
Atrial Fibrillation	4/288	2.510170712180991E-4	0.0015639076203651286	0	0	15.41001564945227	127.74886959807176	SMAD2;MAPK1;HIF1A;MAPK3
Carcinoma, Endometrioid	3/114	2.56645163934489E-4	0.0015939440212912443	0	0	28.26031294452347	233.6510706977752	CTNNB1;PGR;HIF1A
Hypoplastic iliac wing	2/22	2.632757564864869E-4	0.0016299988058332653	0	0	99.79	822.4999723331945	CREBBP;SMAD4
Experimental Hepatoma	3/116	2.701307409534764E-4	0.001656857805537627	0	0	27.757335817419655	228.07105011927695	CTNNB1;MAPK1;MAPK3
Liver Neoplasms, Experimental	3/116	2.701307409534764E-4	0.001656857805537627	0	0	27.757335817419655	228.07105011927695	CTNNB1;MAPK1;MAPK3
Primary microcephaly	3/116	2.701307409534764E-4	0.001656857805537627	0	0	27.757335817419655	228.07105011927695	CREBBP;CDK6;CTNNB1
Pituitary Adenoma	4/294	2.715352182992484E-4	0.0016603159632848782	0	0	15.086590038314176	123.88230770332387	GSK3B;CTNNB1;HIF1A;MAPK3
Adenocarcinoma of large intestine	4/297	2.822354330128486E-4	0.0017204166055567159	0	0	14.929844520288206	122.01816997001305	SMAD2;SMAD4;CREBBP;CTNNB1
Cholesteatoma	2/23	2.881577630424514E-4	0.0017511125600272047	0	0	95.03333333333333	774.7119651640849	MAPK1;MAPK3
Hepatoma, Novikoff	3/119	2.9120613130839733E-4	0.0017642089243376832	0	0	27.035390199637025	220.1080666104974	CTNNB1;MAPK1;MAPK3
Congestive heart failure	6/884	2.973767804748053E-4	0.0017960830013386557	0	0	8.157744874715261	66.2450537439781	GSK3B;XRCC6;MAPK8;MAPK1;FOS;HIF1A
Hepatoma, Morris	3/121	3.0583053303929634E-4	0.0018415100693677142	0	0	26.57448706512043	215.05348975180772	CTNNB1;MAPK1;MAPK3
Lupus Erythematosus	4/304	3.0838063446338767E-4	0.0018512211339367496	0	0	14.576296296296297	117.83734048674445	XRCC6;CREBBP;XRCC5;MAPK1
Basophilic leukemia	2/24	3.14144742212557E-4	0.0018801086844539396	0	0	90.7090909090909	731.6283882755846	HDAC3;FOS
Infection caused by Helicobacter pylori	4/308	3.2408023601505524E-4	0.0019337113780354504	0	0	14.381578947368421	115.54907549833649	SMAD4;JUND;FOS;MAPK3
Small head	5/570	3.253258929177516E-4	0.0019352971039534922	0	0	10.105674128058302	81.1554667436466	SMAD4;CREBBP;CDK6;CTNNB1;MAPK1
Lupus Erythematosus, Discoid	4/309	3.2809330189360647E-4	0.0019458987124320504	0	0	14.333697632058287	114.98796878867005	XRCC6;CREBBP;XRCC5;MAPK1
Astrocytosis	2/25	3.41234455643778E-4	0.002005768005644231	0	0	86.76086956521739	692.6068823488023	MAPK1;MAPK3
Pulmonary Sclerosing Hemangioma	2/25	3.41234455643778E-4	0.002005768005644231	0	0	86.76086956521739	692.6068823488023	CTNNB1;MAPK1
Pyemia	2/25	3.41234455643778E-4	0.002005768005644231	0	0	86.76086956521739	692.6068823488023	MAPK1;MAPK3
Peritonitis	3/128	3.607340100973493E-4	0.0021140939760898067	0	0	25.077473684210528	198.79840466930034	GSK3B;FOS;HIF1A
Hypertensive disease	7/1310	3.6235733980351985E-4	0.0021173246926389105	0	0	6.688411358403684	52.99147862021026	GSK3B;XRCC6;SMAD4;MAPK8;JUND;FOS;HIF1A
Rett Syndrome	3/129	3.6906007143765646E-4	0.0021438048267334456	0	0	24.87719298245614	196.6430439491986	NCOR2;CREBBP;UBE2I
Malignant neoplasm of larynx	3/129	3.6906007143765646E-4	0.0021438048267334456	0	0	24.87719298245614	196.6430439491986	GSK3B;HIF1A;MAPK3
Tauopathies	3/130	3.775091666073563E-4	0.0021800602457588557	0	0	24.680066307501036	194.52620228300103	GSK3B;MAPK8;MAPK1
Aortic Valve Stenosis	3/130	3.775091666073563E-4	0.0021800602457588557	0	0	24.680066307501036	194.52620228300103	SMAD4;JUND;FOS
precancerous lesions	3/132	3.94779572280116E-4	0.0022731476829540207	0	0	24.29498164014688	190.40421694213597	XRCC6;SMAD4;CTNNB1
Heart Diseases	4/325	3.972771239678776E-4	0.002280878836734181	0	0	13.608168916580132	106.56388984399777	XRCC6;HDAC3;MAPK1;HIF1A
Achondroplasia	2/27	3.9871314788414447E-4	0.0022824883103512617	0	0	79.812	624.7099397333159	MAPK1;MAPK3
Impaired glucose tolerance	4/326	4.019216609055041E-4	0.0022875944676898287	0	0	13.565217391304348	106.06987168921468	MAPK8;PGR;HIF1A;MAPK3
Juvenile arthritis	4/326	4.019216609055041E-4	0.0022875944676898287	0	0	13.565217391304348	106.06987168921468	CDK6;MAPK1;FOS;HIF1A
Skin Carcinogenesis	3/134	4.12551429062236E-4	0.002341347909189414	0	0	23.921655283246285	186.42504029814702	SMAD2;SMAD4;CDK6
Low intelligence	6/947	4.3045055000449467E-4	0.0024241909462488923	0	0	7.586477151965994	58.800342371894345	SMAD4;CREBBP;CDK6;CTNNB1;MAPK1;FOS
Dull intelligence	6/947	4.3045055000449467E-4	0.0024241909462488923	0	0	7.586477151965994	58.800342371894345	SMAD4;CREBBP;CDK6;CTNNB1;MAPK1;FOS
Amyotrophic Lateral Sclerosis, Sporadic	3/136	4.3083089728271454E-4	0.0024241909462488923	0	0	23.559556786703602	182.58173290326513	CREBBP;JUND;FOS
Colitis	5/608	4.37621659688252E-4	0.002455405618989482	0	0	9.450297531948102	73.09007357746121	SMAD4;MAPK8;MAPK1;HIF1A;MAPK3
Female sterility	2/29	4.605759965452021E-4	0.002540887131778699	0	0	73.89259259259259	567.7192040967302	MAPK1;MAPK3
Head Neoplasms	2/29	4.605759965452021E-4	0.002540887131778699	0	0	73.89259259259259	567.7192040967302	MAPK1;MAPK3
Sterility, Postpartum	2/29	4.605759965452021E-4	0.002540887131778699	0	0	73.89259259259259	567.7192040967302	MAPK1;MAPK3
Subfertility, Female	2/29	4.605759965452021E-4	0.002540887131778699	0	0	73.89259259259259	567.7192040967302	MAPK1;MAPK3
Upper Aerodigestive Tract Neoplasms	2/29	4.605759965452021E-4	0.002540887131778699	0	0	73.89259259259259	567.7192040967302	MAPK1;MAPK3
LEOPARD Syndrome	2/29	4.605759965452021E-4	0.002540887131778699	0	0	73.89259259259259	567.7192040967302	MAPK1;MAPK3
Cancer of Head	2/30	4.931459174352375E-4	0.0026979589665778233	0	0	71.25	542.5477632515199	MAPK1;MAPK3
Cancer of Neck	2/30	4.931459174352375E-4	0.0026979589665778233	0	0	71.25	542.5477632515199	MAPK1;MAPK3
Poorly differentiated carcinoma	2/30	4.931459174352375E-4	0.0026979589665778233	0	0	71.25	542.5477632515199	SMAD4;CREBBP
Arthritis	5/630	5.14842342196512E-4	0.002805234993508416	0	0	9.10729411764706	68.95724201069834	MAPK8;JUND;MAPK1;FOS;HIF1A
Conventional (Clear Cell) Renal Cell Carcinoma	5/631	5.185819439859745E-4	0.002805234993508416	0	0	9.09227588799098	68.77772540154686	MAPK8;CDK6;MAPK1;HIF1A;MAPK3
Frontotemporal dementia	3/145	5.195333041696945E-4	0.002805234993508416	0	0	22.056338028169016	166.8028129347241	GSK3B;CDK6;MAPK3
Nerve Degeneration	3/145	5.195333041696945E-4	0.002805234993508416	0	0	22.056338028169016	166.8028129347241	CTNNB1;MAPK1;MAPK3
Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse	4/349	5.198562063919393E-4	0.002805234993508416	0	0	12.646054750402577	95.62893881862037	GSK3B;MAPK8;CDK6;CTNNB1
Poor school performance	6/985	5.309733829306131E-4	0.0028574180689045258	0	0	7.277451481103166	54.87779640811182	SMAD4;CREBBP;CDK6;CTNNB1;MAPK1;FOS
Verrucous carcinoma	2/32	5.615516558705586E-4	0.002989392238124941	0	0	66.49333333333334	497.68975294339197	CDK6;MAPK1
Bowen's Disease	2/32	5.615516558705586E-4	0.002989392238124941	0	0	66.49333333333334	497.68975294339197	MAPK1;MAPK3
Oropharyngeal disorders	2/32	5.615516558705586E-4	0.002989392238124941	0	0	66.49333333333334	497.68975294339197	JUND;FOS
Peritoneal Fibrosis	2/32	5.615516558705586E-4	0.002989392238124941	0	0	66.49333333333334	497.68975294339197	MAPK1;MAPK3
Brain Neoplasms	5/646	5.771844640173277E-4	0.0030643530011672643	0	0	8.872625493255024	66.1662617222871	MAPK8;CTNNB1;MAPK1;PGR;HIF1A
Periapical Periodontitis	2/33	5.973830443360625E-4	0.0031546297127372286	0	0	64.34516129032258	477.63104594339933	MAPK1;MAPK3
Craniopharyngioma	2/33	5.973830443360625E-4	0.0031546297127372286	0	0	64.34516129032258	477.63104594339933	CTNNB1;PGR
Familial lichen amyloidosis	3/153	6.075550675373435E-4	0.0031912799425166316	0	0	20.87157894736842	154.57632753969705	SMAD4;MAPK8;MAPK3
Squamous cell carcinoma of tongue	3/153	6.075550675373435E-4	0.0031912799425166316	0	0	20.87157894736842	154.57632753969705	CREBBP;HIF1A;MAPK3
prostatitis	2/34	6.342971648874719E-4	0.0033229095508030687	0	0	62.33125	458.94455736927694	SMAD4;HIF1A
Nephroblastoma	4/370	6.474727550562546E-4	0.0033829595006246104	0	0	11.907710989678202	87.43158015623935	CTNNB1;PGR;HIF1A;MAPK3
Abnormal behavior	4/372	6.606880475363675E-4	0.0034428994561591713	0	0	11.841787439613526	86.70827667499188	GSK3B;XRCC6;MAPK1;HIF1A
Acinar Cell Carcinoma	2/35	6.722918107605481E-4	0.0034941482269791645	0	0	60.43939393939394	441.49877695773813	CTNNB1;PGR
Mental deficiency	6/1032	6.798756030442922E-4	0.003515063654482924	0	0	6.926900584795321	50.52204704572711	SMAD4;CREBBP;CDK6;CTNNB1;MAPK1;FOS
Primary malignant neoplasm	6/1032	6.798756030442922E-4	0.003515063654482924	0	0	6.926900584795321	50.52204704572711	CREBBP;MAPK8;HDAC3;MAPK1;FOS;HIF1A
Mammary Neoplasms, Experimental	3/160	6.919647504825212E-4	0.003568225540999946	0	0	19.933959101575596	145.03899888333748	UBE2I;CDK6;PGR
Familial multiple trichoepitheliomata	3/161	7.046016267425588E-4	0.0036239276375431085	0	0	19.806795469686875	143.75530475943634	SMAD4;CDK6;PGR
Idiopathic Pulmonary Fibrosis	4/379	7.084571267898448E-4	0.003630349968791194	0	0	11.616592592592593	84.24842022159326	SMAD2;GSK3B;CREBBP;HIF1A
Familial medullary thyroid carcinoma	2/36	7.113647786947809E-4	0.003630349968791194	0	0	58.65882352941176	425.1782293491763	FOS;MAPK3
Mesenchymal Cell Neoplasm	2/36	7.113647786947809E-4	0.003630349968791194	0	0	58.65882352941176	425.1782293491763	CTNNB1;MAPK1
Autistic Disorder	5/677	7.140523692198052E-4	0.003634673786621431	0	0	8.449754901960784	61.21470780393384	SMAD4;CREBBP;CTNNB1;MAPK1;MAPK3
Age related macular degeneration	4/382	7.296631446437566E-4	0.0036983960434890124	0	0	11.522633744855968	83.22714902403135	SMAD4;MAPK8;CTNNB1;HIF1A
androgen independent prostate cancer	3/163	7.303161807396025E-4	0.0036983960434890124	0	0	19.55723684210526	141.24300973131525	MAPK1;HIF1A;MAPK3
Tubular Aggregate Myopathy	2/37	7.515138680371676E-4	0.003776691830466682	0	0	56.98	409.88112260467307	CREBBP;MAPK3
ACTH-Secreting Pituitary Adenoma	2/37	7.515138680371676E-4	0.003776691830466682	0	0	56.98	409.88112260467307	HDAC2;MAPK3
Mitochondrial abnormalities	2/37	7.515138680371676E-4	0.003776691830466682	0	0	56.98	409.88112260467307	CREBBP;HIF1A
Bone Diseases	3/165	7.566231137769022E-4	0.0037927173850491928	0	0	19.313840155945417	138.8017185179149	SMAD4;MAPK8;HIF1A
Anaplastic astrocytoma	3/166	7.700004546135333E-4	0.003840280045105374	0	0	19.19438165967065	137.60681493907595	MAPK1;PGR;HIF1A
Classical Hodgkin's Lymphoma	3/166	7.700004546135333E-4	0.003840280045105374	0	0	19.19438165967065	137.60681493907595	JUND;MAPK1;FOS
Cardiomyopathy, Familial Idiopathic	4/388	7.734241134698613E-4	0.003847638851644776	0	0	11.33912037037037	81.24120296109479	MAPK8;MAPK1;PGR;HIF1A
Breast adenocarcinoma	3/168	7.972063280722975E-4	0.003955986175735647	0	0	18.95980861244019	135.26680228779006	SMAD4;MAPK1;HIF1A
Developmental Disabilities	3/170	8.250183531529712E-4	0.004083737462348668	0	0	18.73085408131106	132.99102932399242	SMAD4;CREBBP;MAPK1
Streptococcal pneumonia	2/39	8.350316260813204E-4	0.004122968653776519	0	0	53.894594594594594	382.007093916608	MAPK1;MAPK3
Keloid	3/171	8.391533744525244E-4	0.004132987318064179	0	0	18.61842105263158	131.87645582434536	SMAD2;CREBBP;HIF1A
Anthrax disease	2/40	8.78395909700633E-4	0.004315502292683458	0	0	52.473684210526315	369.2789949643409	MAPK1;HIF1A
Carcinomatosis	3/176	9.121455580342138E-4	0.00447019225091209	0	0	18.075752966230606	126.5250464646184	UBE2I;PGR;HIF1A
Dermatologic disorders	4/406	9.158851265898261E-4	0.004477408725284422	0	0	10.821448313985627	75.7027360210133	JUND;MAPK1;FOS;PIAS1
Refractory cancer	3/177	9.272120956204086E-4	0.004510452928202726	0	0	17.970961887477316	125.49712530201889	MAPK1;PGR;HIF1A
Carcinoma of larynx	3/177	9.272120956204086E-4	0.004510452928202726	0	0	17.970961887477316	125.49712530201889	GSK3B;HIF1A;MAPK3
Scleroderma	3/179	9.578185836806674E-4	0.004647891161595376	0	0	17.76495215311005	123.48155618394075	SMAD2;SMAD4;MAPK1
Vascular Neoplasms	2/42	9.683243476237373E-4	0.004664489235504589	0	0	49.845	345.92148161176414	FOS;HIF1A
Disease due to Parvoviridae	2/42	9.683243476237373E-4	0.004664489235504589	0	0	49.845	345.92148161176414	SMAD4;MAPK1
Rat Adrenal Gland Pheochromocytoma	2/42	9.683243476237373E-4	0.004664489235504589	0	0	49.845	345.92148161176414	MAPK1;MAPK3
Gastritis	3/181	9.89060675672424E-4	0.004752785485287196	0	0	17.563571850975755	121.5180484136885	JUND;FOS;HIF1A
Primary Carcinoma	2/43	0.001014884135775059	0.0048650392430964595	0	0	48.62682926829268	335.18380172445745	SMAD4;PGR
Adrenocortical carcinoma	3/185	0.0010534725589437803	0.0050322466292561175	0	0	17.17408906882591	117.73977338646442	CTNNB1;MAPK1;PGR
Medullomyoblastoma	2/44	0.0010625047313416714	0.0050322466292561175	0	0	47.46666666666667	325.0102571568994	CDK6;CTNNB1
Melanotic medulloblastoma	2/44	0.0010625047313416714	0.0050322466292561175	0	0	47.46666666666667	325.0102571568994	CDK6;CTNNB1
Oral Submucous Fibrosis	2/44	0.0010625047313416714	0.0050322466292561175	0	0	47.46666666666667	325.0102571568994	SMAD2;HIF1A
Osteosclerosis	2/44	0.0010625047313416714	0.0050322466292561175	0	0	47.46666666666667	325.0102571568994	MAPK1;MAPK3
Astrocytoma	5/741	0.001072611381100024	0.005055865101843788	0	0	7.689418158567775	52.577619743540616	MAPK8;MAPK1;PGR;HIF1A;MAPK3
Depressive disorder	5/741	0.001072611381100024	0.005055865101843788	0	0	7.689418158567775	52.577619743540616	GSK3B;HDAC2;MAPK8;MAPK1;MAPK3
Craniofacial Abnormalities	3/187	0.0010866526997007997	0.00510985495692638	0	0	16.98569794050343	115.9214982351622	SMAD2;SMAD4;CTNNB1
Carcinoma, Spindle-Cell	3/188	0.0011034885654210486	0.005164431082243059	0	0	16.89302987197724	115.02934839149952	UBE2I;PGR;HIF1A
Familial Alzheimer Disease (FAD)	3/188	0.0011034885654210486	0.005164431082243059	0	0	16.89302987197724	115.02934839149952	GSK3B;SMAD4;FOS
Mammary adenocarcinoma	2/45	0.0011111839587462763	0.005175915845575226	0	0	46.36046511627907	315.3591457066678	PGR;HIF1A
Endometrial Stromal Sarcoma	2/45	0.0011111839587462763	0.005175915845575226	0	0	46.36046511627907	315.3591457066678	HDAC2;PGR
Malignant neoplasm of male breast	2/46	0.001160919646192999	0.005394861885249819	0	0	45.304545454545455	306.1927090143132	PGR;HIF1A
Hematopoietic Neoplasms	3/192	0.0011724854843877747	0.005435818853675716	0	0	16.53216374269006	111.56944690401058	CREBBP;CDK6;MAPK1
Carcinoma, Pancreatic Ductal	2/47	0.0012117096246851804	0.005578383470287252	0	0	44.29555555555555	297.4766814031406	SMAD4;HIF1A
Rhinovirus infection	2/47	0.0012117096246851804	0.005578383470287252	0	0	44.29555555555555	297.4766814031406	MAPK1;MAPK3
Muscular Atrophy	2/47	0.0012117096246851804	0.005578383470287252	0	0	44.29555555555555	297.4766814031406	GSK3B;CTNNB1
Disseminated Malignant Neoplasm	3/195	0.0012259869245403914	0.005630986455737844	0	0	16.27138157894737	109.08349028325718	SMAD2;GSK3B;SMAD4
Mental Retardation	6/1158	0.0012433153536449912	0.005674855142130028	0	0	6.128255208333333	40.99786675266553	SMAD4;CREBBP;CDK6;CTNNB1;MAPK1;FOS
Carcinoma, Papillary	3/196	0.0012441581147049632	0.005674855142130028	0	0	16.186255794927735	108.27465923376577	SMAD4;HDAC2;HIF1A
Spinal Muscular Atrophy	3/196	0.0012441581147049632	0.005674855142130028	0	0	16.186255794927735	108.27465923376577	NCOR2;HDAC2;MAPK1
Endogenous depression	2/49	0.0013164437942291545	0.005990729247932212	0	0	42.40638297872341	281.27395914374284	GSK3B;CREBBP
Erythroblastosis	2/50	0.001370383663162003	0.0061722770811545175	0	0	41.520833333333336	273.7329252658829	JUND;FOS
Turcot syndrome (disorder)	2/50	0.001370383663162003	0.0061722770811545175	0	0	41.520833333333336	273.7329252658829	CTNNB1;HIF1A
Atypical Ductal Breast Hyperplasia	2/50	0.001370383663162003	0.0061722770811545175	0	0	41.520833333333336	273.7329252658829	PGR;HIF1A
Clostridium; difficile (disorder)	2/50	0.001370383663162003	0.0061722770811545175	0	0	41.520833333333336	273.7329252658829	JUND;FOS
Hepatitis C	5/783	0.0013719643739882699	0.0061722770811545175	0	0	7.258430364433691	47.84402879053814	SMAD2;SMAD4;MAPK8;CTNNB1;MAPK1
Anaplastic carcinoma	3/204	0.0013956889789124613	0.00625477343504474	0	0	15.535742340926944	102.137673226115	UBE2I;PGR;HIF1A
Cholangiocarcinoma	4/455	0.0013966354860023952	0.00625477343504474	0	0	9.621581670362158	63.249287119117575	SMAD4;HDAC3;MAPK1;MAPK3
Squamous cell carcinoma of skin	3/205	0.001415409618671249	0.006324511305148681	0	0	15.458051068264721	101.41001365271087	SMAD4;CDK6;MAPK1
Metaplasia	2/51	0.0014253691779825303	0.006354636854436789	0	0	40.67142857142857	266.5330663196843	CTNNB1;PGR
Colorectal cancer metastatic	3/208	0.0014756249868215275	0.006560003176429496	0	0	15.229525032092425	99.27630366662376	SMAD4;MAPK1;HIF1A
Idiopathic crescentic glomerulonephritis	2/52	0.001481398185664585	0.006560003176429496	0	0	39.856	259.65262996111744	JUND;FOS
Desmoplastic Medulloblastoma	2/52	0.001481398185664585	0.006560003176429496	0	0	39.856	259.65262996111744	CDK6;CTNNB1
Glomerulonephritis	3/210	0.0015166523627972346	0.006686134858313702	0	0	15.080854309687261	97.89359200664423	JUND;MAPK1;FOS
Neurofibromatosis 1	3/210	0.0015166523627972346	0.006686134858313702	0	0	15.080854309687261	97.89359200664423	MAPK1;PGR;MAPK3
Turner Syndrome, Male	2/53	0.001538468535676127	0.006767205697016372	0	0	39.07254901960784	253.0716424387	MAPK1;MAPK3
HIV Infections	5/806	0.0015601696428090062	0.006847411210106195	0	0	7.041565689946391	45.50936244904876	NCOR2;JUND;MAPK1;FOS;HIF1A
Restenosis	3/215	0.0016223482903171822	0.007104518566244866	0	0	14.721449851042701	94.5688363583507	JUND;UBE2I;FOS
Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site	3/216	0.0016440282574157637	0.0071554841102439565	0	0	14.651593773165308	93.92559193778936	MAPK8;MAPK1;HIF1A
Carcinoma	3/216	0.0016440282574157637	0.0071554841102439565	0	0	14.651593773165308	93.92559193778936	UBE2I;PGR;HIF1A
Mammary Neoplasms, Human	4/476	0.0016486168859122844	0.0071554841102439565	0	0	9.18361581920904	58.84694420244584	CTNNB1;PGR;FOS;HIF1A
Thyroid Neoplasm	4/476	0.0016486168859122844	0.0071554841102439565	0	0	9.18361581920904	58.84694420244584	SMAD4;CTNNB1;FOS;HIF1A
Fetal Alcohol Syndrome	2/55	0.0016557246776615132	0.0071554841102439565	0	0	37.594339622641506	240.73597386560573	MAPK8;MAPK1
Osteoporosis, Postmenopausal	2/55	0.0016557246776615132	0.0071554841102439565	0	0	37.594339622641506	240.73597386560573	HIF1A;MAPK3
Cardiomyopathies	4/480	0.0016999868209698142	0.007330729195230094	0	0	9.104575163398692	58.061102934553944	HDAC2;MAPK1;HIF1A;MAPK3
Nasal Polyps	3/219	0.0017101600548270674	0.007351224974902124	0	0	14.445906432748538	92.03730132459921	HDAC2;JUND;FOS
Holoprosencephaly	2/56	0.0017159061840151286	0.007351224974902124	0	0	36.8962962962963	234.94875028585096	SMAD2;GSK3B
Hyperandrogenism	2/56	0.0017159061840151286	0.007351224974902124	0	0	36.8962962962963	234.94875028585096	HDAC3;FOS
Dermatitis, Atopic	4/484	0.0017524673054682824	0.007486928591615087	0	0	9.026851851851852	57.29099682619495	SMAD2;MAPK8;JUND;FOS
Status Epilepticus	3/221	0.0017551635128697648	0.007486928591615087	0	0	14.311926605504587	90.81194018731782	GSK3B;JUND;FOS
Ameloblastoma	2/57	0.0017771204626455066	0.007547984760698657	0	0	36.223636363636366	229.39562954849325	CTNNB1;FOS
Atrophic	2/57	0.0017771204626455066	0.007547984760698657	0	0	36.223636363636366	229.39562954849325	GSK3B;MAPK3
Intestinal Cancer	2/58	0.0018393653781464217	0.0077457284047743775	0	0	35.575	224.06325588650645	SMAD4;CTNNB1
Carcinoma of Male Breast	2/58	0.0018393653781464217	0.0077457284047743775	0	0	35.575	224.06325588650645	PGR;HIF1A
Nerve Sheath Tumors	2/58	0.0018393653781464217	0.0077457284047743775	0	0	35.575	224.06325588650645	MAPK1;PGR
Congenital aneurysm of ascending aorta	2/58	0.0018393653781464217	0.0077457284047743775	0	0	35.575	224.06325588650645	SMAD2;SMAD4
Gastrointestinal Carcinoid Tumor	3/225	0.0018473881033586547	0.0077629606470922185	0	0	14.051209103840684	88.4380638309696	CTNNB1;FOS;MAPK3
Fibromatosis, Aggressive	2/59	0.0019026387993678797	0.007944422048100554	0	0	34.949122807017545	218.93925214748256	SMAD2;CTNNB1
Squamous cell carcinoma of mouth	2/59	0.0019026387993678797	0.007944422048100554	0	0	34.949122807017545	218.93925214748256	MAPK1;HIF1A
SVEINSSON CHORIORETINAL ATROPHY	2/59	0.0019026387993678797	0.007944422048100554	0	0	34.949122807017545	218.93925214748256	MAPK1;MAPK3
Ki-1+ Anaplastic Large Cell Lymphoma	3/228	0.0019185145249015745	0.007993810520423228	0	0	13.861754385964913	86.72196430853442	MAPK8;CDK6;MAPK3
Congenital chromosomal disease	4/497	0.0019308534988906312	0.00802828560065052	0	0	8.782961460446247	54.89169234072044	XRCC6;CDK6;XRCC5;FOS
Seminoma	3/229	0.0019425992170270159	0.008060154314345288	0	0	13.799720540288774	86.16170705015809	SMAD4;CDK6;PGR
Cavernous Hemangioma of Brain	2/60	0.001966938596934448	0.008144032974728585	0	0	34.3448275862069	214.01213271870947	MAPK1;MAPK3
Noonan Syndrome	2/61	0.00203226264523873	0.008396901096959189	0	0	33.76101694915254	209.27122545032168	MAPK1;MAPK3
Microcephaly	3/235	0.002091092174789183	0.008621935376218446	0	0	13.43874773139746	82.91799779061546	MAPK8;CDK6;CTNNB1
Bulbo-Spinal Atrophy, X-Linked	2/63	0.0021659750080163095	0.008875105063967242	0	0	32.65081967213115	200.30901302971847	CREBBP;HIF1A
Iron deficiency	2/63	0.0021659750080163095	0.008875105063967242	0	0	32.65081967213115	200.30901302971847	MAPK1;HIF1A
Lymphangioleiomyomatosis	2/63	0.0021659750080163095	0.008875105063967242	0	0	32.65081967213115	200.30901302971847	MAPK1;HIF1A
Malignant neoplasm of large intestine	4/516	0.0022138267945262264	0.009052397348218007	0	0	8.448784722222221	51.64769711050253	SMAD4;CREBBP;MAPK1;HIF1A
Unipolar Depression	4/517	0.0022294740986316995	0.009061312515051177	0	0	8.431882174572234	51.48498445769058	GSK3B;FOS;HIF1A;MAPK3
Adenocarcinoma, Endometrioid	2/64	0.0022343590859898346	0.009061312515051177	0	0	32.12258064516129	196.06983518944284	CTNNB1;PGR
Retinopathy of Prematurity	2/64	0.0022343590859898346	0.009061312515051177	0	0	32.12258064516129	196.06983518944284	UBE2I;HIF1A
Adult Medulloblastoma	2/64	0.0022343590859898346	0.009061312515051177	0	0	32.12258064516129	196.06983518944284	CDK6;CTNNB1
FRIEDREICH ATAXIA 1	2/65	0.0023037589431788717	0.009285559005669942	0	0	31.61111111111111	191.98101622282033	HDAC3;HIF1A
Mammary Ductal Carcinoma	2/65	0.0023037589431788717	0.009285559005669942	0	0	31.61111111111111	191.98101622282033	SMAD4;HIF1A
Melanocytic nevus of skin	2/65	0.0023037589431788717	0.009285559005669942	0	0	31.61111111111111	191.98101622282033	CREBBP;HIF1A
Hypertrophic disorder of skin, unspecified	2/66	0.002374172468896089	0.009530468752174342	0	0	31.115625	188.03503059735857	HDAC2;MAPK1
Skeletal dysplasia	2/66	0.002374172468896089	0.009530468752174342	0	0	31.115625	188.03503059735857	CREBBP;MAPK1
neurofibroma	2/67	0.0024455975557341574	0.009797272155324464	0	0	30.635384615384616	184.22483725138	MAPK1;PGR
Alveolar rhabdomyosarcoma	2/68	0.0025180320994553636	0.010059269466851295	0	0	30.169696969696968	180.54384163711242	MAPK8;MAPK1
Patent ductus arteriosus	3/251	0.002521183992957666	0.010059269466851295	0	0	12.561544991511036	75.15605844088137	GSK3B;SMAD4;CREBBP
Simple Partial Status Epilepticus	2/69	0.00259147399914311	0.010195540136071001	0	0	29.717910447761195	176.98586125065358	JUND;FOS
Grand Mal Status Epilepticus	2/69	0.00259147399914311	0.010195540136071001	0	0	29.717910447761195	176.98586125065358	JUND;FOS
Highly arched eyebrow	2/69	0.00259147399914311	0.010195540136071001	0	0	29.717910447761195	176.98586125065358	CREBBP;MAPK1
Status Epilepticus, Subclinical	2/69	0.00259147399914311	0.010195540136071001	0	0	29.717910447761195	176.98586125065358	JUND;FOS
Bowed and upward slanting eyebrows	2/69	0.00259147399914311	0.010195540136071001	0	0	29.717910447761195	176.98586125065358	CREBBP;MAPK1
Non-Convulsive Status Epilepticus	2/69	0.00259147399914311	0.010195540136071001	0	0	29.717910447761195	176.98586125065358	JUND;FOS
Complex Partial Status Epilepticus	2/69	0.00259147399914311	0.010195540136071001	0	0	29.717910447761195	176.98586125065358	JUND;FOS
Brain Injuries, Focal	2/70	0.0026659211559916535	0.010364884954980613	0	0	29.279411764705884	173.5450943005154	GSK3B;FOS
Injuries, Acute Brain	2/70	0.0026659211559916535	0.010364884954980613	0	0	29.279411764705884	173.5450943005154	GSK3B;FOS
Brain Injuries	2/70	0.0026659211559916535	0.010364884954980613	0	0	29.279411764705884	173.5450943005154	GSK3B;FOS
Brain Lacerations	2/70	0.0026659211559916535	0.010364884954980613	0	0	29.279411764705884	173.5450943005154	GSK3B;FOS
Neck Neoplasms	2/70	0.0026659211559916535	0.010364884954980613	0	0	29.279411764705884	173.5450943005154	MAPK1;MAPK3
Skin Neoplasms	3/256	0.002666005851711469	0.010364884954980613	0	0	12.31017266486374	72.96453365942634	SMAD2;CTNNB1;HIF1A
Metastatic Neoplasm	4/544	0.0026816235092387234	0.010405120689089348	0	0	7.99917695473251	47.36578952175431	SMAD4;MAPK1;HIF1A;MAPK3
Urothelial Carcinoma	3/257	0.0026955765483440385	0.0104387523195676	0	0	12.261085785329465	72.5383388632067	HDAC2;CREBBP;HIF1A
Splenic Marginal Zone B-Cell Lymphoma	2/71	0.002741371475892866	0.010574626298610177	0	0	28.8536231884058	170.21609113224113	CREBBP;CDK6
Neurofibromatoses	2/71	0.002741371475892866	0.010574626298610177	0	0	28.8536231884058	170.21609113224113	MAPK1;PGR
Lymphoma, T-Cell, Cutaneous	3/260	0.002785510057441584	0.010703078528107255	0	0	12.116117141101782	71.28304612974323	HDAC2;HDAC3;FOS
Malignant Pleural Mesothelioma	3/260	0.002785510057441584	0.010703078528107255	0	0	12.116117141101782	71.28304612974323	MAPK8;MAPK1;HIF1A
Benign melanocytic nevus	2/72	0.0028178228656184404	0.01080621390212897	0	0	28.44	166.99372823811356	CDK6;FOS
Endothelial dysfunction	3/262	0.0028464883961173497	0.010894989500642957	0	0	12.021337126600285	70.46510141101936	HDAC2;MAPK1;HIF1A
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1	2/73	0.0028952732366765354	0.011038927881150884	0	0	28.038028169014083	163.87318444267802	CTNNB1;MAPK1
Urinary tract infection	2/73	0.0028952732366765354	0.011038927881150884	0	0	28.038028169014083	163.87318444267802	MAPK1;HIF1A
Refractory anemias	3/266	0.002970916631495668	0.01125114558091832	0	0	11.836101660996597	68.87291137947287	JUND;CDK6;FOS
Hereditary gingival fibromatosis	2/74	0.0029737205029060063	0.01125114558091832	0	0	27.647222222222222	160.8499191916803	MAPK8;MAPK1
Thick eyebrow	2/74	0.0029737205029060063	0.01125114558091832	0	0	27.647222222222222	160.8499191916803	SMAD4;CREBBP
Necrotizing enterocolitis in fetus OR newborn	2/74	0.0029737205029060063	0.01125114558091832	0	0	27.647222222222222	160.8499191916803	SMAD2;MAPK8
Angiogenic Switch	2/75	0.003053162581007562	0.011529629249502744	0	0	27.267123287671232	157.91965264488547	MAPK1;HIF1A
Granulomatosis with polyangiitis	2/76	0.003133597391756124	0.011765883742810542	0	0	26.897297297297296	155.0783474227624	CDK6;CTNNB1
Petit mal status	2/76	0.003133597391756124	0.011765883742810542	0	0	26.897297297297296	155.0783474227624	JUND;FOS
Primary infection NOS	2/76	0.003133597391756124	0.011765883742810542	0	0	26.897297297297296	155.0783474227624	MAPK8;MAPK1
aggressive cancer	2/77	0.0032150228568515217	0.01204870994740371	0	0	26.537333333333333	152.3221918917233	XRCC5;HIF1A
Diffuse Large B-Cell Lymphoma	4/575	0.0032747931308810103	0.0122494629422159	0	0	7.552831290134267	43.21352859229037	XRCC6;CREBBP;HDAC3;HIF1A
Giant Cell Glioblastoma	2/78	0.0032974369030788577	0.012310846660833165	0	0	26.186842105263157	149.64758474395342	CDK6;HIF1A
Dwarfism	3/277	0.003330304390301264	0.012410096548764144	0	0	11.354590856703803	64.77443874862678	SMAD4;CDK6;MAPK1
Gliosis	2/79	0.003380837459685028	0.012574677933856743	0	0	25.845454545454544	147.05112086949833	MAPK1;MAPK3
Pheochromocytoma	3/280	0.0034327575391187542	0.012743789736390112	0	0	11.229906897206916	63.72288704767485	SMAD2;CREBBP;HIF1A
Extrahepatic Cholangiocarcinoma	2/80	0.003465222458352275	0.012816131751396523	0	0	25.512820512820515	144.5295783236449	SMAD4;MAPK1
Paroxysmal kinesigenic choreoathetosis	2/80	0.003465222458352275	0.012816131751396523	0	0	25.512820512820515	144.5295783236449	JUND;MAPK1
Anaplasia	3/283	0.0035371355889207835	0.013057650071249621	0	0	11.107894736842105	62.697823541982174	SMAD2;MAPK1;HIF1A
Vascular lesions	2/81	0.003550589833371784	0.013058500783816152	0	0	25.18860759493671	142.07990631084704	SMAD4;HIF1A
Acute myelomonocytic leukemia	2/81	0.003550589833371784	0.013058500783816152	0	0	25.18860759493671	142.07990631084704	CREBBP;MAPK1
Influenza	4/589	0.003570083174143851	0.01310578860396674	0	0	7.3667616334283	41.51292752582045	MAPK8;JUND;MAPK1;FOS
Hodgkin Disease	4/592	0.0036356563903718613	0.01330176223944769	0	0	7.328042328042328	41.16136173959886	NCOR2;FOS;HIF1A;MAPK3
Malignant neoplasm of tongue	2/82	0.0036369375236970903	0.01330176223944769	0	0	24.8725	139.69921408293405	FOS;HIF1A
Lymphoma, Large-Cell, Follicular	2/83	0.003724263469993397	0.013520993296391467	0	0	24.5641975308642	137.38476071819665	CREBBP;MAPK1
Van der Woude syndrome	2/83	0.003724263469993397	0.013520993296391467	0	0	24.5641975308642	137.38476071819665	MAPK1;FOS
bone destruction	2/83	0.003724263469993397	0.013520993296391467	0	0	24.5641975308642	137.38476071819665	MAPK8;HIF1A
Paraganglioma	2/83	0.003724263469993397	0.013520993296391467	0	0	24.5641975308642	137.38476071819665	PGR;HIF1A
Retrusion of upper jaw bones	2/84	0.0038125656163165316	0.013690576531318454	0	0	24.26341463414634	135.13394563762242	SMAD4;CREBBP
Hypoplasia of the maxilla	2/84	0.0038125656163165316	0.013690576531318454	0	0	24.26341463414634	135.13394563762242	SMAD4;CREBBP
Hypotrophic maxilla	2/84	0.0038125656163165316	0.013690576531318454	0	0	24.26341463414634	135.13394563762242	SMAD4;CREBBP
Maxillary retrognathia	2/84	0.0038125656163165316	0.013690576531318454	0	0	24.26341463414634	135.13394563762242	SMAD4;CREBBP
Decreased projection of maxilla	2/84	0.0038125656163165316	0.013690576531318454	0	0	24.26341463414634	135.13394563762242	SMAD4;CREBBP
Deficiency of upper jaw bones	2/84	0.0038125656163165316	0.013690576531318454	0	0	24.26341463414634	135.13394563762242	SMAD4;CREBBP
Severe Acute Respiratory Syndrome	2/85	0.0039018419094564607	0.013985730982171525	0	0	23.96987951807229	132.94429984239056	UBE2I;MAPK1
Congenital Abnormality	4/607	0.003975954289286191	0.01422556108938447	0	0	7.140224801916344	39.467524667007844	SMAD4;CTNNB1;PGR;MAPK3
Pituitary Neoplasms	3/296	0.004011968276584302	0.014328458130658221	0	0	10.608047422310042	58.54022663537103	MAPK8;MAPK1;HIF1A
Adrenal Gland Neoplasms	2/87	0.0040833087396631345	0.014530693262765208	0	0	23.403529411764705	128.7392498510691	SMAD2;CTNNB1
Nevus	2/87	0.0040833087396631345	0.014530693262765208	0	0	23.403529411764705	128.7392498510691	CDK6;FOS
Adenocarcinoma Of Esophagus	3/299	0.004126807837997613	0.014659074604397995	0	0	10.498933143669985	57.64177915107378	SMAD4;MAPK1;PGR
Spina Bifida	2/88	0.004175495185413075	0.014805391366590348	0	0	23.130232558139536	126.71949534645874	JUND;FOS
Myocardial Diseases, Secondary	2/89	0.004268647595016652	0.015081536672912142	0	0	22.863218390804597	124.75219602446865	MAPK1;MAPK3
Cerebral Palsy	2/89	0.004268647595016652	0.015081536672912142	0	0	22.863218390804597	124.75219602446865	CTNNB1;PGR
Adenovirus Infections	2/90	0.004362763930827339	0.015379818215834229	0	0	22.602272727272727	122.83543002652111	CREBBP;HIF1A
Mental and motor retardation	5/1021	0.004368647098269875	0.015379818215834229	0	0	5.489231125521075	29.824649938434966	SMAD4;CREBBP;CDK6;CTNNB1;MAPK1
Cardiomyopathies, Primary	2/92	0.004553880244907289	0.015974979544745818	0	0	22.09777777777778	119.14625922138045	MAPK1;MAPK3
Adrenal Cortical Adenoma	2/92	0.004553880244907289	0.015974979544745818	0	0	22.09777777777778	119.14625922138045	CTNNB1;PGR
Kidney Failure, Acute	3/310	0.004565053298370468	0.0159857806104285	0	0	10.117092405280301	54.52429993323718	GSK3B;HDAC3;HIF1A
Celiac Disease	3/312	0.004647659936569874	0.01622876398757361	0	0	10.050587634133878	53.985640239199725	KAT5;CTNNB1;HIF1A
Childhood Medulloblastoma	2/93	0.00465087616048945	0.01622876398757361	0	0	21.853846153846153	117.37044401027833	CDK6;CTNNB1
Rheumatism	2/95	0.004847733378279495	0.01688584377795768	0	0	21.381720430107528	113.94840590959562	XRCC6;MAPK1
Hepatitis	3/317	0.004858155250703025	0.016892353204469142	0	0	9.888032182366745	52.67450154328527	GSK3B;CTNNB1;HIF1A
Steroid Sulfatase Deficiency Disease	2/96	0.004947590636398427	0.017083027109942122	0	0	21.153191489361703	112.29921711841662	MAPK8;HIF1A
Idiopathic pulmonary hypertension	2/96	0.004947590636398427	0.017083027109942122	0	0	21.153191489361703	112.29921711841662	HIF1A;MAPK3
Werner Syndrome	2/96	0.004947590636398427	0.017083027109942122	0	0	21.153191489361703	112.29921711841662	CREBBP;MAPK1
Aortic Aneurysm	2/96	0.004947590636398427	0.017083027109942122	0	0	21.153191489361703	112.29921711841662	SMAD2;SMAD4
Gastrointestinal Stromal Tumors	3/323	0.005118305749838187	0.017641629766021676	0	0	9.69967105263158	51.16510331346314	CDK6;MAPK1;HIF1A
High density lipoprotein measurement	3/324	0.00516247071327274	0.017731964623849846	0	0	9.668962124938515	50.920041935988046	GSK3B;SMAD4;PGR
T-Cell Lymphoma	3/324	0.00516247071327274	0.017731964623849846	0	0	9.668962124938515	50.920041935988046	CDK6;CTNNB1;HIF1A
Ischemia of kidney	2/99	0.005252852807148348	0.01801108384395484	0	0	20.495876288659794	107.58252584688383	MAPK1;HIF1A
Childhood Neuroblastoma	2/100	0.005356496957732583	0.01833462996797548	0	0	20.285714285714285	106.08302856731788	MAPK1;HIF1A
Secondary malignant neoplasm of bone	3/330	0.005432332455644339	0.018562035639961193	0	0	9.488652824722356	49.48699362364508	SMAD4;MAPK1;HIF1A
Heart Decompensation	2/102	0.005566608358088013	0.01885772128168752	0	0	19.878	103.18608820015623	GSK3B;HIF1A
Hypertrophy of lower jaw	2/102	0.005566608358088013	0.01885772128168752	0	0	19.878	103.18608820015623	SMAD4;FOS
Intervertebral Disc Degeneration	2/102	0.005566608358088013	0.01885772128168752	0	0	19.878	103.18608820015623	CTNNB1;MAPK1
mandibular excess (physical finding)	2/102	0.005566608358088013	0.01885772128168752	0	0	19.878	103.18608820015623	SMAD4;FOS
Mandibular hyperplasia	2/102	0.005566608358088013	0.01885772128168752	0	0	19.878	103.18608820015623	SMAD4;FOS
Graves Disease	3/335	0.005663635825425515	0.019119993894194116	0	0	9.343373493975903	48.339710733712614	HDAC2;CREBBP;HIF1A
Severe Sepsis	2/103	0.005673071606074811	0.019119993894194116	0	0	19.68019801980198	101.78646786734524	MAPK1;MAPK3
Ichthyosis, X-Linked	2/103	0.005673071606074811	0.019119993894194116	0	0	19.68019801980198	101.78646786734524	MAPK8;HIF1A
Mood Disorders	3/336	0.005710600854411377	0.01921369112003828	0	0	9.31484115694642	48.11516957403314	GSK3B;HDAC2;HIF1A
Enterovirus Infections	2/104	0.0057804705554863455	0.019349880249297513	0	0	19.48627450980392	100.41803751878932	MAPK1;MAPK3
Increased size of the mandible	2/104	0.0057804705554863455	0.019349880249297513	0	0	19.48627450980392	100.41803751878932	SMAD4;FOS
Acquired flat foot	2/104	0.0057804705554863455	0.019349880249297513	0	0	19.48627450980392	100.41803751878932	CREBBP;MAPK1
Leukoencephalopathy, Progressive Multifocal	2/105	0.005888803212265024	0.019546867805417516	0	0	19.296116504854368	99.07981749824071	KAT5;HIF1A
M5b Acute differentiated monocytic leukemia	2/105	0.005888803212265024	0.019546867805417516	0	0	19.296116504854368	99.07981749824071	CREBBP;MAPK3
Biliary Atresia	2/105	0.005888803212265024	0.019546867805417516	0	0	19.296116504854368	99.07981749824071	MAPK1;HIF1A
Mixed Salivary Gland Tumor	2/105	0.005888803212265024	0.019546867805417516	0	0	19.296116504854368	99.07981749824071	CTNNB1;HIF1A
Pick Disease of the Brain	2/105	0.005888803212265024	0.019546867805417516	0	0	19.296116504854368	99.07981749824071	GSK3B;MAPK3
Heart Failure, Right-Sided	2/106	0.005998067585202097	0.01980967137253201	0	0	19.109615384615385	97.770867842282	GSK3B;HIF1A
Teratocarcinoma	2/106	0.005998067585202097	0.01980967137253201	0	0	19.109615384615385	97.770867842282	HDAC2;MAPK1
Atrial Premature Complexes	2/106	0.005998067585202097	0.01980967137253201	0	0	19.109615384615385	97.770867842282	HDAC2;CTNNB1
Alcohol abuse	2/107	0.0061082616847449875	0.02010636137895225	0	0	18.926666666666666	96.49028631861954	SMAD2;HDAC2
Microstomia	2/107	0.0061082616847449875	0.02010636137895225	0	0	18.926666666666666	96.49028631861954	SMAD4;CREBBP
Flatfoot	2/108	0.0062193835276940865	0.020281854706956502	0	0	18.747169811320756	95.23720656075557	CREBBP;MAPK1
Leukemia, Myelomonocytic, Chronic	2/108	0.0062193835276940865	0.020281854706956502	0	0	18.747169811320756	95.23720656075557	CREBBP;MAPK1
Myocardial Failure	2/108	0.0062193835276940865	0.020281854706956502	0	0	18.747169811320756	95.23720656075557	GSK3B;HIF1A
Class III malocclusion	2/108	0.0062193835276940865	0.020281854706956502	0	0	18.747169811320756	95.23720656075557	SMAD4;FOS
Refractory Hodgkin Lymphoma	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	MAPK1
Anoxia-Ischemia, Brain	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	HIF1A
Anoxia-Ischemia, Cerebral	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	HIF1A
Exercise-induced angina	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	HIF1A
Fetal hydantoin syndrome	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	CREBBP
Secondary Peritonitis	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	GSK3B
Gastritis, Hypertrophic	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	SMAD4
Small intestine carcinoma	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	CTNNB1
Stiff skin	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	SMAD4
Tension Headache	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	PGR
Ventricular Remodeling	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	SMAD2
Vipoma	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	SMAD4
Acromicric Dysplasia	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	SMAD2
Alpha fetoprotein abnormal	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	CTNNB1
Large iliac wings	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	SMAD4
Left Ventricle Remodeling	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	SMAD2
Anoxic-Ischemic Encephalopathy	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	HIF1A
Aortic aneurysm and dissection	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	SMAD4
Malignant melanoma of conjunctiva	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	MAPK1
Malignant neoplasm of cecum	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	CTNNB1
Malignant neoplasm of thymus	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	HIF1A
Bifid uterus	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	CREBBP
Microcystic stromal tumor	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	CTNNB1
Brain Stem Neoplasms	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	CDK6
Cecal Neoplasms	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	CTNNB1
Cerebral Hypoxia-Ischemia	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	HIF1A
Childhood Ganglioglioma	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	MAPK1
Childhood Hepatocellular Carcinoma	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	CTNNB1
Childhood Malignant Peripheral Nerve Sheath Tumor	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	HIF1A
Chorioretinal dystrophy	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	CREBBP
Ovarian papillary adenocarcinoma	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	CTNNB1
Partial/complete duplication of the phalanges of the hallux	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	CREBBP
Premature development of the breasts	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	CREBBP
Duplication of phalanx of hallux	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	CREBBP
Elevated alpha-fetoprotein	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	CTNNB1
Endometrial neoplasm malignant metastatic	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	PGR
Rectal polyp	1/6	0.006582617147928667	0.020281854706956502	0	0	190.21904761904761	955.5316921910462	SMAD4
Adenocarcinoma, Clear Cell	2/113	0.006788839592670734	0.020852190039696267	0	0	17.898198198198198	89.35631155051506	CTNNB1;HIF1A
Obesity, Morbid	2/113	0.006788839592670734	0.020852190039696267	0	0	17.898198198198198	89.35631155051506	NCOR2;HIF1A
Lymphoma, Follicular	3/359	0.006856479007548581	0.021027245403584544	0	0	8.702838557066825	43.36242601337211	CREBBP;MAPK1;MAPK3
Head and Neck Carcinoma	2/114	0.0069054863588978894	0.021111974549262124	0	0	17.7375	88.25185030626267	SMAD4;MAPK8
Neuroectodermal Tumor, Primitive	2/114	0.0069054863588978894	0.021111974549262124	0	0	17.7375	88.25185030626267	CDK6;CTNNB1
Carcinoma, Cribriform	2/115	0.007023047051020588	0.02137213856050179	0	0	17.579646017699115	87.16969619603317	CTNNB1;PGR
Carcinoma, Granular Cell	2/115	0.007023047051020588	0.02137213856050179	0	0	17.579646017699115	87.16969619603317	CTNNB1;PGR
Pancreatic intraepithelial neoplasia	2/115	0.007023047051020588	0.02137213856050179	0	0	17.579646017699115	87.16969619603317	SMAD4;HIF1A
Leukemia, T-Cell	3/364	0.007122455455864358	0.02163267089202042	0	0	8.58011371920105	42.42439584227564	JUND;CDK6;FOS
Ataxia, Spinocerebellar	2/116	0.00714151970713788	0.02163267089202042	0	0	17.424561403508772	86.10921472473723	CREBBP;MAPK1
Condition, Preneoplastic	2/116	0.00714151970713788	0.02163267089202042	0	0	17.424561403508772	86.10921472473723	SMAD4;MAPK8
Adenocarcinoma, Basal Cell	2/117	0.0072609023659122255	0.021927036961279272	0	0	17.272173913043478	85.069794688056	CTNNB1;PGR
Carcinoma, Small Cell	2/117	0.0072609023659122255	0.021927036961279272	0	0	17.272173913043478	85.069794688056	SMAD4;CREBBP
Precursor B-cell lymphoblastic leukemia	3/367	0.007284971299712037	0.021966134835009574	0	0	8.508097165991902	41.87635890095244	HDAC3;MAPK1;HIF1A
Infarction, Middle Cerebral Artery	2/119	0.007502389873702966	0.022260646218147686	0	0	16.975213675213674	83.05180428099584	FOS;HIF1A
Liver Failure, Acute	2/120	0.007624490817309644	0.022260646218147686	0	0	16.83050847457627	82.07211879014802	GSK3B;MAPK8
Fibromatosis, Abdominal	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	CTNNB1
Fundic gland polyp	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	CTNNB1
Gastrointestinal polyps	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	CTNNB1
Globe retraction and deviation on adduction	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	CREBBP
Hemangioma of liver	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	HIF1A
Hyperplasia of foramen magnum	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	CREBBP
Ulcer of esophagus	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	HIF1A
Increased circumference of foramen magnum	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	CREBBP
Increased diameter of foramen magnum	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	CREBBP
Vascular ring	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	CREBBP
Adamantinous Craniopharyngioma	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	CTNNB1
Intracortical osteosarcoma	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	MAPK3
Large foramen magnum	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	CREBBP
Angiodysplasia	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	HIF1A
Angiodysplasia of colon	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	HIF1A
Limited eye motility from Duane anomaly	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	CREBBP
lupus erythematodes	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	CREBBP
Ataxic cerebral palsy	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	CTNNB1
Multiple fibrofolliculomas	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	HIF1A
Opioid withdrawal	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	MAPK3
Pancreatic Intraepithelial Neoplasia-3	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	SMAD4
Papillary cystic tumor	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	CTNNB1
Pediatric follicular lymphoma	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	MAPK1
Cornela disease	1/7	0.0076756962402828215	0.022260646218147686	0	0	158.5079365079365	771.8855078560287	CREBBP
Diabetes Mellitus, Non-Insulin-Dependent	6/1672	0.00783899377243639	0.022628835162167835	0	0	4.121848739495798	19.985380449761827	NCOR2;GSK3B;SMAD4;MAPK8;MAPK1;HIF1A
Hyperinsulinism	3/377	0.007842673031036364	0.022628835162167835	0	0	8.276386152547143	40.125373027634446	MAPK8;FOS;HIF1A
Adenocarcinoma, Oxyphilic	2/122	0.007871397345017368	0.022628835162167835	0	0	16.548333333333332	80.16872648706051	CTNNB1;PGR
Gastrointestinal Neoplasms	2/122	0.007871397345017368	0.022628835162167835	0	0	16.548333333333332	80.16872648706051	SMAD4;CTNNB1
Congenital heart disease	2/122	0.007871397345017368	0.022628835162167835	0	0	16.548333333333332	80.16872648706051	SMAD2;HDAC3
Pilocytic Astrocytoma	2/122	0.007871397345017368	0.022628835162167835	0	0	16.548333333333332	80.16872648706051	MAPK1;HIF1A
Glaucoma	3/381	0.008072682368613348	0.023173761159900236	0	0	8.187134502923977	39.456007309603265	SMAD4;CREBBP;MAPK3
Adenocarcinoma, Tubular	2/125	0.008248489601395681	0.02360980719240068	0	0	16.142276422764226	77.44620595940778	CTNNB1;PGR
Arthropathy	2/125	0.008248489601395681	0.02360980719240068	0	0	16.142276422764226	77.44620595940778	MAPK8;MAPK1
Hepatitis C, Chronic	3/386	0.008365799961668707	0.023870923265663542	0	0	8.078191562457057	38.642863954477335	SMAD2;MAPK1;FOS
Short stature	4/750	0.008370418095276238	0.023870923265663542	0	0	5.728924635090855	27.401741248910483	SMAD4;CREBBP;CDK6;MAPK1
Left-Sided Heart Failure	2/126	0.008375974593977131	0.023870923265663542	0	0	16.011290322580646	76.57220011918446	GSK3B;HIF1A
Biliary Tract Cancer	2/128	0.008633614355752776	0.02391721657160502	0	0	15.755555555555556	74.87185027706946	SMAD4;CTNNB1
Cleft palate, isolated	2/129	0.00876376526785897	0.02391721657160502	0	0	15.630708661417323	74.04469331427653	CTNNB1;PGR
tumor vasculature	2/129	0.00876376526785897	0.02391721657160502	0	0	15.630708661417323	74.04469331427653	MAPK1;HIF1A
Chronic liver disease	2/129	0.00876376526785897	0.02391721657160502	0	0	15.630708661417323	74.04469331427653	MAPK8;CTNNB1
early pregnancy	2/129	0.00876376526785897	0.02391721657160502	0	0	15.630708661417323	74.04469331427653	PGR;HIF1A
Exudative vitreoretinopathy 1	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	CTNNB1
Rounded columella	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	CREBBP
Endometrial stromal sarcoma, high grade	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	CTNNB1
Geleophysic dysplasia	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	SMAD2
Grade III Chondrosarcoma	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	HIF1A
Nephrogenic rest, intralobar	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	CTNNB1
SPHEROCYTOSIS, HEREDITARY, 2	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	CREBBP
Abnormality of the cervical spine	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	CREBBP
Urethral Obstruction	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	MAPK1
Uterine Diseases	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	PGR
Allergic bronchitis	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	KAT5
Altitude Sickness	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	HIF1A
Apocrine Carcinoma	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	PGR
Low hanging columella	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	CREBBP
Malignant neoplasm of border of tongue	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	FOS
Malignant neoplasm of dorsal surface of tongue	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	FOS
Malignant neoplasm of ventral surface of tongue	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	FOS
Malignant tumor of base of tongue	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	FOS
Malignant tumor of junctional zone of tongue	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	FOS
malignant tumor of lingual tonsil	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	FOS
Central Nervous System Sensitization	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	MAPK1
Claudication (finding)	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	HIF1A
Dental White Spot	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	MAPK1
Prominent columella	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	CREBBP
Qualitative abnormality of granulocyte	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	HIF1A
Endometrial Stromal Tumors	1/8	0.008767627745742801	0.02391721657160502	0	0	135.85714285714286	643.5130349149837	CTNNB1
Primary sclerosing cholangitis	2/130	0.008894800972672576	0.024230664718659773	0	0	15.5078125	73.23236204384786	HIF1A;MAPK3
Neoplastic Cell Transformation	2/131	0.009026719548951435	0.024556158552588272	0	0	15.386821705426357	72.43448272713856	MAPK8;FOS
Carcinoma, Transitional Cell	3/399	0.009157276130393209	0.02487705688793203	0	0	7.807814992025518	36.64368815097724	HDAC2;CREBBP;HIF1A
PACHYONYCHIA CONGENITA 3	2/133	0.009293197652452087	0.025211628246693506	0	0	15.150381679389312	70.8806452888945	MAPK1;HIF1A
Tumor Immunity	2/134	0.009427753354147904	0.025541581446422646	0	0	15.034848484848485	70.12399855816885	JUND;FOS
Middle Cerebral Artery Occlusion	2/135	0.009563184277962643	0.025720429503411215	0	0	14.921052631578947	69.38042565939267	CDK6;FOS
Neurilemmoma	2/135	0.009563184277962643	0.025720429503411215	0	0	14.921052631578947	69.38042565939267	FOS;MAPK3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	3/408	0.009730290560728917	0.025720429503411215	0	0	7.6307992202729045	35.34976530138734	CREBBP;MAPK8;HIF1A
Pruritus	2/137	0.00983666417016876	0.025720429503411215	0	0	14.698518518518519	67.93124102556283	MAPK1;MAPK3
Secondary Adrenal Insufficiency	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	CTNNB1
Functional intestinal obstruction	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	SMAD4
Hypoxia-Ischemia, Brain	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	HIF1A
Glycogen storage disease type Ia	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	CTNNB1
Spinal Cord Contusion	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	HIF1A
Spinal Cord Injuries	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	HIF1A
Spinal Cord Laceration	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	HIF1A
Spinal Cord transection injury	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	HIF1A
Spindle cell hemangioma	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	HIF1A
Spontaneous hematomas	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	SMAD4
Stage I Endometrial Carcinoma	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	PGR
Polyposis, Gastric	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	SMAD4
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2 (disorder)	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	MAPK1
Transposition of Great Vessels	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	HIF1A
Abnormality of earlobe	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	MAPK1
Adult-onset citrullinemia type 2	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	MAPK8
Isovaleryl-CoA dehydrogenase deficiency	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	GSK3B
Amelogenesis imperfecta nephrocalcinosis	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	MAPK8
Atypical polypoid adenomyoma	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	CTNNB1
Avascular Necrosis of Femur Head	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	HIF1A
Myocardial hypoxia	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	HIF1A
Chronic fatigue	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	SMAD4
Post-Traumatic Myelopathy	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	HIF1A
Prominent fingertip pads	1/9	0.009858412726117614	0.025720429503411215	0	0	118.86904761904762	549.107257058779	CREBBP
Cardiovascular Diseases	4/787	0.009883577428832642	0.025752065200454446	0	0	5.447708244643111	25.151419298100027	HDAC3;JUND;FOS;HIF1A
Hamartoma Syndrome, Multiple	2/138	0.009974709335575873	0.02592111965495046	0	0	14.589705882352941	67.22502362528864	SMAD4;MAPK8
Abdominal discomfort	2/138	0.009974709335575873	0.02592111965495046	0	0	14.589705882352941	67.22502362528864	SMAD4;CTNNB1
Gastrointestinal pain	2/140	0.010253400622663585	0.0265754149996858	0	0	14.376811594202898	65.84789410830417	SMAD4;CTNNB1
Thyroid Diseases	2/140	0.010253400622663585	0.0265754149996858	0	0	14.376811594202898	65.84789410830417	JUND;FOS
Liver Cirrhosis, Experimental	4/801	0.010500123853225449	0.02717921967250362	0	0	5.348110971699429	24.36796290240737	SMAD2;NCOR2;SMAD4;FOS
Benign Prostatic Hyperplasia	3/420	0.010526543900396677	0.02721194267445476	0	0	7.406664142370314	33.7288761771312	SMAD4;KAT5;HIF1A
Alcoholic Intoxication, Chronic	3/424	0.01080020555109486	0.027447776182696535	0	0	7.334791848981123	33.21333192798012	HDAC2;XRCC5;MAPK1
Lipomatosis, Multiple Symmetrical	1/10	0.010948052258043297	0.027447776182696535	0	0	105.65608465608466	476.99429568907004	MAPK3
Liver Diseases, Parasitic	1/10	0.010948052258043297	0.027447776182696535	0	0	105.65608465608466	476.99429568907004	SMAD4
Small cell carcinoma of the cervix	1/10	0.010948052258043297	0.027447776182696535	0	0	105.65608465608466	476.99429568907004	HIF1A
Stage III Breast Cancer AJCC v6	1/10	0.010948052258043297	0.027447776182696535	0	0	105.65608465608466	476.99429568907004	PGR
Stage III Breast Cancer AJCC v7	1/10	0.010948052258043297	0.027447776182696535	0	0	105.65608465608466	476.99429568907004	PGR
Subacute progressive viral hepatitis	1/10	0.010948052258043297	0.027447776182696535	0	0	105.65608465608466	476.99429568907004	CTNNB1
Histiocytoid hemangioma	1/10	0.010948052258043297	0.027447776182696535	0	0	105.65608465608466	476.99429568907004	FOS
stage, endometrial cancer	1/10	0.010948052258043297	0.027447776182696535	0	0	105.65608465608466	476.99429568907004	CTNNB1
Induced hypothermia (finding)	1/10	0.010948052258043297	0.027447776182696535	0	0	105.65608465608466	476.99429568907004	MAPK3
Insulin resistance in diabetes	1/10	0.010948052258043297	0.027447776182696535	0	0	105.65608465608466	476.99429568907004	MAPK8
Intestinal carcinoma	1/10	0.010948052258043297	0.027447776182696535	0	0	105.65608465608466	476.99429568907004	MAPK1
Lobstein Disease	1/10	0.010948052258043297	0.027447776182696535	0	0	105.65608465608466	476.99429568907004	SMAD4
Bisphosphonate-associated osteonecrosis	1/10	0.010948052258043297	0.027447776182696535	0	0	105.65608465608466	476.99429568907004	MAPK3
cervical cancer metastasis	1/10	0.010948052258043297	0.027447776182696535	0	0	105.65608465608466	476.99429568907004	MAPK3
Oculocutaneous albinism type 1	1/10	0.010948052258043297	0.027447776182696535	0	0	105.65608465608466	476.99429568907004	HIF1A
Papilledema	1/10	0.010948052258043297	0.027447776182696535	0	0	105.65608465608466	476.99429568907004	CTNNB1
Cutaneous anaphylaxis	1/10	0.010948052258043297	0.027447776182696535	0	0	105.65608465608466	476.99429568907004	HDAC3
Pilomatrixoma	1/10	0.010948052258043297	0.027447776182696535	0	0	105.65608465608466	476.99429568907004	CTNNB1
Pressure Ulcer	1/10	0.010948052258043297	0.027447776182696535	0	0	105.65608465608466	476.99429568907004	HIF1A
Pulmonary lymphangioleiomyomatosis	1/10	0.010948052258043297	0.027447776182696535	0	0	105.65608465608466	476.99429568907004	PGR
Embryo Loss	1/10	0.010948052258043297	0.027447776182696535	0	0	105.65608465608466	476.99429568907004	MAPK8
Mammary Carcinoma, Animal	2/145	0.010965212864884845	0.027447776182696535	0	0	13.87062937062937	62.59853157250422	UBE2I;PGR
Thrombocythemia, Essential	2/145	0.010965212864884845	0.027447776182696535	0	0	13.87062937062937	62.59853157250422	SMAD4;CTNNB1
Animal Mammary Neoplasms	2/145	0.010965212864884845	0.027447776182696535	0	0	13.87062937062937	62.59853157250422	UBE2I;PGR
Inflammation	3/429	0.011148111295370985	0.027870278238427464	0	0	7.246849518161601	32.58535150339571	CTNNB1;PGR;HIF1A
Hematological Disease	2/147	0.011255931824542001	0.028068769385695014	0	0	13.677931034482759	61.37096186020985	CREBBP;CTNNB1
Monosomy	2/147	0.011255931824542001	0.028068769385695014	0	0	13.677931034482759	61.37096186020985	CTNNB1;PGR
Adrenoleukodystrophy	2/149	0.011550053456011726	0.028765896060054422	0	0	13.49047619047619	60.18189405091592	CTNNB1;MAPK3
nervous system disorder	3/436	0.011646103109051627	0.028968581411054108	0	0	7.12714233621004	31.735622880182856	CREBBP;KAT5;FOS
Mild cognitive disorder	2/150	0.011698385603882498	0.029062027129142055	0	0	13.39864864864865	59.60126813005706	GSK3B;HIF1A
Pulmonary Hypertension	2/151	0.011847562817634955	0.029132574989773015	0	0	13.308053691275168	59.029643475571206	SMAD4;HIF1A
Osteochondrodysplasias	2/152	0.011997583236434258	0.029132574989773015	0	0	13.218666666666667	58.466824213888636	CREBBP;MAPK1
Amyloidosis	4/833	0.012003035337527326	0.029132574989773015	0	0	5.133092078809811	22.701591039555755	GSK3B;MAPK8;MAPK1;MAPK3
Osteoporosis	3/441	0.012009646053847139	0.029132574989773015	0	0	7.043979812545062	31.148796515138685	MAPK1;HIF1A;MAPK3
Recurrent Endometrial Cancer	1/11	0.012036547438812547	0.029132574989773015	0	0	95.08571428571429	420.26056624547704	PGR
Colitis, Ischemic	1/11	0.012036547438812547	0.029132574989773015	0	0	95.08571428571429	420.26056624547704	HIF1A
Shawl scrotum	1/11	0.012036547438812547	0.029132574989773015	0	0	95.08571428571429	420.26056624547704	CREBBP
Spontaneous pneumothorax	1/11	0.012036547438812547	0.029132574989773015	0	0	95.08571428571429	420.26056624547704	HIF1A
NEUROFIBROMATOSIS, TYPE 1-LIKE SYNDROME	1/11	0.012036547438812547	0.029132574989773015	0	0	95.08571428571429	420.26056624547704	MAPK1
Sturge-Weber Syndrome	1/11	0.012036547438812547	0.029132574989773015	0	0	95.08571428571429	420.26056624547704	HIF1A
High Grade Ovarian Serous Adenocarcinoma	1/11	0.012036547438812547	0.029132574989773015	0	0	95.08571428571429	420.26056624547704	PGR
Hyperoxia	1/11	0.012036547438812547	0.029132574989773015	0	0	95.08571428571429	420.26056624547704	HIF1A
Absent fingernail	1/11	0.012036547438812547	0.029132574989773015	0	0	95.08571428571429	420.26056624547704	MAPK1
Absent toenail	1/11	0.012036547438812547	0.029132574989773015	0	0	95.08571428571429	420.26056624547704	MAPK1
Analgesic Overuse Headache	1/11	0.012036547438812547	0.029132574989773015	0	0	95.08571428571429	420.26056624547704	HDAC3
Lipoatrophic Diabetes Mellitus	1/11	0.012036547438812547	0.029132574989773015	0	0	95.08571428571429	420.26056624547704	FOS
Arterial aneurysm	1/11	0.012036547438812547	0.029132574989773015	0	0	95.08571428571429	420.26056624547704	SMAD2
Non-Hereditary Clear Cell Renal Cell Carcinoma	1/11	0.012036547438812547	0.029132574989773015	0	0	95.08571428571429	420.26056624547704	HIF1A
Pityriasis Rubra Pilaris	1/11	0.012036547438812547	0.029132574989773015	0	0	95.08571428571429	420.26056624547704	MAPK3
Early onset schizophrenia	1/11	0.012036547438812547	0.029132574989773015	0	0	95.08571428571429	420.26056624547704	GSK3B
Pulmonary Blastoma	1/11	0.012036547438812547	0.029132574989773015	0	0	95.08571428571429	420.26056624547704	CTNNB1
Sezary Syndrome	2/153	0.012148445004617918	0.02931608294772908	0	0	13.13046357615894	57.91261996788644	CREBBP;MAPK1
Abdominal Pain	2/153	0.012148445004617918	0.02931608294772908	0	0	13.13046357615894	57.91261996788644	SMAD4;CTNNB1
Fatty Liver	3/443	0.012156897181868414	0.02931608294772908	0	0	7.011244019138756	30.91859474129331	MAPK8;HDAC3;MAPK3
Invasive Carcinoma	2/154	0.012300146266281639	0.029625352287690535	0	0	13.04342105263158	57.366845673926676	SMAD4;CTNNB1
Focal glomerulosclerosis	2/155	0.012452685165147954	0.02991977275081169	0	0	12.957516339869281	56.82932140040243	MAPK1;PIAS1
Abnormality of metabolism/homeostasis	2/155	0.012452685165147954	0.02991977275081169	0	0	12.957516339869281	56.82932140040243	CTNNB1;PGR
Curvature of little finger	2/157	0.012760268487644343	0.03062154345455356	0	0	12.789032258064516	55.7783277695483	CREBBP;MAPK1
Sporadic Breast Carcinoma	2/159	0.01307118020119427	0.030856787206465595	0	0	12.62484076433121	54.75829573373798	PGR;HIF1A
Clinodactyly of the 5th finger	2/159	0.01307118020119427	0.030856787206465595	0	0	12.62484076433121	54.75829573373798	CREBBP;MAPK1
ARTHROGRYPOSIS, DISTAL, TYPE 2B	1/12	0.013123899368825872	0.030856787206465595	0	0	86.43722943722943	374.56020373045595	HIF1A
Foot Ulcer	1/12	0.013123899368825872	0.030856787206465595	0	0	86.43722943722943	374.56020373045595	HIF1A
Glycogen Storage Disease Type VII	1/12	0.013123899368825872	0.030856787206465595	0	0	86.43722943722943	374.56020373045595	HIF1A
Melanoma, Experimental	1/12	0.013123899368825872	0.030856787206465595	0	0	86.43722943722943	374.56020373045595	HIF1A
Hamartomatous polyposis	1/12	0.013123899368825872	0.030856787206465595	0	0	86.43722943722943	374.56020373045595	SMAD4
Stage IV Colorectal Cancer	1/12	0.013123899368825872	0.030856787206465595	0	0	86.43722943722943	374.56020373045595	SMAD4
Trichoepithelioma	1/12	0.013123899368825872	0.030856787206465595	0	0	86.43722943722943	374.56020373045595	HIF1A
increased risk of pancreatic cancer	1/12	0.013123899368825872	0.030856787206465595	0	0	86.43722943722943	374.56020373045595	SMAD4
Influenza A	1/12	0.013123899368825872	0.030856787206465595	0	0	86.43722943722943	374.56020373045595	HIF1A
Acute mountain sickness	1/12	0.013123899368825872	0.030856787206465595	0	0	86.43722943722943	374.56020373045595	HIF1A
Lacrimal Duct Obstruction	1/12	0.013123899368825872	0.030856787206465595	0	0	86.43722943722943	374.56020373045595	CREBBP
Carcinoma of anal margin	1/12	0.013123899368825872	0.030856787206465595	0	0	86.43722943722943	374.56020373045595	SMAD4
Cardiac sarcoidosis	1/12	0.013123899368825872	0.030856787206465595	0	0	86.43722943722943	374.56020373045595	MAPK1
Myelokathexis	1/12	0.013123899368825872	0.030856787206465595	0	0	86.43722943722943	374.56020373045595	MAPK1
Obstruction of nasolacrimal duct	1/12	0.013123899368825872	0.030856787206465595	0	0	86.43722943722943	374.56020373045595	CREBBP
Juvenile psoriatic arthritis	2/161	0.01338540558187868	0.031434216437824486	0	0	12.464779874213836	53.767953572565595	MAPK1;FOS
Inflammatory dermatosis	2/163	0.01370292994885573	0.031928288506466646	0	0	12.308695652173913	52.80609654479609	HDAC3;MAPK3
Metastatic malignant neoplasm to brain	2/163	0.01370292994885573	0.031928288506466646	0	0	12.308695652173913	52.80609654479609	MAPK1;PGR
Atrial Septal Defects	2/165	0.014023738666224554	0.031928288506466646	0	0	12.156441717791411	51.87158259449825	CREBBP;MAPK3
Malaria	3/469	0.014167195360819984	0.031928288506466646	0	0	6.6112491529252315	28.14293842926529	CREBBP;MAPK1;FOS
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)	2/166	0.014185370094036713	0.031928288506466646	0	0	12.081707317073171	51.4142385392671	MAPK1;MAPK3
refractory plasma cell neoplasm	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	HIF1A
Breast Cancer, Familial Male	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	HIF1A
EPILEPSY, PYRIDOXINE-DEPENDENT	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	MAPK1
Gastrointestinal hamartomatous polyps	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	SMAD4
Sotos' syndrome	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	MAPK1
Hamartomatous polyp	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	CTNNB1
Hemangioblastic Meningioma	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	PGR
Hemangiopericytic Meningioma	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	PGR
Stage IV Colorectal Cancer AJCC v7	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	SMAD4
Subependymal Glioma	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	HIF1A
stage, pancreatic cancer	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	MAPK1
Abnormality of the abdominal wall	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	CTNNB1
Acute asthma	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	MAPK3
Waisman syndrome	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	MAPK8
Intraorbital Meningioma	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	PGR
Xanthomatous Meningioma	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	PGR
Intraventricular Meningioma	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	PGR
Angioblastic Meningioma	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	PGR
Angiomatous Meningioma	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	PGR
Lymphatic Abnormalities	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	MAPK1
Microcystic meningioma	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	PGR
cancer angiogenesis	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	HIF1A
Cerebral Cavernous Malformations 3	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	MAPK1
Cerebral Convexity Meningioma	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	PGR
Olfactory Groove Meningioma	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	PGR
Coffin-Lowry syndrome	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	MAPK1
Osteitis Fibrosa Disseminata	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	FOS
Parasagittal Meningioma	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	PGR
Patellar Dislocation	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	CREBBP
Peritoneal Neoplasms	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	CTNNB1
Phonophobia	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	CREBBP
Posterior Fossa Meningioma	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	PGR
Distal Spinal Muscular Atrophy	1/13	0.014210109163131231	0.031928288506466646	0	0	79.23015873015873	337.0293803138913	MAPK3
Progressive Neoplastic Disease	2/167	0.014347817139488146	0.03220106687555578	0	0	12.007878787878788	50.963328385132165	GSK3B;PGR
Juvenile-Onset Still Disease	2/168	0.014511077983134337	0.03249362700305024	0	0	11.934939759036144	50.51872528851306	MAPK1;FOS
Childhood Leukemia	2/168	0.014511077983134337	0.03249362700305024	0	0	11.934939759036144	50.51872528851306	HDAC2;FOS
Fibrosis	2/169	0.01467515081397942	0.03278667744073457	0	0	11.862874251497006	50.080305626643764	MAPK1;MAPK3
Progressive cGVHD	2/169	0.01467515081397942	0.03278667744073457	0	0	11.862874251497006	50.080305626643764	GSK3B;PGR
Intellectual Disability	7/2503	0.014748582601201276	0.03291350354505369	0	0	3.2685363247863246	13.782137381719286	SMAD4;CREBBP;CDK6;KAT5;CTNNB1;MAPK1;FOS
Reduced concentration span	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	CREBBP
Familial Exudative Vitreoretinopathy	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	CTNNB1
Cystadenoma, Serous	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	SMAD4
Fibromatosis	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	CTNNB1
Hashimoto's encephalitis	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	HIF1A
hemangiopericytoma	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	CTNNB1
Transitional Meningioma	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	PGR
Uterine Polyp	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	CTNNB1
Leiomyomatosis	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	PGR
Benign tumor of pancreas	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	SMAD4
Meningothelial meningioma	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	PGR
Micronodular cirrhosis	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	CTNNB1
Mirror movements disorder	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	CREBBP
Cancer Relapse	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	HIF1A
Cardio-facio-cutaneous syndrome	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	MAPK1
Myxoma of heart	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	MAPK3
Nephrogenic rest	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	CTNNB1
Other specified iron deficiency anemias	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	KAT5
Contralateral breast cancer	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	PGR
Copper-Overload Cirrhosis	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	SMAD2
Peritoneal Surface Malignancy	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	CTNNB1
Phosphate Diabetes	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	MAPK3
Pigmented lesions	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	HIF1A
Poikiloderma with Neutropenia	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	CREBBP
Disorder of endocrine ovary	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	HDAC3
Easily distracted	1/14	0.01529517792933681	0.03315913985778288	0	0	73.13186813186813	305.7071272789262	CREBBP
Pain	3/485	0.015493690398595307	0.03355267383467733	0	0	6.386547281065734	26.61480160046717	SMAD2;MAPK8;PGR
Anaplastic thyroid carcinoma	2/176	0.015846244334273996	0.034241064070231	0	0	11.381609195402298	47.17475280728676	CTNNB1;MAPK1
Mammary Tumorigenesis	2/176	0.015846244334273996	0.034241064070231	0	0	11.381609195402298	47.17475280728676	CTNNB1;PGR
Anemia	3/490	0.015922297835545298	0.03436780133901854	0	0	6.319355884577975	26.162353102446943	SMAD4;CDK6;HIF1A
Intrahepatic Cholangiocarcinoma	2/177	0.01601674803649822	0.034523730970841986	0	0	11.316	46.781705902376295	SMAD4;HIF1A
Crohn Disease	4/912	0.016295766767043293	0.034523730970841986	0	0	4.667156142927068	19.213981358365338	JUND;KAT5;MAPK1;FOS
Coronary heart disease	4/913	0.016355605144304168	0.034523730970841986	0	0	4.661777288839995	19.174750637499113	MAPK8;FOS;HIF1A;MAPK3
Myasthenia Gravis	2/179	0.016360140971545267	0.034523730970841986	0	0	11.187005649717515	46.01111754868441	MAPK1;MAPK3
Erythrophagocytosis	1/15	0.016379106794774147	0.034523730970841986	0	0	67.9047619047619	279.20731867751766	CREBBP
Carcinoma of urinary bladder, invasive	1/15	0.016379106794774147	0.034523730970841986	0	0	67.9047619047619	279.20731867751766	MAPK1
Glycogen Storage Disease Type V	1/15	0.016379106794774147	0.034523730970841986	0	0	67.9047619047619	279.20731867751766	HIF1A
Sphenoid Wing Meningioma	1/15	0.016379106794774147	0.034523730970841986	0	0	67.9047619047619	279.20731867751766	PGR
Hematochezia	1/15	0.016379106794774147	0.034523730970841986	0	0	67.9047619047619	279.20731867751766	SMAD4
PNEUMOTHORAX, PRIMARY SPONTANEOUS	1/15	0.016379106794774147	0.034523730970841986	0	0	67.9047619047619	279.20731867751766	HIF1A
Hereditary Paraganglioma	1/15	0.016379106794774147	0.034523730970841986	0	0	67.9047619047619	279.20731867751766	HIF1A
Thanatophoric Dysplasia	1/15	0.016379106794774147	0.034523730970841986	0	0	67.9047619047619	279.20731867751766	MAPK1
Uterine Corpus Carcinosarcoma	1/15	0.016379106794774147	0.034523730970841986	0	0	67.9047619047619	279.20731867751766	SMAD2
Bacterial sepsis	1/15	0.016379106794774147	0.034523730970841986	0	0	67.9047619047619	279.20731867751766	HIF1A
Nodular melanoma	1/15	0.016379106794774147	0.034523730970841986	0	0	67.9047619047619	279.20731867751766	HIF1A
Clear Cell Meningioma	1/15	0.016379106794774147	0.034523730970841986	0	0	67.9047619047619	279.20731867751766	PGR
Oestrogen receptor positive breast cancer	1/15	0.016379106794774147	0.034523730970841986	0	0	67.9047619047619	279.20731867751766	HIF1A
Periodic fever	1/15	0.016379106794774147	0.034523730970841986	0	0	67.9047619047619	279.20731867751766	MAPK1
Cyclocephaly	1/15	0.016379106794774147	0.034523730970841986	0	0	67.9047619047619	279.20731867751766	SMAD2
Poor coordination	1/15	0.016379106794774147	0.034523730970841986	0	0	67.9047619047619	279.20731867751766	CREBBP
Progesterone Resistance	1/15	0.016379106794774147	0.034523730970841986	0	0	67.9047619047619	279.20731867751766	PGR
Psammomatous Meningioma	1/15	0.016379106794774147	0.034523730970841986	0	0	67.9047619047619	279.20731867751766	PGR
MIXED LINEAGE LEUKEMIA	2/185	0.01740927559636096	0.03570108315216039	0	0	10.816939890710383	43.816742351570596	MAPK8;CDK6
Replication Error Phenotype	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	HDAC2
Cystadenocarcinoma, Mucinous	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	SMAD4
Fibrous Meningioma	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	PGR
Secretory meningioma	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	PGR
Focal Nodular Hyperplasia	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	CTNNB1
Focal nodular hyperplasia of liver	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	CTNNB1
Gaucher Disease, Type 3 (disorder)	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	MAPK1
Growth hormone excess	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	FOS
Spinal Meningioma	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	PGR
Stage III Colorectal Cancer	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	SMAD4
SPHEROCYTOSIS, TYPE 1 (disorder)	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	MAPK3
Thinking and speaking disturbances	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	HIF1A
Tonsillitis	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	HIF1A
Visceral angiomatosis	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	SMAD4
Adenocarcinoma of salivary gland	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	CDK6
Juvenile polyp	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	SMAD4
Lepidic Predominant Adenocarcinoma	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	MAPK3
Lhermitte-Duclos disease	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	HIF1A
Blastoma	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	CTNNB1
Microsatellite Instability	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	HDAC2
BREAST CANCER 3	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	HIF1A
Broad ribs	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	SMAD4
Myxoma of the Endocardium	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	MAPK3
Choroidal Neovascularization	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	HIF1A
Other anxiety states	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	HDAC2
Condyloma	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	PGR
Ovarian Granulosa Cell Tumor	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	CTNNB1
Papillary Meningioma	1/16	0.01746189687341111	0.03570108315216039	0	0	63.37460317460317	256.52354192445085	PGR
Vomiting	2/187	0.017765258385127766	0.03628374902857015	0	0	10.698918918918919	43.1221050948196	CTNNB1;MAPK3
Bronchopulmonary Dysplasia	2/188	0.017944417677846457	0.036611802596845815	0	0	10.640860215053763	42.78132529848109	GSK3B;HDAC2
Dermatitis	2/190	0.018305063253887765	0.036993444289397166	0	0	10.52659574468085	42.1124628968764	HDAC3;MAPK3
Transient Ischemic Attack	2/191	0.018486546019089473	0.036993444289397166	0	0	10.47037037037037	41.78423324351141	GSK3B;HIF1A
Enlargement of craniofacial bones	1/17	0.018543549289368706	0.036993444289397166	0	0	59.410714285714285	236.908142520545	SMAD4
Keratoconjunctivitis, Vernal	1/17	0.018543549289368706	0.036993444289397166	0	0	59.410714285714285	236.908142520545	SMAD2
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME	1/17	0.018543549289368706	0.036993444289397166	0	0	59.410714285714285	236.908142520545	CTNNB1
Hepatic necrosis	1/17	0.018543549289368706	0.036993444289397166	0	0	59.410714285714285	236.908142520545	CTNNB1
Thick craniofacial bones	1/17	0.018543549289368706	0.036993444289397166	0	0	59.410714285714285	236.908142520545	SMAD4
SYNOVITIS, GRANULOMATOUS, WITH UVEITIS AND CRANIAL NEUROPATHIES (disorder)	1/17	0.018543549289368706	0.036993444289397166	0	0	59.410714285714285	236.908142520545	MAPK1
Hyperkeratosis lenticularis perstans	1/17	0.018543549289368706	0.036993444289397166	0	0	59.410714285714285	236.908142520545	MAPK8
Hypertrophy of craniofacial bones	1/17	0.018543549289368706	0.036993444289397166	0	0	59.410714285714285	236.908142520545	SMAD4
Anal carcinoma	1/17	0.018543549289368706	0.036993444289397166	0	0	59.410714285714285	236.908142520545	SMAD4
Malignant Female Reproductive System Neoplasm	1/17	0.018543549289368706	0.036993444289397166	0	0	59.410714285714285	236.908142520545	PGR
Autosome Abnormalities	1/17	0.018543549289368706	0.036993444289397166	0	0	59.410714285714285	236.908142520545	CDK6
Biliary stricture	1/17	0.018543549289368706	0.036993444289397166	0	0	59.410714285714285	236.908142520545	SMAD4
Bone Cysts	1/17	0.018543549289368706	0.036993444289397166	0	0	59.410714285714285	236.908142520545	FOS
Chromosome Aberrations	1/17	0.018543549289368706	0.036993444289397166	0	0	59.410714285714285	236.908142520545	CDK6
Color blindness	1/17	0.018543549289368706	0.036993444289397166	0	0	59.410714285714285	236.908142520545	CREBBP
Overriding toe	1/17	0.018543549289368706	0.036993444289397166	0	0	59.410714285714285	236.908142520545	SMAD4
Coronary Restenosis	1/17	0.018543549289368706	0.036993444289397166	0	0	59.410714285714285	236.908142520545	MAPK1
Craniofacial hyperostosis	1/17	0.018543549289368706	0.036993444289397166	0	0	59.410714285714285	236.908142520545	SMAD4
Poisoning	1/17	0.018543549289368706	0.036993444289397166	0	0	59.410714285714285	236.908142520545	GSK3B
Portal vein thrombosis	1/17	0.018543549289368706	0.036993444289397166	0	0	59.410714285714285	236.908142520545	CTNNB1
Inflammatory disorder	2/192	0.01866879976749371	0.03720573112088807	0	0	10.414736842105263	41.46004266439194	MAPK1;HIF1A
Allergic asthma	2/197	0.019591572002695453	0.03852637049034465	0	0	10.145128205128206	39.897297329224884	KAT5;HIF1A
Residual Cancer	1/18	0.019624065171284413	0.03852637049034465	0	0	55.91316526610644	219.7945772360195	HIF1A
Retinal ischemia	1/18	0.019624065171284413	0.03852637049034465	0	0	55.91316526610644	219.7945772360195	HIF1A
Decreased visual acuity, slowly progressive	1/18	0.019624065171284413	0.03852637049034465	0	0	55.91316526610644	219.7945772360195	CTNNB1
Heat Stroke	1/18	0.019624065171284413	0.03852637049034465	0	0	55.91316526610644	219.7945772360195	FOS
Papillary renal cell carcinoma, sporadic	1/18	0.019624065171284413	0.03852637049034465	0	0	55.91316526610644	219.7945772360195	HIF1A
Human immunodeficiency virus II infection	1/18	0.019624065171284413	0.03852637049034465	0	0	55.91316526610644	219.7945772360195	MAPK8
Infection by Candida albicans	1/18	0.019624065171284413	0.03852637049034465	0	0	55.91316526610644	219.7945772360195	MAPK8
Kabuki make-up syndrome	1/18	0.019624065171284413	0.03852637049034465	0	0	55.91316526610644	219.7945772360195	MAPK1
Malignant neoplasm tonsil	1/18	0.019624065171284413	0.03852637049034465	0	0	55.91316526610644	219.7945772360195	HIF1A
Myoma	1/18	0.019624065171284413	0.03852637049034465	0	0	55.91316526610644	219.7945772360195	PGR
Narrowing	1/18	0.019624065171284413	0.03852637049034465	0	0	55.91316526610644	219.7945772360195	NCOR2
Choroid Plexus Carcinoma	1/18	0.019624065171284413	0.03852637049034465	0	0	55.91316526610644	219.7945772360195	SMAD2
Pancreatic carcinoma resectable	1/18	0.019624065171284413	0.03852637049034465	0	0	55.91316526610644	219.7945772360195	SMAD4
Degeneration of lumbar intervertebral disc	1/18	0.019624065171284413	0.03852637049034465	0	0	55.91316526610644	219.7945772360195	HIF1A
Cognitive delay	4/966	0.019730968549647086	0.038697778436497514	0	0	4.392700392700393	17.243834738511353	SMAD4;CDK6;CTNNB1;MAPK1
Arteriovenous Malformations, Cerebral	1/19	0.020703445636816073	0.039930962043663816	0	0	52.804232804232804	204.7460437251252	SMAD4
Flared iliac wings	1/19	0.020703445636816073	0.039930962043663816	0	0	52.804232804232804	204.7460437251252	CREBBP
Self Mutilation	1/19	0.020703445636816073	0.039930962043663816	0	0	52.804232804232804	204.7460437251252	CREBBP
Leukemia, Monocytic, Chronic	1/19	0.020703445636816073	0.039930962043663816	0	0	52.804232804232804	204.7460437251252	HDAC2
Slow decrease in visual acuity	1/19	0.020703445636816073	0.039930962043663816	0	0	52.804232804232804	204.7460437251252	CTNNB1
Melanoma, Amelanotic	1/19	0.020703445636816073	0.039930962043663816	0	0	52.804232804232804	204.7460437251252	HIF1A
THANATOPHORIC DYSPLASIA, TYPE I (disorder)	1/19	0.020703445636816073	0.039930962043663816	0	0	52.804232804232804	204.7460437251252	MAPK1
Tuberculosis, Drug-Resistant	1/19	0.020703445636816073	0.039930962043663816	0	0	52.804232804232804	204.7460437251252	MAPK1
ABLEPHARON-MACROSTOMIA SYNDROME	1/19	0.020703445636816073	0.039930962043663816	0	0	52.804232804232804	204.7460437251252	HIF1A
Abnormality of the musculature	1/19	0.020703445636816073	0.039930962043663816	0	0	52.804232804232804	204.7460437251252	CTNNB1
Agoraphobia	1/19	0.020703445636816073	0.039930962043663816	0	0	52.804232804232804	204.7460437251252	CREBBP
Legg-Calve-Perthes Disease	1/19	0.020703445636816073	0.039930962043663816	0	0	52.804232804232804	204.7460437251252	CREBBP
Apert syndrome	1/19	0.020703445636816073	0.039930962043663816	0	0	52.804232804232804	204.7460437251252	MAPK8
Back Pain	1/19	0.020703445636816073	0.039930962043663816	0	0	52.804232804232804	204.7460437251252	SMAD4
Multiple adenomatous polyps	1/19	0.020703445636816073	0.039930962043663816	0	0	52.804232804232804	204.7460437251252	HDAC2
Carcinoma in situ of endometrium	1/19	0.020703445636816073	0.039930962043663816	0	0	52.804232804232804	204.7460437251252	CTNNB1
Cholecystitis	1/19	0.020703445636816073	0.039930962043663816	0	0	52.804232804232804	204.7460437251252	SMAD4
Coronary Artery Disease	4/981	0.02076013618308221	0.04000123801130475	0	0	4.321846923689298	16.745949568151598	MAPK8;MAPK1;FOS;HIF1A
Osteogenesis Imperfecta	2/204	0.020915346369852938	0.04026102249557462	0	0	9.79009900990099	37.86097688832336	SMAD4;CREBBP
Thymoma	2/205	0.021107464447248363	0.04059127778316993	0	0	9.741379310344827	37.583493495174864	GSK3B;MAPK3
Childhood Osteosarcoma	2/206	0.021300329231656354	0.04092232512891177	0	0	9.693137254901961	37.30920273952528	MAPK8;FOS
Metabolic Syndrome X	3/548	0.02138896951426314	0.041048512723735796	0	0	5.630033800096571	21.646803980663822	MAPK8;HDAC3;MAPK3
Visual seizure	2/207	0.02149393899970625	0.041048512723735796	0	0	9.645365853658536	37.03805335496648	HDAC2;FOS
Polycythemia Vera	2/207	0.02149393899970625	0.041048512723735796	0	0	9.645365853658536	37.03805335496648	XRCC5;CTNNB1
Deafness, Acquired	1/20	0.02178169181492411	0.041048512723735796	0	0	50.02255639097744	191.42059056605152	SMAD4
Hearing Loss, Extreme	1/20	0.02178169181492411	0.041048512723735796	0	0	50.02255639097744	191.42059056605152	SMAD4
Solitary fibrous tumor	1/20	0.02178169181492411	0.041048512723735796	0	0	50.02255639097744	191.42059056605152	CTNNB1
Impulsive Behavior	1/20	0.02178169181492411	0.041048512723735796	0	0	50.02255639097744	191.42059056605152	CREBBP
Adenosis of Breast	1/20	0.02178169181492411	0.041048512723735796	0	0	50.02255639097744	191.42059056605152	PGR
Arteriosclerosis Obliterans	1/20	0.02178169181492411	0.041048512723735796	0	0	50.02255639097744	191.42059056605152	HIF1A
Beta thalassemia intermedia	1/20	0.02178169181492411	0.041048512723735796	0	0	50.02255639097744	191.42059056605152	SMAD2
Bilateral Deafness	1/20	0.02178169181492411	0.041048512723735796	0	0	50.02255639097744	191.42059056605152	SMAD4
Morphologically abnormal structure (morphologic abnormality)	1/20	0.02178169181492411	0.041048512723735796	0	0	50.02255639097744	191.42059056605152	UBE2I
Chronic multifocal osteomyelitis	1/20	0.02178169181492411	0.041048512723735796	0	0	50.02255639097744	191.42059056605152	MAPK3
Chronic ulcerative colitis	1/20	0.02178169181492411	0.041048512723735796	0	0	50.02255639097744	191.42059056605152	CTNNB1
Complete Hearing Loss	1/20	0.02178169181492411	0.041048512723735796	0	0	50.02255639097744	191.42059056605152	SMAD4
Deaf Mutism	1/20	0.02178169181492411	0.041048512723735796	0	0	50.02255639097744	191.42059056605152	SMAD4
Placental Choriocarcinoma	1/20	0.02178169181492411	0.041048512723735796	0	0	50.02255639097744	191.42059056605152	PGR
Poikiloderma	1/20	0.02178169181492411	0.041048512723735796	0	0	50.02255639097744	191.42059056605152	CREBBP
Destructive Arthritis	1/20	0.02178169181492411	0.041048512723735796	0	0	50.02255639097744	191.42059056605152	MAPK1
Prune Belly Syndrome	1/20	0.02178169181492411	0.041048512723735796	0	0	50.02255639097744	191.42059056605152	HIF1A
Hematologic Neoplasms	3/557	0.022319458031141593	0.04202185854290243	0	0	5.536006080182405	21.049536119277608	SMAD2;CREBBP;CDK6
Congenital contractural arachnodactyly	2/212	0.022473102781810455	0.04227083618483395	0	0	9.413333333333334	35.72770531271647	SMAD4;MAPK3
Lymphoma, Follicular, Grade 2	1/21	0.022858804833681204	0.04255055565176284	0	0	47.51904761904762	179.54686782262274	CREBBP
Lymphoma, Mixed-Cell, Follicular	1/21	0.022858804833681204	0.04255055565176284	0	0	47.51904761904762	179.54686782262274	CREBBP
Lymphoma, Small Cleaved-Cell, Follicular	1/21	0.022858804833681204	0.04255055565176284	0	0	47.51904761904762	179.54686782262274	CREBBP
SMITH-MCCORT DYSPLASIA 1	1/21	0.022858804833681204	0.04255055565176284	0	0	47.51904761904762	179.54686782262274	PGR
Meningiomas, Multiple	1/21	0.022858804833681204	0.04255055565176284	0	0	47.51904761904762	179.54686782262274	PGR
Intestinal Polyposis	1/21	0.022858804833681204	0.04255055565176284	0	0	47.51904761904762	179.54686782262274	CTNNB1
Little's Disease	1/21	0.022858804833681204	0.04255055565176284	0	0	47.51904761904762	179.54686782262274	CTNNB1
Lumbar disc disease	1/21	0.022858804833681204	0.04255055565176284	0	0	47.51904761904762	179.54686782262274	HIF1A
Chronic venous insufficiency	1/21	0.022858804833681204	0.04255055565176284	0	0	47.51904761904762	179.54686782262274	MAPK3
pathologic fistula	1/21	0.022858804833681204	0.04255055565176284	0	0	47.51904761904762	179.54686782262274	MAPK3
Duane Retraction Syndrome	1/21	0.022858804833681204	0.04255055565176284	0	0	47.51904761904762	179.54686782262274	CREBBP
Lymphoproliferative Disorders	2/215	0.023069431684193193	0.0429021916914139	0	0	9.279342723004694	34.976133249960554	CDK6;XRCC5
Steatohepatitis	3/569	0.023594642544447684	0.043688726414973185	0	0	5.415287334945137	20.2896498612919	MAPK8;HDAC3;MAPK3
Renal Artery Stenosis	1/22	0.023934785813165056	0.043688726414973185	0	0	45.25396825396825	168.9069250201691	HIF1A
Restrictive cardiomyopathy	1/22	0.023934785813165056	0.043688726414973185	0	0	45.25396825396825	168.9069250201691	MAPK8
Familial generalized lipodystrophy	1/22	0.023934785813165056	0.043688726414973185	0	0	45.25396825396825	168.9069250201691	FOS
Short finger	1/22	0.023934785813165056	0.043688726414973185	0	0	45.25396825396825	168.9069250201691	SMAD4
Lymphoma, Follicular, Grade 3	1/22	0.023934785813165056	0.043688726414973185	0	0	45.25396825396825	168.9069250201691	CREBBP
Pancreatic carcinoma, familial	1/22	0.023934785813165056	0.043688726414973185	0	0	45.25396825396825	168.9069250201691	SMAD4
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	1/22	0.023934785813165056	0.043688726414973185	0	0	45.25396825396825	168.9069250201691	MAPK3
THYROID CARCINOMA, SPORADIC MEDULLARY	1/22	0.023934785813165056	0.043688726414973185	0	0	45.25396825396825	168.9069250201691	CDK6
Hypoplastic finger	1/22	0.023934785813165056	0.043688726414973185	0	0	45.25396825396825	168.9069250201691	SMAD4
Wasting	1/22	0.023934785813165056	0.043688726414973185	0	0	45.25396825396825	168.9069250201691	SMAD4
Intracranial Meningioma	1/22	0.023934785813165056	0.043688726414973185	0	0	45.25396825396825	168.9069250201691	PGR
Adrenal Cancer	1/22	0.023934785813165056	0.043688726414973185	0	0	45.25396825396825	168.9069250201691	CTNNB1
Laryngomalacia	1/22	0.023934785813165056	0.043688726414973185	0	0	45.25396825396825	168.9069250201691	CREBBP
ANOPHTHALMIA AND PULMONARY HYPOPLASIA	1/22	0.023934785813165056	0.043688726414973185	0	0	45.25396825396825	168.9069250201691	SMAD4
Bare Lymphocyte Syndrome	1/22	0.023934785813165056	0.043688726414973185	0	0	45.25396825396825	168.9069250201691	MAPK1
Basal-Like Breast Carcinoma	1/22	0.023934785813165056	0.043688726414973185	0	0	45.25396825396825	168.9069250201691	PGR
Nephrosclerosis	1/22	0.023934785813165056	0.043688726414973185	0	0	45.25396825396825	168.9069250201691	HIF1A
Other specified manifestations of hyperkinetic syndrome	1/22	0.023934785813165056	0.043688726414973185	0	0	45.25396825396825	168.9069250201691	CREBBP
Prelingual Deafness	1/22	0.023934785813165056	0.043688726414973185	0	0	45.25396825396825	168.9069250201691	SMAD4
Nonorganic psychosis	2/220	0.02407788406722227	0.04390934536727976	0	0	9.064220183486238	33.77746784371144	HDAC2;FOS
Acute Erythroblastic Leukemia	2/224	0.024897638535404422	0.04506754640550183	0	0	8.899099099099098	32.86421561860828	MAPK8;MAPK1
Rubinstein-Taybi Syndrome	1/23	0.025009635878698734	0.04506754640550183	0	0	43.1948051948052	159.3237838191313	CREBBP
fibroma	1/23	0.025009635878698734	0.04506754640550183	0	0	43.1948051948052	159.3237838191313	CTNNB1
Skin Diseases, Infectious	1/23	0.025009635878698734	0.04506754640550183	0	0	43.1948051948052	159.3237838191313	HIF1A
Tumor Necrosis Factor Receptor 1-Associated Periodic Syndrome	1/23	0.025009635878698734	0.04506754640550183	0	0	43.1948051948052	159.3237838191313	FOS
Hypoxic-Ischemic Encephalopathy	1/23	0.025009635878698734	0.04506754640550183	0	0	43.1948051948052	159.3237838191313	HIF1A
Varicocele	1/23	0.025009635878698734	0.04506754640550183	0	0	43.1948051948052	159.3237838191313	HIF1A
Increased gastric cancer	1/23	0.025009635878698734	0.04506754640550183	0	0	43.1948051948052	159.3237838191313	CTNNB1
Involuntary Movements	1/23	0.025009635878698734	0.04506754640550183	0	0	43.1948051948052	159.3237838191313	MAPK3
Chronic glomerulonephritis	1/23	0.025009635878698734	0.04506754640550183	0	0	43.1948051948052	159.3237838191313	HIF1A
Congenital dislocation of radial head	1/23	0.025009635878698734	0.04506754640550183	0	0	43.1948051948052	159.3237838191313	CREBBP
Persistant truncus arteriosus	1/23	0.025009635878698734	0.04506754640550183	0	0	43.1948051948052	159.3237838191313	MAPK1
Cryptogenic Chronic Hepatitis	1/23	0.025009635878698734	0.04506754640550183	0	0	43.1948051948052	159.3237838191313	SMAD2
Graft-vs-Host Disease	2/226	0.02531180977943735	0.04552898389288594	0	0	8.81875	32.42199506044415	KAT5;MAPK1
Ventricular Septal Defects	2/226	0.02531180977943735	0.04552898389288594	0	0	8.81875	32.42199506044415	SMAD2;CREBBP
Neurogenic Muscular Atrophy	2/228	0.025728825920877788	0.04623697105890231	0	0	8.739823008849557	31.989004493355413	GSK3B;CTNNB1
Fetal Alcohol Spectrum Disorders	1/24	0.026083356159203222	0.04632610468923234	0	0	41.31469979296066	150.65231192236567	MAPK1
Secondary hypothyroidism	1/24	0.026083356159203222	0.04632610468923234	0	0	41.31469979296066	150.65231192236567	CTNNB1
Focal Segmental Glomerulosclerosis, Not Otherwise Specified	1/24	0.026083356159203222	0.04632610468923234	0	0	41.31469979296066	150.65231192236567	MAPK1
Gardner Syndrome	1/24	0.026083356159203222	0.04632610468923234	0	0	41.31469979296066	150.65231192236567	CTNNB1
Leukemia, Mast-Cell	1/24	0.026083356159203222	0.04632610468923234	0	0	41.31469979296066	150.65231192236567	CTNNB1
Thickened calvaria	1/24	0.026083356159203222	0.04632610468923234	0	0	41.31469979296066	150.65231192236567	SMAD4
Increased thickness of cranium	1/24	0.026083356159203222	0.04632610468923234	0	0	41.31469979296066	150.65231192236567	SMAD4
Intestinal Pseudo-Obstruction	1/24	0.026083356159203222	0.04632610468923234	0	0	41.31469979296066	150.65231192236567	SMAD4
Bronchitis	1/24	0.026083356159203222	0.04632610468923234	0	0	41.31469979296066	150.65231192236567	HDAC2
Childhood Solid Neoplasm	1/24	0.026083356159203222	0.04632610468923234	0	0	41.31469979296066	150.65231192236567	XRCC6
Complications of Diabetes Mellitus	1/24	0.026083356159203222	0.04632610468923234	0	0	41.31469979296066	150.65231192236567	HIF1A
Paroxysmal nonkinesigenic dyskinesia	1/24	0.026083356159203222	0.04632610468923234	0	0	41.31469979296066	150.65231192236567	HIF1A
Dupuytren's Disease	1/24	0.026083356159203222	0.04632610468923234	0	0	41.31469979296066	150.65231192236567	MAPK1
Hyperlipidemia	2/232	0.026571339796382116	0.047065826096730656	0	0	8.58608695652174	31.149654581957325	MAPK1;HIF1A
Hypoglycemia	2/232	0.026571339796382116	0.047065826096730656	0	0	8.58608695652174	31.149654581957325	MAPK8;HIF1A
Metastasis from malignant tumor of prostate	2/232	0.026571339796382116	0.047065826096730656	0	0	8.58608695652174	31.149654581957325	MAPK8;HIF1A
Autoimmune Diseases	4/1060	0.026734812853167336	0.047312952853947564	0	0	3.981902356902357	14.421609003237108	CREBBP;HDAC3;KAT5;MAPK1
Epstein-Barr Virus Infections	2/234	0.02699681108868059	0.047631435931420815	0	0	8.511206896551725	30.742790205835593	MAPK8;MAPK1
Familial erythrocytosis	1/25	0.027155947776597387	0.047631435931420815	0	0	39.59126984126984	142.77242140898989	HIF1A
Hemangioma, Cavernous	1/25	0.027155947776597387	0.047631435931420815	0	0	39.59126984126984	142.77242140898989	SMAD4
Frontal lobe hypoplasia	1/25	0.027155947776597387	0.047631435931420815	0	0	39.59126984126984	142.77242140898989	CDK6
Lymphoma, Follicular, Grade 1	1/25	0.027155947776597387	0.047631435931420815	0	0	39.59126984126984	142.77242140898989	CREBBP
Uterine Carcinosarcoma	1/25	0.027155947776597387	0.047631435931420815	0	0	39.59126984126984	142.77242140898989	SMAD2
Cancer of Digestive System	1/25	0.027155947776597387	0.047631435931420815	0	0	39.59126984126984	142.77242140898989	HIF1A
Non-infiltrating lobular carcinoma	1/25	0.027155947776597387	0.047631435931420815	0	0	39.59126984126984	142.77242140898989	PGR
Diabetes Insipidus	1/25	0.027155947776597387	0.047631435931420815	0	0	39.59126984126984	142.77242140898989	PGR
Diabetic foot ulcer	1/25	0.027155947776597387	0.047631435931420815	0	0	39.59126984126984	142.77242140898989	HIF1A
Epidermolysis Bullosa Simplex	1/26	0.028227411859507716	0.04898869808657974	0	0	38.005714285714284	135.5839309094672	MAPK8
Carcinoid, Goblet Cell	1/26	0.028227411859507716	0.04898869808657974	0	0	38.005714285714284	135.5839309094672	SMAD4
Hereditary nonpolyposis colorectal carcinoma	1/26	0.028227411859507716	0.04898869808657974	0	0	38.005714285714284	135.5839309094672	CTNNB1
Hyperprolactinemia	1/26	0.028227411859507716	0.04898869808657974	0	0	38.005714285714284	135.5839309094672	CTNNB1
Yellow Fever	1/26	0.028227411859507716	0.04898869808657974	0	0	38.005714285714284	135.5839309094672	MAPK1
Adult T Acute Lymphoblastic Leukemia	1/26	0.028227411859507716	0.04898869808657974	0	0	38.005714285714284	135.5839309094672	KAT5
Klatskin Tumor	1/26	0.028227411859507716	0.04898869808657974	0	0	38.005714285714284	135.5839309094672	HIF1A
Malignant Uterine Corpus Neoplasm	1/26	0.028227411859507716	0.04898869808657974	0	0	38.005714285714284	135.5839309094672	CTNNB1
Bare lymphocyte syndrome 2	1/26	0.028227411859507716	0.04898869808657974	0	0	38.005714285714284	135.5839309094672	MAPK1
Menkes Kinky Hair Syndrome	1/26	0.028227411859507716	0.04898869808657974	0	0	38.005714285714284	135.5839309094672	MAPK1
Carpal Tunnel Syndrome	1/26	0.028227411859507716	0.04898869808657974	0	0	38.005714285714284	135.5839309094672	PGR
Cortical gyral simplification	1/26	0.028227411859507716	0.04898869808657974	0	0	38.005714285714284	135.5839309094672	CDK6
Pituitary Diseases	2/240	0.028289924528736972	0.049054083357555324	0	0	8.294117647058824	29.57059930374123	HDAC2;MAPK1
Metastatic Prostate Carcinoma	2/241	0.028507861611188002	0.049388619896575704	0	0	8.258995815899581	29.38200020905147	MAPK8;HIF1A
Vitiligo	2/243	0.028945793832710322	0.049924983014877695	0	0	8.189626556016597	29.010362919697524	MAPK1;MAPK3
Precursor Cell Lymphoblastic Leukemia Lymphoma	3/618	0.029211927498130525	0.049924983014877695	0	0	4.971245186136072	17.564295004908622	CREBBP;CDK6;MAPK1
Chronic Infantile Neurological, Cutaneous, and Articular Syndrome	1/27	0.029297749526199113	0.049924983014877695	0	0	36.54212454212454	129.00263688319484	MAPK1
Rothmund-Thomson syndrome	1/27	0.029297749526199113	0.049924983014877695	0	0	36.54212454212454	129.00263688319484	CREBBP
Encephalopathy, Toxic	1/27	0.029297749526199113	0.049924983014877695	0	0	36.54212454212454	129.00263688319484	FOS
Fused vertebrae	1/27	0.029297749526199113	0.049924983014877695	0	0	36.54212454212454	129.00263688319484	SMAD4
Hereditary Leiomyomatosis and Renal Cell Cancer	1/27	0.029297749526199113	0.049924983014877695	0	0	36.54212454212454	129.00263688319484	HIF1A
Toxic Encephalitis	1/27	0.029297749526199113	0.049924983014877695	0	0	36.54212454212454	129.00263688319484	FOS
Vascular anomaly	1/27	0.029297749526199113	0.049924983014877695	0	0	36.54212454212454	129.00263688319484	SMAD4
Vertebral body fusion	1/27	0.029297749526199113	0.049924983014877695	0	0	36.54212454212454	129.00263688319484	SMAD4
Intracranial Astrocytoma	1/27	0.029297749526199113	0.049924983014877695	0	0	36.54212454212454	129.00263688319484	HIF1A
Lobular carcinoma in situ of breast	1/27	0.029297749526199113	0.049924983014877695	0	0	36.54212454212454	129.00263688319484	PGR
Loss of appetite (finding)	1/27	0.029297749526199113	0.049924983014877695	0	0	36.54212454212454	129.00263688319484	SMAD4
Autosomal Recessive Primary Microcephaly	1/27	0.029297749526199113	0.049924983014877695	0	0	36.54212454212454	129.00263688319484	CDK6
Mucinous neoplasm	1/27	0.029297749526199113	0.049924983014877695	0	0	36.54212454212454	129.00263688319484	HIF1A
Childhood Cerebral Astrocytoma	1/27	0.029297749526199113	0.049924983014877695	0	0	36.54212454212454	129.00263688319484	HIF1A
Congenital central hypoventilation	1/27	0.029297749526199113	0.049924983014877695	0	0	36.54212454212454	129.00263688319484	CREBBP
Congenital vascular anomaly	1/27	0.029297749526199113	0.049924983014877695	0	0	36.54212454212454	129.00263688319484	SMAD4
Decreased albumin	1/27	0.029297749526199113	0.049924983014877695	0	0	36.54212454212454	129.00263688319484	SMAD4
Acute myocardial infarction	2/247	0.029829845106883916	0.05074413788638737	0	0	8.054285714285715	28.28863175993996	MAPK1;HIF1A
Diabetic Retinopathy	2/247	0.029829845106883916	0.05074413788638737	0	0	8.054285714285715	28.28863175993996	HIF1A;MAPK3
Global developmental delay	4/1102	0.03029946316157308	0.05121669492648902	0	0	3.821088848411253	13.360915880008259	SMAD4;CDK6;CTNNB1;MAPK1
Single kidney	1/28	0.030366961903249945	0.05121669492648902	0	0	35.18694885361552	122.95727551819456	CDK6
Spina Bifida Occulta	1/28	0.030366961903249945	0.05121669492648902	0	0	35.18694885361552	122.95727551819456	CREBBP
Tumor Expansion	1/28	0.030366961903249945	0.05121669492648902	0	0	35.18694885361552	122.95727551819456	HIF1A
Viral myocarditis	1/28	0.030366961903249945	0.05121669492648902	0	0	35.18694885361552	122.95727551819456	MAPK3
Benign Meningioma	1/28	0.030366961903249945	0.05121669492648902	0	0	35.18694885361552	122.95727551819456	PGR
Cerebral Astrocytoma	1/28	0.030366961903249945	0.05121669492648902	0	0	35.18694885361552	122.95727551819456	HIF1A
Chronic colitis	1/28	0.030366961903249945	0.05121669492648902	0	0	35.18694885361552	122.95727551819456	SMAD4
Odontogenic Tumors	1/28	0.030366961903249945	0.05121669492648902	0	0	35.18694885361552	122.95727551819456	CTNNB1
Plasma cell dyscrasia	1/28	0.030366961903249945	0.05121669492648902	0	0	35.18694885361552	122.95727551819456	MAPK1
Recurrent major depressive episodes	1/29	0.031435050111481094	0.0521716167816598	0	0	33.92857142857143	117.38714910240454	GSK3B
Stage IV Breast Cancer AJCC v6 and v7	1/29	0.031435050111481094	0.0521716167816598	0	0	33.92857142857143	117.38714910240454	CDK6
Staphylococcus aureus infection	1/29	0.031435050111481094	0.0521716167816598	0	0	33.92857142857143	117.38714910240454	HIF1A
Hereditary hemorrhagic telangiectasia	1/29	0.031435050111481094	0.0521716167816598	0	0	33.92857142857143	117.38714910240454	SMAD4
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C	1/29	0.031435050111481094	0.0521716167816598	0	0	33.92857142857143	117.38714910240454	MAPK1
Treatment related leukaemia	1/29	0.031435050111481094	0.0521716167816598	0	0	33.92857142857143	117.38714910240454	CREBBP
Acute monocytic/monoblastic leukemia	1/29	0.031435050111481094	0.0521716167816598	0	0	33.92857142857143	117.38714910240454	CREBBP
Intermittent Claudication	1/29	0.031435050111481094	0.0521716167816598	0	0	33.92857142857143	117.38714910240454	HIF1A
Asbestosis	1/29	0.031435050111481094	0.0521716167816598	0	0	33.92857142857143	117.38714910240454	MAPK1
Breast cancer recurrent	1/29	0.031435050111481094	0.0521716167816598	0	0	33.92857142857143	117.38714910240454	NCOR2
Muckle-Wells Syndrome	1/29	0.031435050111481094	0.0521716167816598	0	0	33.92857142857143	117.38714910240454	MAPK1
Multiple endocrine neoplasia Type 2	1/29	0.031435050111481094	0.0521716167816598	0	0	33.92857142857143	117.38714910240454	MAPK1
Cholesterol gallstones	1/29	0.031435050111481094	0.0521716167816598	0	0	33.92857142857143	117.38714910240454	HIF1A
Contiguous gene syndrome	1/29	0.031435050111481094	0.0521716167816598	0	0	33.92857142857143	117.38714910240454	CREBBP
Costello syndrome (disorder)	1/29	0.031435050111481094	0.0521716167816598	0	0	33.92857142857143	117.38714910240454	MAPK1
Pierre Robin Syndrome	1/29	0.031435050111481094	0.0521716167816598	0	0	33.92857142857143	117.38714910240454	MAPK1
Diffusely thickened skin	1/29	0.031435050111481094	0.0521716167816598	0	0	33.92857142857143	117.38714910240454	SMAD4
Discordant ventriculoarterial connection	1/29	0.031435050111481094	0.0521716167816598	0	0	33.92857142857143	117.38714910240454	HIF1A
Dysgerminoma	1/29	0.031435050111481094	0.0521716167816598	0	0	33.92857142857143	117.38714910240454	CTNNB1
Carcinoma, Signet Ring Cell	1/30	0.03250201526892278	0.053138642513346435	0	0	32.756978653530375	112.24025378249362	SMAD4
Hemorrhagic Fevers, Viral	1/30	0.03250201526892278	0.053138642513346435	0	0	32.756978653530375	112.24025378249362	UBE2I
High grade serous carcinoma	1/30	0.03250201526892278	0.053138642513346435	0	0	32.756978653530375	112.24025378249362	PGR
Hyperplasia of supraorbital margins	1/30	0.03250201526892278	0.053138642513346435	0	0	32.756978653530375	112.24025378249362	FOS
Hyperplasia of supraorbital ridge	1/30	0.03250201526892278	0.053138642513346435	0	0	32.756978653530375	112.24025378249362	FOS
Tongue Neoplasms	1/30	0.03250201526892278	0.053138642513346435	0	0	32.756978653530375	112.24025378249362	HIF1A
Hypertrophy of supraorbital margins	1/30	0.03250201526892278	0.053138642513346435	0	0	32.756978653530375	112.24025378249362	FOS
Hypertrophy of supraorbital ridge	1/30	0.03250201526892278	0.053138642513346435	0	0	32.756978653530375	112.24025378249362	FOS
Lymphoid neoplasm	1/30	0.03250201526892278	0.053138642513346435	0	0	32.756978653530375	112.24025378249362	XRCC5
Bilateral Wilms Tumor	1/30	0.03250201526892278	0.053138642513346435	0	0	32.756978653530375	112.24025378249362	CTNNB1
Broad foot	1/30	0.03250201526892278	0.053138642513346435	0	0	32.756978653530375	112.24025378249362	FOS
Narrow palate	1/30	0.03250201526892278	0.053138642513346435	0	0	32.756978653530375	112.24025378249362	CREBBP
Overlap syndrome	1/30	0.03250201526892278	0.053138642513346435	0	0	32.756978653530375	112.24025378249362	SMAD4
Pancreatic Insufficiency	1/30	0.03250201526892278	0.053138642513346435	0	0	32.756978653530375	112.24025378249362	SMAD4
Congenital malformation syndrome	1/30	0.03250201526892278	0.053138642513346435	0	0	32.756978653530375	112.24025378249362	CREBBP
Prominent supraorbital ridges	1/30	0.03250201526892278	0.053138642513346435	0	0	32.756978653530375	112.24025378249362	FOS
Protoplasmic astrocytoma	1/30	0.03250201526892278	0.053138642513346435	0	0	32.756978653530375	112.24025378249362	HIF1A
Dysequilibrium syndrome	1/30	0.03250201526892278	0.053138642513346435	0	0	32.756978653530375	112.24025378249362	SMAD2
Hearing Loss, Partial	2/260	0.0327772727032382	0.05354434540024437	0	0	7.6434108527131785	26.12533046839452	SMAD4;CREBBP
Recurrent upper respiratory tract infection	1/31	0.03356785849795628	0.05416382396524808	0	0	31.663492063492065	107.4717897739846	CREBBP
Sebaceous Adenocarcinoma	1/31	0.03356785849795628	0.05416382396524808	0	0	31.663492063492065	107.4717897739846	CTNNB1
Spinal fusion	1/31	0.03356785849795628	0.05416382396524808	0	0	31.663492063492065	107.4717897739846	SMAD4
HIV Encephalopathy	1/31	0.03356785849795628	0.05416382396524808	0	0	31.663492063492065	107.4717897739846	XRCC5
Thick skin	1/31	0.03356785849795628	0.05416382396524808	0	0	31.663492063492065	107.4717897739846	SMAD4
Hyperdiploid B Acute Lymphoblastic Leukemia	1/31	0.03356785849795628	0.05416382396524808	0	0	31.663492063492065	107.4717897739846	CREBBP
Acute interstitial pneumonia	1/31	0.03356785849795628	0.05416382396524808	0	0	31.663492063492065	107.4717897739846	SMAD4
Intervertebral disc disorder	1/31	0.03356785849795628	0.05416382396524808	0	0	31.663492063492065	107.4717897739846	HIF1A
Invasive Skin Melanoma	1/31	0.03356785849795628	0.05416382396524808	0	0	31.663492063492065	107.4717897739846	MAPK1
AIDS-Associated Nephropathy	1/31	0.03356785849795628	0.05416382396524808	0	0	31.663492063492065	107.4717897739846	MAPK1
Large hand	1/31	0.03356785849795628	0.05416382396524808	0	0	31.663492063492065	107.4717897739846	FOS
Bright Disease	1/31	0.03356785849795628	0.05416382396524808	0	0	31.663492063492065	107.4717897739846	JUND
Mycoplasma-Induced Stevens-Johnson Syndrome	1/31	0.03356785849795628	0.05416382396524808	0	0	31.663492063492065	107.4717897739846	CTNNB1
Pericardial effusion	1/31	0.03356785849795628	0.05416382396524808	0	0	31.663492063492065	107.4717897739846	SMAD4
Drug-Induced Stevens Johnson Syndrome	1/31	0.03356785849795628	0.05416382396524808	0	0	31.663492063492065	107.4717897739846	CTNNB1
Myeloproliferative disease	2/264	0.033706643384423716	0.05434336382386681	0	0	7.525190839694656	25.51085092615022	CREBBP;CTNNB1
Fibrillation	1/32	0.034632580928246975	0.05520528436907811	0	0	30.640552995391705	103.04296619408238	HIF1A
Gastrinoma	1/32	0.034632580928246975	0.05520528436907811	0	0	30.640552995391705	103.04296619408238	SMAD4
Grade I Astrocytoma	1/32	0.034632580928246975	0.05520528436907811	0	0	30.640552995391705	103.04296619408238	HIF1A
Squamous cell carcinoma of the hypopharynx	1/32	0.034632580928246975	0.05520528436907811	0	0	30.640552995391705	103.04296619408238	CDK6
HIV encephalitis	1/32	0.034632580928246975	0.05520528436907811	0	0	30.640552995391705	103.04296619408238	XRCC5
Increased hepatocellular carcinoma risk	1/32	0.034632580928246975	0.05520528436907811	0	0	30.640552995391705	103.04296619408238	CTNNB1
Increased incidence of hepatocellular carcinoma	1/32	0.034632580928246975	0.05520528436907811	0	0	30.640552995391705	103.04296619408238	CTNNB1
Juvenile polyposis syndrome	1/32	0.034632580928246975	0.05520528436907811	0	0	30.640552995391705	103.04296619408238	SMAD4
Anhedonia	1/32	0.034632580928246975	0.05520528436907811	0	0	30.640552995391705	103.04296619408238	MAPK1
Neurotoxicity Syndromes	1/32	0.034632580928246975	0.05520528436907811	0	0	30.640552995391705	103.04296619408238	FOS
Chronic Persistent Hepatitis	1/32	0.034632580928246975	0.05520528436907811	0	0	30.640552995391705	103.04296619408238	SMAD2
Papillary serous cystadenocarcinoma	1/32	0.034632580928246975	0.05520528436907811	0	0	30.640552995391705	103.04296619408238	MAPK8
Congenital malrotation of intestine	1/32	0.034632580928246975	0.05520528436907811	0	0	30.640552995391705	103.04296619408238	HDAC3
Decrease in appetite	1/32	0.034632580928246975	0.05520528436907811	0	0	30.640552995391705	103.04296619408238	SMAD4
Fibrillary Astrocytoma	1/33	0.035696183669855816	0.056399970198372194	0	0	29.68154761904762	98.92003496654242	HIF1A
Gastric Cardia Adenocarcinoma	1/33	0.035696183669855816	0.056399970198372194	0	0	29.68154761904762	98.92003496654242	SMAD4
Hyperkinesia, Generalized	1/33	0.035696183669855816	0.056399970198372194	0	0	29.68154761904762	98.92003496654242	FOS
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum	1/33	0.035696183669855816	0.056399970198372194	0	0	29.68154761904762	98.92003496654242	CTNNB1
Iron-Refractory Iron Deficiency Anemia	1/33	0.035696183669855816	0.056399970198372194	0	0	29.68154761904762	98.92003496654242	SMAD4
Megacolon	1/33	0.035696183669855816	0.056399970198372194	0	0	29.68154761904762	98.92003496654242	CREBBP
Mixed oligoastrocytoma	1/33	0.035696183669855816	0.056399970198372194	0	0	29.68154761904762	98.92003496654242	HIF1A
Central Diabetes Insipidus	1/33	0.035696183669855816	0.056399970198372194	0	0	29.68154761904762	98.92003496654242	CTNNB1
Chronic Airflow Obstruction	1/33	0.035696183669855816	0.056399970198372194	0	0	29.68154761904762	98.92003496654242	HDAC2
Primary Lesion	1/33	0.035696183669855816	0.056399970198372194	0	0	29.68154761904762	98.92003496654242	SMAD4
Ectopic Tissue	1/33	0.035696183669855816	0.056399970198372194	0	0	29.68154761904762	98.92003496654242	CDK6
Deafness	2/273	0.03583558925267807	0.05657497104239743	0	0	7.271955719557195	24.206986306280495	SMAD4;CREBBP
Infant, Small for Gestational Age	2/275	0.03631572183340252	0.057287181007164525	0	0	7.217948717948718	23.93114162198905	SMAD4;MAPK1
Bacterial Infections	2/276	0.03655673792829779	0.05752644135652035	0	0	7.191240875912409	23.795023307023865	KAT5;HIF1A
Biliary Cirrhosis, Secondary	1/34	0.03675866784401453	0.05752644135652035	0	0	28.78066378066378	95.0735042734142	HIF1A
Carcinoma, Ehrlich Tumor	1/34	0.03675866784401453	0.05752644135652035	0	0	28.78066378066378	95.0735042734142	HIF1A
Short long bone	1/34	0.03675866784401453	0.05752644135652035	0	0	28.78066378066378	95.0735042734142	SMAD4
Infant Acute Lymphoblastic Leukemia	1/34	0.03675866784401453	0.05752644135652035	0	0	28.78066378066378	95.0735042734142	CDK6
Metastatic Carcinoma	1/34	0.03675866784401453	0.05752644135652035	0	0	28.78066378066378	95.0735042734142	PGR
Cancer of Urinary Tract	1/34	0.03675866784401453	0.05752644135652035	0	0	28.78066378066378	95.0735042734142	CTNNB1
Neuroectodermal Tumors	1/34	0.03675866784401453	0.05752644135652035	0	0	28.78066378066378	95.0735042734142	XRCC5
Nonnuclear polymorphic congenital cataract	1/34	0.03675866784401453	0.05752644135652035	0	0	28.78066378066378	95.0735042734142	SMAD2
Parathyroid Gland Adenocarcinoma	1/34	0.03675866784401453	0.05752644135652035	0	0	28.78066378066378	95.0735042734142	GSK3B
Intrauterine retardation	2/278	0.037040662030830736	0.05792185867845662	0	0	7.138405797101449	23.526322354503655	SMAD4;MAPK1
Epilepsy	4/1177	0.037352739531186605	0.05821868142394371	0	0	3.5625651226674244	11.71139497372842	SMAD4;CREBBP;MAPK1;FOS
Excessive daytime somnolence	1/35	0.037820034565529	0.05821868142394371	0	0	27.932773109243698	91.47749401004982	CTNNB1
Right Middle Cerebral Artery Infarction	1/35	0.037820034565529	0.05821868142394371	0	0	27.932773109243698	91.47749401004982	FOS
Embolic Infarction, Middle Cerebral Artery	1/35	0.037820034565529	0.05821868142394371	0	0	27.932773109243698	91.47749401004982	FOS
Follicular neoplasm	1/35	0.037820034565529	0.05821868142394371	0	0	27.932773109243698	91.47749401004982	CDK6
Split-Hand/Foot Malformation	1/35	0.037820034565529	0.05821868142394371	0	0	27.932773109243698	91.47749401004982	UBE2I
Hepatitis B Virus-Related Hepatocellular Carcinoma	1/35	0.037820034565529	0.05821868142394371	0	0	27.932773109243698	91.47749401004982	MAPK3
Hereditary Melanoma	1/35	0.037820034565529	0.05821868142394371	0	0	27.932773109243698	91.47749401004982	CDK6
Therapy-related myelodysplastic syndrome	1/35	0.037820034565529	0.05821868142394371	0	0	27.932773109243698	91.47749401004982	CREBBP
Thrombotic Infarction, Middle Cerebral Artery	1/35	0.037820034565529	0.05821868142394371	0	0	27.932773109243698	91.47749401004982	FOS
Abnormal pigmentation	1/35	0.037820034565529	0.05821868142394371	0	0	27.932773109243698	91.47749401004982	FOS
Varicose Ulcer	1/35	0.037820034565529	0.05821868142394371	0	0	27.932773109243698	91.47749401004982	HIF1A
Acanthosis Nigricans	1/35	0.037820034565529	0.05821868142394371	0	0	27.932773109243698	91.47749401004982	FOS
Left Middle Cerebral Artery Infarction	1/35	0.037820034565529	0.05821868142394371	0	0	27.932773109243698	91.47749401004982	FOS
Leiomyosarcoma of uterus	1/35	0.037820034565529	0.05821868142394371	0	0	27.932773109243698	91.47749401004982	CTNNB1
Middle Cerebral Artery Embolus	1/35	0.037820034565529	0.05821868142394371	0	0	27.932773109243698	91.47749401004982	FOS
Middle Cerebral Artery Syndrome	1/35	0.037820034565529	0.05821868142394371	0	0	27.932773109243698	91.47749401004982	FOS
Middle Cerebral Artery Thrombosis	1/35	0.037820034565529	0.05821868142394371	0	0	27.932773109243698	91.47749401004982	FOS
Neoplasm of uncertain or unknown behavior of ovary	1/35	0.037820034565529	0.05821868142394371	0	0	27.932773109243698	91.47749401004982	CTNNB1
Pre-renal acute kidney injury	1/35	0.037820034565529	0.05821868142394371	0	0	27.932773109243698	91.47749401004982	HIF1A
Low density lipoprotein cholesterol measurement	2/283	0.038261436683532095	0.05885228773362608	0	0	7.009608540925267	22.87454503022449	GSK3B;PGR
Astrocytoma, low grade	1/36	0.038880284957489374	0.05929618748342974	0	0	27.133333333333333	88.10920425980879	HIF1A
Exocrine pancreatic insufficiency	1/36	0.038880284957489374	0.05929618748342974	0	0	27.133333333333333	88.10920425980879	SMAD4
Seckel syndrome	1/36	0.038880284957489374	0.05929618748342974	0	0	27.133333333333333	88.10920425980879	MAPK1
Somatotropin deficiency	1/36	0.038880284957489374	0.05929618748342974	0	0	27.133333333333333	88.10920425980879	FOS
Hepatic Encephalopathy	1/36	0.038880284957489374	0.05929618748342974	0	0	27.133333333333333	88.10920425980879	HIF1A
Hepatitis E	1/36	0.038880284957489374	0.05929618748342974	0	0	27.133333333333333	88.10920425980879	PGR
High-grade hypermetropia	1/36	0.038880284957489374	0.05929618748342974	0	0	27.133333333333333	88.10920425980879	SMAD4
Tethered Cord Syndrome	1/36	0.038880284957489374	0.05929618748342974	0	0	27.133333333333333	88.10920425980879	CREBBP
Barrett's Adenocarcinoma	1/36	0.038880284957489374	0.05929618748342974	0	0	27.133333333333333	88.10920425980879	MAPK1
Oestrogen deficiency	1/36	0.038880284957489374	0.05929618748342974	0	0	27.133333333333333	88.10920425980879	HIF1A
Parvovirus B19 (disease)	1/36	0.038880284957489374	0.05929618748342974	0	0	27.133333333333333	88.10920425980879	XRCC5
Congenital deafness	2/289	0.039746823395102396	0.06021401126343452	0	0	6.860975609756098	22.128192501175963	SMAD4;CREBBP
Adenoma, Basal Cell	1/37	0.03993942012916417	0.06021401126343452	0	0	26.37830687830688	84.948474454672	CTNNB1
Adenoma, Monomorphic	1/37	0.03993942012916417	0.06021401126343452	0	0	26.37830687830688	84.948474454672	CTNNB1
Escherichia coli Infections	1/37	0.03993942012916417	0.06021401126343452	0	0	26.37830687830688	84.948474454672	HIF1A
Salivary Gland Pleomorphic Adenoma	1/37	0.03993942012916417	0.06021401126343452	0	0	26.37830687830688	84.948474454672	HIF1A
Hematopoetic Myelodysplasia	1/37	0.03993942012916417	0.06021401126343452	0	0	26.37830687830688	84.948474454672	CREBBP
Hemorrhage	1/37	0.03993942012916417	0.06021401126343452	0	0	26.37830687830688	84.948474454672	FOS
Hereditary pyropoikilocytosis	1/37	0.03993942012916417	0.06021401126343452	0	0	26.37830687830688	84.948474454672	MAPK3
Simple syndactyly of toes, first web space	1/37	0.03993942012916417	0.06021401126343452	0	0	26.37830687830688	84.948474454672	SMAD4
Thyroid Hormone Resistance Syndrome	1/37	0.03993942012916417	0.06021401126343452	0	0	26.37830687830688	84.948474454672	NCOR2
Abscess	1/37	0.03993942012916417	0.06021401126343452	0	0	26.37830687830688	84.948474454672	HIF1A
Juvenile Pilocytic Astrocytoma	1/37	0.03993942012916417	0.06021401126343452	0	0	26.37830687830688	84.948474454672	HIF1A
Bone Marrow Diseases	1/37	0.03993942012916417	0.06021401126343452	0	0	26.37830687830688	84.948474454672	HIF1A
Cone-shaped epiphysis	1/37	0.03993942012916417	0.06021401126343452	0	0	26.37830687830688	84.948474454672	SMAD4
Paget Disease	1/37	0.03993942012916417	0.06021401126343452	0	0	26.37830687830688	84.948474454672	FOS
Migraine Disorders	2/290	0.03999653626149054	0.06025412594694417	0	0	6.836805555555555	22.007420170403627	SMAD4;PGR
Low set ears	2/293	0.040749327609730664	0.06106930956594054	0	0	6.765292096219931	21.651072132976907	SMAD4;CREBBP
Adenoma, Trabecular	1/38	0.04099744119754651	0.06106930956594054	0	0	25.664092664092664	81.97741568726948	CTNNB1
Salmonella infections	1/38	0.04099744119754651	0.06106930956594054	0	0	25.664092664092664	81.97741568726948	KAT5
Eczema, Infantile	1/38	0.04099744119754651	0.06106930956594054	0	0	25.664092664092664	81.97741568726948	MAPK8
Shprintzen syndrome	1/38	0.04099744119754651	0.06106930956594054	0	0	25.664092664092664	81.97741568726948	MAPK1
Anti-Basement Membrane Glomerulonephritis	1/38	0.04099744119754651	0.06106930956594054	0	0	25.664092664092664	81.97741568726948	MAPK8
Arteriovenous hemangioma	1/38	0.04099744119754651	0.06106930956594054	0	0	25.664092664092664	81.97741568726948	SMAD4
Bladder neck obstruction	1/38	0.04099744119754651	0.06106930956594054	0	0	25.664092664092664	81.97741568726948	HIF1A
Comedone	1/38	0.04099744119754651	0.06106930956594054	0	0	25.664092664092664	81.97741568726948	PGR
Painful Bladder Syndrome	1/38	0.04099744119754651	0.06106930956594054	0	0	25.664092664092664	81.97741568726948	HIF1A
Papillary adenoma	1/38	0.04099744119754651	0.06106930956594054	0	0	25.664092664092664	81.97741568726948	CTNNB1
Pelvic Inflammatory Disease	1/38	0.04099744119754651	0.06106930956594054	0	0	25.664092664092664	81.97741568726948	PGR
Disorder of the optic nerve	1/38	0.04099744119754651	0.06106930956594054	0	0	25.664092664092664	81.97741568726948	MAPK8
Prostatic Diseases	1/38	0.04099744119754651	0.06106930956594054	0	0	25.664092664092664	81.97741568726948	FOS
hearing impairment	2/294	0.04100147062503147	0.06106930956594054	0	0	6.741780821917808	21.534241306279558	SMAD4;CREBBP
Epithelioma	2/298	0.042016065541807944	0.062075739774390265	0	0	6.649324324324325	21.076384727872128	HDAC3;CTNNB1
Short toe	1/39	0.04205434927500464	0.062075739774390265	0	0	24.9874686716792	79.18010249314726	SMAD4
Obesity, Abdominal	1/39	0.04205434927500464	0.062075739774390265	0	0	24.9874686716792	79.18010249314726	CREBBP
Stage IV Ovarian Carcinoma	1/39	0.04205434927500464	0.062075739774390265	0	0	24.9874686716792	79.18010249314726	MAPK1
Subependymal Giant Cell Astrocytoma	1/39	0.04205434927500464	0.062075739774390265	0	0	24.9874686716792	79.18010249314726	HIF1A
Hyperphosphaturia	1/39	0.04205434927500464	0.062075739774390265	0	0	24.9874686716792	79.18010249314726	MAPK3
Abnormal cortical bone morphology	1/39	0.04205434927500464	0.062075739774390265	0	0	24.9874686716792	79.18010249314726	CDK6
Adenocarcinoma of rectum	1/39	0.04205434927500464	0.062075739774390265	0	0	24.9874686716792	79.18010249314726	HIF1A
Malignant neoplasm of adrenal cortex	1/39	0.04205434927500464	0.062075739774390265	0	0	24.9874686716792	79.18010249314726	CTNNB1
Benign Ovarian Neoplasm	1/39	0.04205434927500464	0.062075739774390265	0	0	24.9874686716792	79.18010249314726	HIF1A
Broad hallux	1/39	0.04205434927500464	0.062075739774390265	0	0	24.9874686716792	79.18010249314726	CREBBP
Optic Neuropathy	1/39	0.04205434927500464	0.062075739774390265	0	0	24.9874686716792	79.18010249314726	MAPK8
Choriocarcinoma	2/300	0.04252695578138395	0.06272646577164548	0	0	6.604026845637584	20.852988429658954	PGR;HIF1A
Senile Plaques	2/301	0.0427832938820368	0.06301044400971118	0	0	6.581605351170569	20.742637329454954	CREBBP;HDAC3
Hyperreflexia	2/301	0.0427832938820368	0.06301044400971118	0	0	6.581605351170569	20.742637329454954	CREBBP;CDK6
Anemia, severe	1/40	0.043110145479118074	0.06302186330218963	0	0	24.345543345543344	76.54231318763195	HIF1A
Anxiety States, Neurotic	1/40	0.043110145479118074	0.06302186330218963	0	0	24.345543345543344	76.54231318763195	FOS
Depression, Neurotic	1/40	0.043110145479118074	0.06302186330218963	0	0	24.345543345543344	76.54231318763195	GSK3B
Fibrodysplasia Ossificans Progressiva	1/40	0.043110145479118074	0.06302186330218963	0	0	24.345543345543344	76.54231318763195	MAPK1
Spinal Cord Diseases	1/40	0.043110145479118074	0.06302186330218963	0	0	24.345543345543344	76.54231318763195	HIF1A
Muscular Dystrophy, Oculopharyngeal	1/40	0.043110145479118074	0.06302186330218963	0	0	24.345543345543344	76.54231318763195	CTNNB1
Xeroderma pigmentosum, group A	1/40	0.043110145479118074	0.06302186330218963	0	0	24.345543345543344	76.54231318763195	HIF1A
Hypokalemia	1/40	0.043110145479118074	0.06302186330218963	0	0	24.345543345543344	76.54231318763195	SMAD4
Islet Cell Tumor	1/40	0.043110145479118074	0.06302186330218963	0	0	24.345543345543344	76.54231318763195	SMAD4
Malignant neoplasm of stomach stage IV	1/40	0.043110145479118074	0.06302186330218963	0	0	24.345543345543344	76.54231318763195	MAPK3
Fetal Growth Retardation	2/304	0.043555862300081585	0.06362635210256001	0	0	6.51523178807947	20.416853352124562	SMAD4;MAPK1
Gastrointestinal mucositis	1/41	0.04416483092056729	0.06427821744150361	0	0	23.735714285714284	74.05131012000572	MAPK1
Unilateral agenesis of kidney	1/41	0.04416483092056729	0.06427821744150361	0	0	23.735714285714284	74.05131012000572	CDK6
Intestinal Polyps	1/41	0.04416483092056729	0.06427821744150361	0	0	23.735714285714284	74.05131012000572	CTNNB1
Malignant Meningioma	1/41	0.04416483092056729	0.06427821744150361	0	0	23.735714285714284	74.05131012000572	PGR
Congenital anomaly of the kidney	1/41	0.04416483092056729	0.06427821744150361	0	0	23.735714285714284	74.05131012000572	CREBBP
Late fontanel closure	1/42	0.04521840670763814	0.06566643621145979	0	0	23.155632984901278	71.69565287330235	CREBBP
Arrhythmogenic Right Ventricular Dysplasia	1/42	0.04521840670763814	0.06566643621145979	0	0	23.155632984901278	71.69565287330235	CTNNB1
Melancholia	1/42	0.04521840670763814	0.06566643621145979	0	0	23.155632984901278	71.69565287330235	GSK3B
Flushing	1/43	0.04627087395770182	0.06665570829063537	0	0	22.603174603174605	69.46503881508069	MAPK3
Gemistocytic astrocytoma	1/43	0.04627087395770182	0.06665570829063537	0	0	22.603174603174605	69.46503881508069	HIF1A
Thin dental enamel	1/43	0.04627087395770182	0.06665570829063537	0	0	22.603174603174605	69.46503881508069	CREBBP
Transient Cerebral Ischemia	1/43	0.04627087395770182	0.06665570829063537	0	0	22.603174603174605	69.46503881508069	GSK3B
Acute intermittent porphyria	1/43	0.04627087395770182	0.06665570829063537	0	0	22.603174603174605	69.46503881508069	SMAD4
Broad thumbs	1/43	0.04627087395770182	0.06665570829063537	0	0	22.603174603174605	69.46503881508069	CREBBP
Chloracne	1/43	0.04627087395770182	0.06665570829063537	0	0	22.603174603174605	69.46503881508069	CDK6
Defective enamel matrix	1/43	0.04627087395770182	0.06665570829063537	0	0	22.603174603174605	69.46503881508069	CREBBP
Depressive Syndrome	1/43	0.04627087395770182	0.06665570829063537	0	0	22.603174603174605	69.46503881508069	GSK3B
Dysplasia of tooth enamel	1/43	0.04627087395770182	0.06665570829063537	0	0	22.603174603174605	69.46503881508069	CREBBP
Radial deviation of finger	1/43	0.04627087395770182	0.06665570829063537	0	0	22.603174603174605	69.46503881508069	SMAD4
Endometriosis of uterus	1/44	0.04732223377598174	0.06772566065765502	0	0	22.07641196013289	67.35016647561174	PGR
Arthritis, Adjuvant-Induced	1/44	0.04732223377598174	0.06772566065765502	0	0	22.07641196013289	67.35016647561174	GSK3B
Arthritis, Collagen-Induced	1/44	0.04732223377598174	0.06772566065765502	0	0	22.07641196013289	67.35016647561174	GSK3B
Arthritis, Experimental	1/44	0.04732223377598174	0.06772566065765502	0	0	22.07641196013289	67.35016647561174	GSK3B
Strawberry nevus of skin	1/44	0.04732223377598174	0.06772566065765502	0	0	22.07641196013289	67.35016647561174	CREBBP
Japanese Encephalitis	1/44	0.04732223377598174	0.06772566065765502	0	0	22.07641196013289	67.35016647561174	MAPK1
Birthmark	1/44	0.04732223377598174	0.06772566065765502	0	0	22.07641196013289	67.35016647561174	CREBBP
Monoclonal Gammapathies	1/44	0.04732223377598174	0.06772566065765502	0	0	22.07641196013289	67.35016647561174	HIF1A
Pneumococcal Infections	1/44	0.04732223377598174	0.06772566065765502	0	0	22.07641196013289	67.35016647561174	MAPK3
Adenoma, Microcystic	1/45	0.048372487263530745	0.06882972791460606	0	0	21.573593073593074	65.34261801768183	CTNNB1
gallbladder neoplasm	1/45	0.048372487263530745	0.06882972791460606	0	0	21.573593073593074	65.34261801768183	CTNNB1
MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA	1/45	0.048372487263530745	0.06882972791460606	0	0	21.573593073593074	65.34261801768183	HIF1A
Abetalipoproteinemia	1/45	0.048372487263530745	0.06882972791460606	0	0	21.573593073593074	65.34261801768183	HIF1A
Lipoatrophy	1/45	0.048372487263530745	0.06882972791460606	0	0	21.573593073593074	65.34261801768183	FOS
Cafe-au-Lait Spots	1/45	0.048372487263530745	0.06882972791460606	0	0	21.573593073593074	65.34261801768183	CREBBP
Nicotinamide adenine dinucleotide coenzyme Q reductase deficiency	1/45	0.048372487263530745	0.06882972791460606	0	0	21.573593073593074	65.34261801768183	HIF1A
Panhypopituitarism	1/45	0.048372487263530745	0.06882972791460606	0	0	21.573593073593074	65.34261801768183	CREBBP
Barrett Esophagus	2/323	0.04857024220375333	0.06906135950497684	0	0	6.123676012461059	18.52255372147025	SMAD4;HIF1A
Coronary Arteriosclerosis	3/760	0.04918674125836711	0.06986952770064568	0	0	4.009107974692345	12.07595912822497	FOS;HIF1A;MAPK3
Telangiectasia of the skin	1/46	0.049421635543190894	0.06986952770064568	0	0	21.09312169312169	63.43475777373824	SMAD4
Telangiectasis	1/46	0.049421635543190894	0.06986952770064568	0	0	21.09312169312169	63.43475777373824	SMAD4
Hypoalbuminemia	1/46	0.049421635543190894	0.06986952770064568	0	0	21.09312169312169	63.43475777373824	SMAD4
Adult Diffuse Large B-Cell Lymphoma	1/46	0.049421635543190894	0.06986952770064568	0	0	21.09312169312169	63.43475777373824	CREBBP
Basal Cell Nevus Syndrome	1/46	0.049421635543190894	0.06986952770064568	0	0	21.09312169312169	63.43475777373824	XRCC6
Childhood Diffuse Large B-Cell Lymphoma	1/46	0.049421635543190894	0.06986952770064568	0	0	21.09312169312169	63.43475777373824	CREBBP
Obstructive nephropathy	1/46	0.049421635543190894	0.06986952770064568	0	0	21.09312169312169	63.43475777373824	SMAD2
Mental disorders	2/329	0.05019629442654993	0.07069763189709811	0	0	6.009480122324159	17.97924719064537	GSK3B;MAPK1
Osteopenia	2/329	0.05019629442654993	0.07069763189709811	0	0	6.009480122324159	17.97924719064537	MAPK1;HIF1A
Primary biliary cirrhosis	2/329	0.05019629442654993	0.07069763189709811	0	0	6.009480122324159	17.97924719064537	SMAD2;HIF1A
Serum triglycerides raised	1/47	0.05046967971071609	0.07069763189709811	0	0	20.633540372670808	61.61964439333086	FOS
FRAGILE X TREMOR/ATAXIA SYNDROME	1/47	0.05046967971071609	0.07069763189709811	0	0	20.633540372670808	61.61964439333086	HDAC3
Hemangioblastoma	1/47	0.05046967971071609	0.07069763189709811	0	0	20.633540372670808	61.61964439333086	HIF1A
Hyperparathyroidism	1/47	0.05046967971071609	0.07069763189709811	0	0	20.633540372670808	61.61964439333086	CTNNB1
Abnormality of the cornea	1/47	0.05046967971071609	0.07069763189709811	0	0	20.633540372670808	61.61964439333086	CREBBP
Cholestasis of pregnancy	1/47	0.05046967971071609	0.07069763189709811	0	0	20.633540372670808	61.61964439333086	HDAC3
Colonic Polyps	1/47	0.05046967971071609	0.07069763189709811	0	0	20.633540372670808	61.61964439333086	CTNNB1
Post MI	1/47	0.05046967971071609	0.07069763189709811	0	0	20.633540372670808	61.61964439333086	HIF1A
Diabetic Foot	1/47	0.05046967971071609	0.07069763189709811	0	0	20.633540372670808	61.61964439333086	HIF1A
Cerebrovascular accident	3/768	0.0504727397341308	0.07069763189709811	0	0	3.965531475748194	11.842353474091134	HDAC2;CDK6;HIF1A
Sleep Disorders	1/48	0.05151662087178671	0.071955676253026	0	0	20.193515704154002	59.890954463772765	KAT5
keratoacanthoma	1/48	0.05151662087178671	0.071955676253026	0	0	20.193515704154002	59.890954463772765	CTNNB1
Manic Disorder	1/48	0.05151662087178671	0.071955676253026	0	0	20.193515704154002	59.890954463772765	GSK3B
Dupuytren Contracture	1/48	0.05151662087178671	0.071955676253026	0	0	20.193515704154002	59.890954463772765	MAPK1
Triglycerides measurement	2/336	0.0521184814368196	0.07274487691711569	0	0	5.881437125748503	17.375151306880397	PGR;HIF1A
Blepharoptosis	2/337	0.05239526204376778	0.07305479152649957	0	0	5.863582089552239	17.291346553004594	SMAD4;CREBBP
Female Breast Carcinoma	1/49	0.052562460131218174	0.07305479152649957	0	0	19.771825396825395	58.24291595044674	PGR
Intracranial Hemorrhages	1/49	0.052562460131218174	0.07305479152649957	0	0	19.771825396825395	58.24291595044674	HIF1A
Aortic coarctation	1/49	0.052562460131218174	0.07305479152649957	0	0	19.771825396825395	58.24291595044674	SMAD4
Low anterior hairline	1/49	0.052562460131218174	0.07305479152649957	0	0	19.771825396825395	58.24291595044674	CREBBP
Dental Enamel Hypoplasia	1/49	0.052562460131218174	0.07305479152649957	0	0	19.771825396825395	58.24291595044674	CREBBP
Single transverse palmar crease	1/50	0.05360719859925478	0.07414160870695251	0	0	19.367346938775512	56.67024999786951	CREBBP
Giant Cell Tumors	1/50	0.05360719859925478	0.07414160870695251	0	0	19.367346938775512	56.67024999786951	FOS
Varicella zoster	1/50	0.05360719859925478	0.07414160870695251	0	0	19.367346938775512	56.67024999786951	MAPK3
Advanced bone age	1/50	0.05360719859925478	0.07414160870695251	0	0	19.367346938775512	56.67024999786951	FOS
Microscopic Polyarteritis	1/50	0.05360719859925478	0.07414160870695251	0	0	19.367346938775512	56.67024999786951	PGR
Chronic inflammatory disorder	1/50	0.05360719859925478	0.07414160870695251	0	0	19.367346938775512	56.67024999786951	HIF1A
Pointed chin	1/50	0.05360719859925478	0.07414160870695251	0	0	19.367346938775512	56.67024999786951	MAPK1
Epistaxis	1/51	0.05465083736850441	0.0750593906834466	0	0	18.97904761904762	55.16811991271338	SMAD4
Cockayne Syndrome, Type I	1/51	0.05465083736850441	0.0750593906834466	0	0	18.97904761904762	55.16811991271338	MAPK3
Frequent nosebleeds	1/51	0.05465083736850441	0.0750593906834466	0	0	18.97904761904762	55.16811991271338	SMAD4
Abnormality of the ribs	1/51	0.05465083736850441	0.0750593906834466	0	0	18.97904761904762	55.16811991271338	SMAD4
Malignant neoplasm of female breast	1/51	0.05465083736850441	0.0750593906834466	0	0	18.97904761904762	55.16811991271338	PGR
Pauci-immune Glomerulonephritis associated with Granulomatosis with Polyangiitis	1/51	0.05465083736850441	0.0750593906834466	0	0	18.97904761904762	55.16811991271338	CDK6
Convex nasal ridge	1/51	0.05465083736850441	0.0750593906834466	0	0	18.97904761904762	55.16811991271338	CREBBP
Cystadenoma	1/51	0.05465083736850441	0.0750593906834466	0	0	18.97904761904762	55.16811991271338	HIF1A
Premature coronary artery disease	1/51	0.05465083736850441	0.0750593906834466	0	0	18.97904761904762	55.16811991271338	HIF1A
Rabies (disorder)	1/51	0.05465083736850441	0.0750593906834466	0	0	18.97904761904762	55.16811991271338	CREBBP
Gait, Unsteady	1/52	0.05569337754639787	0.07622620973952585	0	0	18.605975723622784	53.732086291886986	CREBBP
Friedreich Ataxia	1/52	0.05569337754639787	0.07622620973952585	0	0	18.605975723622784	53.732086291886986	HDAC3
Generalized hirsutism	1/52	0.05569337754639787	0.07622620973952585	0	0	18.605975723622784	53.732086291886986	FOS
Invasive Lobular Breast Carcinoma	1/52	0.05569337754639787	0.07622620973952585	0	0	18.605975723622784	53.732086291886986	PGR
Range of joint movement increased	1/52	0.05569337754639787	0.07622620973952585	0	0	18.605975723622784	53.732086291886986	CREBBP
Hyperparathyroidism, Primary	1/53	0.05673482023315897	0.0773300689858447	0	0	18.247252747252748	52.358067488080735	CTNNB1
Leukemia, Lymphocytic, Acute, L2	1/53	0.05673482023315897	0.0773300689858447	0	0	18.247252747252748	52.358067488080735	CDK6
Other specified types of schizophrenia, unspecified	1/53	0.05673482023315897	0.0773300689858447	0	0	18.247252747252748	52.358067488080735	GSK3B
Stevens-Johnson Syndrome	1/53	0.05673482023315897	0.0773300689858447	0	0	18.247252747252748	52.358067488080735	CTNNB1
Language Disorders	1/53	0.05673482023315897	0.0773300689858447	0	0	18.247252747252748	52.358067488080735	MAPK1
Anxiety neurosis (finding)	1/53	0.05673482023315897	0.0773300689858447	0	0	18.247252747252748	52.358067488080735	FOS
Hepatocellular Adenoma	1/54	0.05777516652888407	0.07869376130658347	0	0	17.902066486972146	51.04230466405881	CTNNB1
Russell-Silver syndrome	1/55	0.058814417525785305	0.08005408312434595	0	0	17.569664902998237	49.78133084189748	PGR
Treatment related acute myeloid leukaemia	1/56	0.05985257433019706	0.08096495500146521	0	0	17.24935064935065	48.57194341390608	CREBBP
Vertigo	1/56	0.05985257433019706	0.08096495500146521	0	0	17.24935064935065	48.57194341390608	PGR
Adenoviral infections	1/56	0.05985257433019706	0.08096495500146521	0	0	17.24935064935065	48.57194341390608	SMAD4
Adult Cholangiocarcinoma	1/56	0.05985257433019706	0.08096495500146521	0	0	17.24935064935065	48.57194341390608	HDAC3
Autoimmune arthritis	1/56	0.05985257433019706	0.08096495500146521	0	0	17.24935064935065	48.57194341390608	MAPK1
Caries (morphologic abnormality)	1/56	0.05985257433019706	0.08096495500146521	0	0	17.24935064935065	48.57194341390608	SMAD4
Carotid Stenosis	1/56	0.05985257433019706	0.08096495500146521	0	0	17.24935064935065	48.57194341390608	HIF1A
Parathyroid Neoplasms	1/56	0.05985257433019706	0.08096495500146521	0	0	17.24935064935065	48.57194341390608	CTNNB1
Pituitary-dependent Cushing's disease	1/56	0.05985257433019706	0.08096495500146521	0	0	17.24935064935065	48.57194341390608	HDAC2
Heart Septal Defects	1/57	0.060889638035462136	0.08203071972717442	0	0	16.94047619047619	47.41117969569272	SMAD4
Abnormality of epiphysis morphology	1/57	0.060889638035462136	0.08203071972717442	0	0	16.94047619047619	47.41117969569272	SMAD4
Abnormality of the voice	1/57	0.060889638035462136	0.08203071972717442	0	0	16.94047619047619	47.41117969569272	SMAD4
Long eyelashes	1/57	0.060889638035462136	0.08203071972717442	0	0	16.94047619047619	47.41117969569272	CREBBP
Cardiac defects	1/57	0.060889638035462136	0.08203071972717442	0	0	16.94047619047619	47.41117969569272	HIF1A
Pneumocystis jiroveci pneumonia	1/57	0.060889638035462136	0.08203071972717442	0	0	16.94047619047619	47.41117969569272	CTNNB1
Respiratory Tract Diseases	1/58	0.06192560972922704	0.08286116477996165	0	0	16.642439431913115	46.29629511520948	MAPK8
SCHIZOPHRENIA 1 (disorder)	1/58	0.06192560972922704	0.08286116477996165	0	0	16.642439431913115	46.29629511520948	GSK3B
Severe Dengue	1/58	0.06192560972922704	0.08286116477996165	0	0	16.642439431913115	46.29629511520948	MAPK1
Tooth Crowding	1/58	0.06192560972922704	0.08286116477996165	0	0	16.642439431913115	46.29629511520948	CREBBP
Tooth mass arch size discrepancy	1/58	0.06192560972922704	0.08286116477996165	0	0	16.642439431913115	46.29629511520948	CREBBP
Tooth size discrepancy	1/58	0.06192560972922704	0.08286116477996165	0	0	16.642439431913115	46.29629511520948	CREBBP
Inadequate arch length for tooth size	1/58	0.06192560972922704	0.08286116477996165	0	0	16.642439431913115	46.29629511520948	CREBBP
Wide anterior fontanel	1/58	0.06192560972922704	0.08286116477996165	0	0	16.642439431913115	46.29629511520948	CREBBP
Mycoplasma Infections	1/58	0.06192560972922704	0.08286116477996165	0	0	16.642439431913115	46.29629511520948	SMAD4
Cutis Laxa	1/58	0.06192560972922704	0.08286116477996165	0	0	16.642439431913115	46.29629511520948	FOS
Hepatomegaly	2/373	0.06270917944714219	0.08385282966019351	0	0	5.284905660377358	14.635211467435377	CTNNB1;FOS
Leukocyte adhesion deficiency type 1	1/59	0.06296049051908208	0.08396149140795887	0	0	16.354679802955665	45.22474371763155	MAPK1
Conn Syndrome	1/59	0.06296049051908208	0.08396149140795887	0	0	16.354679802955665	45.22474371763155	MAPK3
Progeria	1/59	0.06296049051908208	0.08396149140795887	0	0	16.354679802955665	45.22474371763155	FOS
Radial club hand	1/59	0.06296049051908208	0.08396149140795887	0	0	16.354679802955665	45.22474371763155	CREBBP
MAJOR AFFECTIVE DISORDER 8	1/60	0.06399428148789535	0.08516759160282569	0	0	16.076674737691686	44.19416072773483	GSK3B
MAJOR AFFECTIVE DISORDER 9	1/60	0.06399428148789535	0.08516759160282569	0	0	16.076674737691686	44.19416072773483	GSK3B
Cerebral calcification	1/60	0.06399428148789535	0.08516759160282569	0	0	16.076674737691686	44.19416072773483	CTNNB1
Epithelial hyperplasia of skin	1/61	0.06502698372913016	0.08602028992969328	0	0	15.807936507936509	43.20234688566271	HIF1A
Depression, Bipolar	1/61	0.06502698372913016	0.08602028992969328	0	0	15.807936507936509	43.20234688566271	GSK3B
Ganglioglioma	1/61	0.06502698372913016	0.08602028992969328	0	0	15.807936507936509	43.20234688566271	MAPK1
Sinusitis	1/61	0.06502698372913016	0.08602028992969328	0	0	15.807936507936509	43.20234688566271	HIF1A
Leukemia, Large Granular Lymphocytic	1/61	0.06502698372913016	0.08602028992969328	0	0	15.807936507936509	43.20234688566271	FOS
MAJOR AFFECTIVE DISORDER 7	1/61	0.06502698372913016	0.08602028992969328	0	0	15.807936507936509	43.20234688566271	GSK3B
Aura	1/61	0.06502698372913016	0.08602028992969328	0	0	15.807936507936509	43.20234688566271	FOS
Awakening Epilepsy	1/61	0.06502698372913016	0.08602028992969328	0	0	15.807936507936509	43.20234688566271	FOS
Bile duct carcinoma	1/61	0.06502698372913016	0.08602028992969328	0	0	15.807936507936509	43.20234688566271	SMAD4
Arsenic Poisoning, Inorganic	1/62	0.06605859834459576	0.0868613393678939	0	0	15.548009367681498	42.247254377649796	PIAS1
Nervous System, Organic Arsenic Poisoning	1/62	0.06605859834459576	0.0868613393678939	0	0	15.548009367681498	42.247254377649796	PIAS1
Abnormality of the pinna	1/62	0.06605859834459576	0.0868613393678939	0	0	15.548009367681498	42.247254377649796	CREBBP
Arsenic Encephalopathy	1/62	0.06605859834459576	0.0868613393678939	0	0	15.548009367681498	42.247254377649796	PIAS1
Arsenic Induced Polyneuropathy	1/62	0.06605859834459576	0.0868613393678939	0	0	15.548009367681498	42.247254377649796	PIAS1
Arsenic Poisoning	1/62	0.06605859834459576	0.0868613393678939	0	0	15.548009367681498	42.247254377649796	PIAS1
Multiple polyps	1/62	0.06605859834459576	0.0868613393678939	0	0	15.548009367681498	42.247254377649796	SMAD4
Nijmegen Breakage Syndrome	1/62	0.06605859834459576	0.0868613393678939	0	0	15.548009367681498	42.247254377649796	XRCC6
Phyllodes Tumor	1/62	0.06605859834459576	0.0868613393678939	0	0	15.548009367681498	42.247254377649796	HIF1A
Invasive carcinoma of breast	2/385	0.0662920325176683	0.08711028890378902	0	0	5.116187989556136	13.883725480755453	PGR;HIF1A
Fibroadenoma	1/63	0.06708912641607817	0.0878071734073919	0	0	15.296466973886329	41.32697417378087	PGR
Epilepsy, Cryptogenic	1/63	0.06708912641607817	0.0878071734073919	0	0	15.296466973886329	41.32697417378087	FOS
Simple ear	1/63	0.06708912641607817	0.0878071734073919	0	0	15.296466973886329	41.32697417378087	CREBBP
Monocytic leukemia	1/63	0.06708912641607817	0.0878071734073919	0	0	15.296466973886329	41.32697417378087	MAPK3
Necrotizing Enterocolitis	1/63	0.06708912641607817	0.0878071734073919	0	0	15.296466973886329	41.32697417378087	MAPK8
Neutrophilia (disorder)	1/63	0.06708912641607817	0.0878071734073919	0	0	15.296466973886329	41.32697417378087	MAPK3
Smooth philtrum	1/64	0.06811856902815693	0.08874285872731526	0	0	15.052910052910052	40.43972459506669	MAPK1
Hirsutism	1/64	0.06811856902815693	0.08874285872731526	0	0	15.052910052910052	40.43972459506669	CREBBP
Uterine Cancer	1/64	0.06811856902815693	0.08874285872731526	0	0	15.052910052910052	40.43972459506669	PGR
Bronchiolitis Obliterans	1/64	0.06811856902815693	0.08874285872731526	0	0	15.052910052910052	40.43972459506669	HIF1A
Multiple Endocrine Neoplasia Type 2a	1/64	0.06811856902815693	0.08874285872731526	0	0	15.052910052910052	40.43972459506669	MAPK1
Congenital Camptodactyly	1/64	0.06811856902815693	0.08874285872731526	0	0	15.052910052910052	40.43972459506669	SMAD4
Cytogenetically normal acute myeloid leukemia	1/64	0.06811856902815693	0.08874285872731526	0	0	15.052910052910052	40.43972459506669	HIF1A
Multiple, subcutaneous nodules	1/65	0.06914692728645229	0.08990466187672368	0	0	14.816964285714286	39.58384098532174	CTNNB1
Subcutaneous nodule	1/65	0.06914692728645229	0.08990466187672368	0	0	14.816964285714286	39.58384098532174	CTNNB1
Limitation of joint mobility	1/65	0.06914692728645229	0.08990466187672368	0	0	14.816964285714286	39.58384098532174	SMAD4
Anxiety Disorders	2/396	0.06963664972262702	0.0904818310540713	0	0	4.970558375634518	13.243875212516599	HDAC2;FOS
Bronchitis, Chronic	1/66	0.07017420225965537	0.09094097733780798	0	0	14.588278388278388	38.75776638076853	HDAC2
Giant Cell Tumor of Bone	1/66	0.07017420225965537	0.09094097733780798	0	0	14.588278388278388	38.75776638076853	HIF1A
Congenital arteriovenous malformation	1/66	0.07017420225965537	0.09094097733780798	0	0	14.588278388278388	38.75776638076853	SMAD4
Diffuse Astrocytoma	1/66	0.07017420225965537	0.09094097733780798	0	0	14.588278388278388	38.75776638076853	HIF1A
Fine hair	1/67	0.07120039504142281	0.09196911720523875	0	0	14.366522366522366	37.96004302786625	SMAD4
Tongue Carcinoma	1/67	0.07120039504142281	0.09196911720523875	0	0	14.366522366522366	37.96004302786625	HIF1A
Toxic Epidermal Necrolysis	1/67	0.07120039504142281	0.09196911720523875	0	0	14.366522366522366	37.96004302786625	CTNNB1
Bipolar I disorder	1/67	0.07120039504142281	0.09196911720523875	0	0	14.366522366522366	37.96004302786625	GSK3B
Congenital muscular dystrophy (disorder)	1/67	0.07120039504142281	0.09196911720523875	0	0	14.366522366522366	37.96004302786625	XRCC6
Strabismus	2/404	0.07210433242865656	0.09274731844759858	0	0	4.8696517412935325	12.805436592089487	SMAD4;CTNNB1
Short palpebral fissure	1/68	0.07222550672020589	0.09274731844759858	0	0	14.15138592750533	37.18930470253887	SMAD4
Human papilloma virus infection	1/68	0.07222550672020589	0.09274731844759858	0	0	14.15138592750533	37.18930470253887	PGR
Adenomatous polyp of colon	1/68	0.07222550672020589	0.09274731844759858	0	0	14.15138592750533	37.18930470253887	SMAD4
Leishmaniasis	1/68	0.07222550672020589	0.09274731844759858	0	0	14.15138592750533	37.18930470253887	MAPK3
Angle class 2 malocclusion	1/68	0.07222550672020589	0.09274731844759858	0	0	14.15138592750533	37.18930470253887	CREBBP
Angle class 3 malocclusion	1/68	0.07222550672020589	0.09274731844759858	0	0	14.15138592750533	37.18930470253887	CREBBP
Low posterior hairline	1/68	0.07222550672020589	0.09274731844759858	0	0	14.15138592750533	37.18930470253887	CREBBP
Precocious Puberty	1/68	0.07222550672020589	0.09274731844759858	0	0	14.15138592750533	37.18930470253887	FOS
Burkitt Lymphoma	2/407	0.07303720859122083	0.09372871147996176	0	0	4.8328395061728395	12.646508021182846	MAPK1;HIF1A
Histiocytosis, Langerhans-Cell	1/69	0.07324953836364095	0.0938183127549876	0	0	13.942577030812325	36.444269724198726	MAPK1
Thin lips	1/69	0.07324953836364095	0.0938183127549876	0	0	13.942577030812325	36.444269724198726	SMAD4
Underdeveloped nasal alae	1/69	0.07324953836364095	0.0938183127549876	0	0	13.942577030812325	36.444269724198726	MAPK1
Angina, Unstable	1/70	0.07427249108472932	0.09488238673501966	0	0	13.739820565907522	35.72373458022456	HIF1A
Chromosome 8, trisomy	1/70	0.07427249108472932	0.09488238673501966	0	0	13.739820565907522	35.72373458022456	CDK6
Philadelphia chromosome-positive acute lymphoblastic leukemia	1/70	0.07427249108472932	0.09488238673501966	0	0	13.739820565907522	35.72373458022456	CDK6
Pulmonary arterial hypertension	1/70	0.07427249108472932	0.09488238673501966	0	0	13.739820565907522	35.72373458022456	SMAD4
Cryptorchidism	2/414	0.07522955372092971	0.09600153179673604	0	0	4.749029126213593	12.286740981750087	SMAD4;CREBBP
Malocclusion	1/71	0.07529436595095905	0.09600153179673604	0	0	13.542857142857143	35.026568142715256	CREBBP
Pterygium	1/71	0.07529436595095905	0.09600153179673604	0	0	13.542857142857143	35.026568142715256	MAPK1
Inflammatory Bowel Diseases	3/911	0.07621371620569047	0.09692761990316727	0	0	3.3161372594481797	8.536446394749198	MAPK8;MAPK1;HIF1A
secondary acute myeloid leukemia	1/72	0.07631516402502538	0.09692761990316727	0	0	13.351441985244803	34.35170636454176	MAPK8
Spinocerebellar Ataxia Type 7	1/72	0.07631516402502538	0.09692761990316727	0	0	13.351441985244803	34.35170636454176	HDAC3
MAJOR AFFECTIVE DISORDER 4	1/72	0.07631516402502538	0.09692761990316727	0	0	13.351441985244803	34.35170636454176	GSK3B
MAJOR AFFECTIVE DISORDER 6	1/72	0.07631516402502538	0.09692761990316727	0	0	13.351441985244803	34.35170636454176	GSK3B
Cockayne Syndrome	1/72	0.07631516402502538	0.09692761990316727	0	0	13.351441985244803	34.35170636454176	MAPK8
Ulcerative Colitis	3/915	0.07700613627732808	0.09774236449082452	0	0	3.3009002770083105	8.463079749052994	CTNNB1;MAPK1;FOS
Guillain-Barre Syndrome	1/73	0.07733488642276296	0.0978452278571152	0	0	13.165343915343914	33.69814742858341	MAPK1
Attention Deficit Disorder	1/73	0.07733488642276296	0.0978452278571152	0	0	13.165343915343914	33.69814742858341	CREBBP
Marfan Syndrome	1/73	0.07733488642276296	0.0978452278571152	0	0	13.165343915343914	33.69814742858341	SMAD2
Bone neoplasms	1/73	0.07733488642276296	0.0978452278571152	0	0	13.165343915343914	33.69814742858341	HIF1A
Congenital small ears	1/73	0.07733488642276296	0.0978452278571152	0	0	13.165343915343914	33.69814742858341	SMAD4
Hamartoma	1/74	0.07835353419741103	0.09888065817245163	0	0	12.984344422700588	33.064947337443236	SMAD4
Keratitis	1/74	0.07835353419741103	0.09888065817245163	0	0	12.984344422700588	33.064947337443236	MAPK8
MAJOR AFFECTIVE DISORDER 1	1/74	0.07835353419741103	0.09888065817245163	0	0	12.984344422700588	33.064947337443236	GSK3B
DiGeorge Syndrome	1/74	0.07835353419741103	0.09888065817245163	0	0	12.984344422700588	33.064947337443236	CTNNB1
Central Nervous System Neoplasms	1/75	0.07937110842625347	0.09990945770672441	0	0	12.808236808236808	32.45121583769236	MAPK1
MYOTONIC DYSTROPHY 1	1/75	0.07937110842625347	0.09990945770672441	0	0	12.808236808236808	32.45121583769236	GSK3B
Polycythemia	1/75	0.07937110842625347	0.09990945770672441	0	0	12.808236808236808	32.45121583769236	HIF1A
Proliferative diabetic retinopathy	1/75	0.07937110842625347	0.09990945770672441	0	0	12.808236808236808	32.45121583769236	MAPK3
Respiration Disorders	1/76	0.08038761020538497	0.10080351120992719	0	0	12.636825396825397	31.85611269580601	MAPK8
Acromegaly	1/76	0.08038761020538497	0.10080351120992719	0	0	12.636825396825397	31.85611269580601	FOS
Amphetamine-Related Disorders	1/76	0.08038761020538497	0.10080351120992719	0	0	12.636825396825397	31.85611269580601	FOS
Amphetamine Abuse	1/76	0.08038761020538497	0.10080351120992719	0	0	12.636825396825397	31.85611269580601	FOS
Platyspondyly	1/76	0.08038761020538497	0.10080351120992719	0	0	12.636825396825397	31.85611269580601	SMAD4
Early-Stage Breast Carcinoma	1/76	0.08038761020538497	0.10080351120992719	0	0	12.636825396825397	31.85611269580601	PGR
Cirrhosis	2/433	0.08128757061297624	0.10162516130383073	0	0	4.535266821345708	11.382441040589109	CTNNB1;HIF1A
Neoplastic Syndromes, Hereditary	1/77	0.0814030405988153	0.10162516130383073	0	0	12.469924812030076	31.278844284190207	SMAD4
Niemann-Pick Disease, Type C	1/77	0.0814030405988153	0.10162516130383073	0	0	12.469924812030076	31.278844284190207	HDAC2
Amphetamine Addiction	1/77	0.0814030405988153	0.10162516130383073	0	0	12.469924812030076	31.278844284190207	FOS
Non-small cell lung cancer stage I	1/77	0.0814030405988153	0.10162516130383073	0	0	12.469924812030076	31.278844284190207	HIF1A
PANIC DISORDER 1	1/77	0.0814030405988153	0.10162516130383073	0	0	12.469924812030076	31.278844284190207	PGR
Parathyroid Adenoma	1/77	0.0814030405988153	0.10162516130383073	0	0	12.469924812030076	31.278844284190207	CTNNB1
Stereotyped Behavior	1/78	0.0824174006878716	0.10224520499908693	0	0	12.307359307359308	30.718660426022282	CREBBP
Pleural Effusion, Malignant	1/78	0.0824174006878716	0.10224520499908693	0	0	12.307359307359308	30.718660426022282	MAPK1
Sudden infant death syndrome	1/78	0.0824174006878716	0.10224520499908693	0	0	12.307359307359308	30.718660426022282	FOS
Acute monocytic leukemia	1/78	0.0824174006878716	0.10224520499908693	0	0	12.307359307359308	30.718660426022282	CREBBP
Androgen-Insensitivity Syndrome	1/78	0.0824174006878716	0.10224520499908693	0	0	12.307359307359308	30.718660426022282	CREBBP
Marinesco-Sjogren syndrome	1/78	0.0824174006878716	0.10224520499908693	0	0	12.307359307359308	30.718660426022282	CTNNB1
Bronchial Hyperreactivity	1/78	0.0824174006878716	0.10224520499908693	0	0	12.307359307359308	30.718660426022282	KAT5
Peripheral Vascular Diseases	1/78	0.0824174006878716	0.10224520499908693	0	0	12.307359307359308	30.718660426022282	HIF1A
Pulmonary Edema	1/78	0.0824174006878716	0.10224520499908693	0	0	12.307359307359308	30.718660426022282	HIF1A
Electromyogram abnormal	1/78	0.0824174006878716	0.10224520499908693	0	0	12.307359307359308	30.718660426022282	SMAD4
Glioblastoma, IDH-Wildtype	1/79	0.08343069154031897	0.10330759610791847	0	0	12.148962148962148	30.174851502656868	HIF1A
Malignancy	1/79	0.08343069154031897	0.10330759610791847	0	0	12.148962148962148	30.174851502656868	HIF1A
Osteitis Deformans	1/79	0.08343069154031897	0.10330759610791847	0	0	12.148962148962148	30.174851502656868	FOS
Eosinophilic esophagitis	1/80	0.08444291423315978	0.10429940938742373	0	0	11.994575045207956	29.646745779715985	SMAD2
Abnormality of the metaphysis	1/80	0.08444291423315978	0.10429940938742373	0	0	11.994575045207956	29.646745779715985	SMAD4
Luminal B Breast Carcinoma	1/80	0.08444291423315978	0.10429940938742373	0	0	11.994575045207956	29.646745779715985	PGR
Desmoplastic	1/80	0.08444291423315978	0.10429940938742373	0	0	11.994575045207956	29.646745779715985	SMAD4
Diabetes Mellitus, Insulin-Dependent	3/956	0.08534447292385172	0.10528495814824475	0	0	3.1520958745236647	7.7574957793797354	CREBBP;HDAC3;FOS
Granulocyte count	1/81	0.08545406982867663	0.10528495814824475	0	0	11.844047619047618	29.13370694679182	CDK6
Neoplasms, Experimental	1/81	0.08545406982867663	0.10528495814824475	0	0	11.844047619047618	29.13370694679182	HIF1A
Insulin Resistance	1/81	0.08545406982867663	0.10528495814824475	0	0	11.844047619047618	29.13370694679182	FOS
Myocardial Ischemia	2/448	0.0861768046716104	0.10610922021597916	0	0	4.379372197309417	10.735392538105748	HIF1A;MAPK3
Salivary Gland Neoplasms	1/82	0.08646415940904789	0.10633045755471332	0	0	11.697236919459142	28.635131837045158	CTNNB1
Prediabetes syndrome	1/82	0.08646415940904789	0.10633045755471332	0	0	11.697236919459142	28.635131837045158	MAPK8
Maturity onset diabetes mellitus in young	1/83	0.08747318404606488	0.1075043798948215	0	0	11.554006968641115	28.150448327888157	CREBBP
Eczema	2/454	0.08815782578849689	0.10827842408723966	0	0	4.319911504424779	10.491451971970697	JUND;FOS
Short philtrum	1/84	0.08848114479384046	0.10847316012900987	0	0	11.414228341939186	27.679113395058145	SMAD4
Sloping forehead	1/84	0.08848114479384046	0.10847316012900987	0	0	11.414228341939186	27.679113395058145	CDK6
Soft Tissue Neoplasms	1/84	0.08848114479384046	0.10847316012900987	0	0	11.414228341939186	27.679113395058145	CTNNB1
Alzheimer's Disease, Focal Onset	1/85	0.08948804274182545	0.10916546288764994	0	0	11.277777777777779	27.220611302509273	GSK3B
Cicatrix, Hypertrophic	1/85	0.08948804274182545	0.10916546288764994	0	0	11.277777777777779	27.220611302509273	SMAD2
Syndactyly	1/85	0.08948804274182545	0.10916546288764994	0	0	11.277777777777779	27.220611302509273	CREBBP
Hyperopia	1/85	0.08948804274182545	0.10916546288764994	0	0	11.277777777777779	27.220611302509273	SMAD4
Acute Confusional Senile Dementia	1/85	0.08948804274182545	0.10916546288764994	0	0	11.277777777777779	27.220611302509273	GSK3B
Convex nasal bridge	1/85	0.08948804274182545	0.10916546288764994	0	0	11.277777777777779	27.220611302509273	SMAD4
Prominent nasal bridge	1/85	0.08948804274182545	0.10916546288764994	0	0	11.277777777777779	27.220611302509273	SMAD4
Prostatic Hyperplasia	1/85	0.08948804274182545	0.10916546288764994	0	0	11.277777777777779	27.220611302509273	HIF1A
Recurrent urinary tract infection	1/86	0.0904938789441273	0.10984966866296952	0	0	11.14453781512605	26.774451939878727	HIF1A
Cystadenocarcinoma, Serous	1/86	0.0904938789441273	0.10984966866296952	0	0	11.14453781512605	26.774451939878727	PGR
Leishmaniasis, Visceral	1/86	0.0904938789441273	0.10984966866296952	0	0	11.14453781512605	26.774451939878727	MAPK1
Headache	1/86	0.0904938789441273	0.10984966866296952	0	0	11.14453781512605	26.774451939878727	CTNNB1
Myocardial Reperfusion Injury	1/86	0.0904938789441273	0.10984966866296952	0	0	11.14453781512605	26.774451939878727	HIF1A
Chronic gastritis	1/86	0.0904938789441273	0.10984966866296952	0	0	11.14453781512605	26.774451939878727	MAPK3
Curvature of digit	1/86	0.0904938789441273	0.10984966866296952	0	0	11.14453781512605	26.774451939878727	SMAD4
Postnatal growth retardation	1/86	0.0904938789441273	0.10984966866296952	0	0	11.14453781512605	26.774451939878727	CREBBP
Multiple tumors	1/87	0.09149865447229137	0.11086493409986226	0	0	11.014396456256922	26.340169264282206	CTNNB1
Chronic active hepatitis	1/87	0.09149865447229137	0.11086493409986226	0	0	11.014396456256922	26.340169264282206	SMAD2
DOSAGE-SENSITIVE SEX REVERSAL	1/87	0.09149865447229137	0.11086493409986226	0	0	11.014396456256922	26.340169264282206	MAPK3
Retroviridae Infections	1/88	0.09250237037972571	0.11180672062420947	0	0	10.887246852764093	25.917319863885282	SMAD4
Abnormality of the skeletal system	1/88	0.09250237037972571	0.11180672062420947	0	0	10.887246852764093	25.917319863885282	CREBBP
Iron Overload	1/88	0.09250237037972571	0.11180672062420947	0	0	10.887246852764093	25.917319863885282	HIF1A
Blepharophimosis	1/88	0.09250237037972571	0.11180672062420947	0	0	10.887246852764093	25.917319863885282	SMAD4
Malaria, Falciparum	1/89	0.09350502774722416	0.11274263113599982	0	0	10.762987012987013	25.505481613016396	CREBBP
Acute Kidney Insufficiency	1/89	0.09350502774722416	0.11274263113599982	0	0	10.762987012987013	25.505481613016396	GSK3B
Bronchioloalveolar Adenocarcinoma	1/89	0.09350502774722416	0.11274263113599982	0	0	10.762987012987013	25.505481613016396	MAPK1
Congenital clinodactyly	1/89	0.09350502774722416	0.11274263113599982	0	0	10.762987012987013	25.505481613016396	SMAD4
Short palm	1/90	0.09450662760956516	0.11346540396893082	0	0	10.641519529159979	25.104252434640532	SMAD4
Gaucher Disease	1/90	0.09450662760956516	0.11346540396893082	0	0	10.641519529159979	25.104252434640532	MAPK1
Skin carcinoma	1/90	0.09450662760956516	0.11346540396893082	0	0	10.641519529159979	25.104252434640532	CTNNB1
Periodontitis, Juvenile	1/90	0.09450662760956516	0.11346540396893082	0	0	10.641519529159979	25.104252434640532	SMAD4
Hip circumference	1/90	0.09450662760956516	0.11346540396893082	0	0	10.641519529159979	25.104252434640532	CDK6
Bacteremia	1/90	0.09450662760956516	0.11346540396893082	0	0	10.641519529159979	25.104252434640532	KAT5
Motor neuron atrophy	1/90	0.09450662760956516	0.11346540396893082	0	0	10.641519529159979	25.104252434640532	HIF1A
Acute Cerebrovascular Accidents	1/91	0.09550717106974846	0.11445792649438907	0	0	10.522751322751322	24.71324912687108	CDK6
Lymphadenopathy	1/91	0.09550717106974846	0.11445792649438907	0	0	10.522751322751322	24.71324912687108	SMAD4
Prolactinoma	1/91	0.09550717106974846	0.11445792649438907	0	0	10.522751322751322	24.71324912687108	FOS
Stereotypic Movement Disorder	1/92	0.0965066591594856	0.11537569723969979	0	0	10.406593406593407	24.332106297541305	CREBBP
Thyroid associated opthalmopathies	1/92	0.0965066591594856	0.11537569723969979	0	0	10.406593406593407	24.332106297541305	FOS
Acute kidney injury	1/92	0.0965066591594856	0.11537569723969979	0	0	10.406593406593407	24.332106297541305	GSK3B
Dejerine-Sottas Disease (disorder)	1/92	0.0965066591594856	0.11537569723969979	0	0	10.406593406593407	24.332106297541305	MAPK3
Speech Disorders	1/93	0.09750509294280582	0.11600756539882016	0	0	10.29296066252588	23.960475343992155	CTNNB1
Osteoarthritis, Knee	1/93	0.09750509294280582	0.11600756539882016	0	0	10.29296066252588	23.960475343992155	MAPK8
PARKINSON DISEASE, LATE-ONSET	1/93	0.09750509294280582	0.11600756539882016	0	0	10.29296066252588	23.960475343992155	MAPK3
Intraepithelial Neoplasia	1/93	0.09750509294280582	0.11600756539882016	0	0	10.29296066252588	23.960475343992155	SMAD4
Joint laxity	1/93	0.09750509294280582	0.11600756539882016	0	0	10.29296066252588	23.960475343992155	CREBBP
Manic	1/93	0.09750509294280582	0.11600756539882016	0	0	10.29296066252588	23.960475343992155	GSK3B
Panic Disorder	1/93	0.09750509294280582	0.11600756539882016	0	0	10.29296066252588	23.960475343992155	PGR
Pregnancy Complications	1/93	0.09750509294280582	0.11600756539882016	0	0	10.29296066252588	23.960475343992155	HIF1A
Gastric ulcer	1/95	0.09949880184268921	0.11802410428787459	0	0	10.072948328267477	23.244433034928196	HIF1A
Intermittent migraine headaches	1/95	0.09949880184268921	0.11802410428787459	0	0	10.072948328267477	23.244433034928196	SMAD4
Pachygyria	1/95	0.09949880184268921	0.11802410428787459	0	0	10.072948328267477	23.244433034928196	CDK6
Congenital diaphragmatic hernia	1/95	0.09949880184268921	0.11802410428787459	0	0	10.072948328267477	23.244433034928196	SMAD2
Polyneuropathy	1/95	0.09949880184268921	0.11802410428787459	0	0	10.072948328267477	23.244433034928196	MAPK3
Retinal Detachment	1/96	0.10049407907293631	0.11884778812517917	0	0	9.96641604010025	22.899400276475088	CTNNB1
Sparse hair	1/96	0.10049407907293631	0.11884778812517917	0	0	9.96641604010025	22.899400276475088	SMAD4
Thin, sparse hair	1/96	0.10049407907293631	0.11884778812517917	0	0	9.96641604010025	22.899400276475088	SMAD4
IMMUNE SUPPRESSION	1/96	0.10049407907293631	0.11884778812517917	0	0	9.96641604010025	22.899400276475088	MAPK3
MAJOR AFFECTIVE DISORDER 2	1/96	0.10049407907293631	0.11884778812517917	0	0	9.96641604010025	22.899400276475088	GSK3B
Acute leukemia	2/492	0.10102129523864793	0.11939979538978436	0	0	3.9771428571428573	9.117297500178042	CREBBP;MAPK1
Neoplasms, Intracranial	1/97	0.10148830622742014	0.11966531629800285	0	0	9.862103174603174	22.56263499711162	MAPK8
Sweating	1/97	0.10148830622742014	0.11966531629800285	0	0	9.862103174603174	22.56263499711162	FOS
Hyperhidrosis disorder	1/97	0.10148830622742014	0.11966531629800285	0	0	9.862103174603174	22.56263499711162	FOS
Increased sweating	1/97	0.10148830622742014	0.11966531629800285	0	0	9.862103174603174	22.56263499711162	FOS
Mycobacterium Infections	1/98	0.10248148436734027	0.12069226692039178	0	0	9.759941089837998	22.233859615850243	MAPK1
Myelofibrosis	1/98	0.10248148436734027	0.12069226692039178	0	0	9.759941089837998	22.233859615850243	NCOR2
Rhinitis	1/100	0.10446469781910508	0.12265789284080139	0	0	9.561808561808562	21.59922753970687	HIF1A
Abnormal heart beat	1/100	0.10446469781910508	0.12265789284080139	0	0	9.561808561808562	21.59922753970687	CREBBP
Myalgia	1/100	0.10446469781910508	0.12265789284080139	0	0	9.561808561808562	21.59922753970687	CTNNB1
ECG abnormality	1/100	0.10446469781910508	0.12265789284080139	0	0	9.561808561808562	21.59922753970687	CREBBP
Rash and Dermatitis Adverse Event Associated with Chemoradiation	1/100	0.10446469781910508	0.12265789284080139	0	0	9.561808561808562	21.59922753970687	MAPK1
Hypertension, Portal	1/101	0.10545473521199025	0.12265789284080139	0	0	9.465714285714286	21.292873143821897	SMAD4
Generalized Absence Seizures	1/101	0.10545473521199025	0.12265789284080139	0	0	9.465714285714286	21.292873143821897	FOS
Single Seizure	1/101	0.10545473521199025	0.12265789284080139	0	0	9.465714285714286	21.292873143821897	FOS
Sleep disturbances	1/101	0.10545473521199025	0.12265789284080139	0	0	9.465714285714286	21.292873143821897	KAT5
Gustatory seizure	1/101	0.10545473521199025	0.12265789284080139	0	0	9.465714285714286	21.292873143821897	FOS
Seizures, Auditory	1/101	0.10545473521199025	0.12265789284080139	0	0	9.465714285714286	21.292873143821897	FOS
Seizures, Clonic	1/101	0.10545473521199025	0.12265789284080139	0	0	9.465714285714286	21.292873143821897	FOS
Seizures, Sensory	1/101	0.10545473521199025	0.12265789284080139	0	0	9.465714285714286	21.292873143821897	FOS
Seizures, Somatosensory	1/101	0.10545473521199025	0.12265789284080139	0	0	9.465714285714286	21.292873143821897	FOS
Vertiginous seizure	1/101	0.10545473521199025	0.12265789284080139	0	0	9.465714285714286	21.292873143821897	FOS
Xeroderma Pigmentosum	1/101	0.10545473521199025	0.12265789284080139	0	0	9.465714285714286	21.292873143821897	MAPK8
Jacksonian Seizure	1/101	0.10545473521199025	0.12265789284080139	0	0	9.465714285714286	21.292873143821897	FOS
Atonic Absence Seizures	1/101	0.10545473521199025	0.12265789284080139	0	0	9.465714285714286	21.292873143821897	FOS
Non-epileptic convulsion	1/101	0.10545473521199025	0.12265789284080139	0	0	9.465714285714286	21.292873143821897	FOS
Nonepileptic Seizures	1/101	0.10545473521199025	0.12265789284080139	0	0	9.465714285714286	21.292873143821897	FOS
Olfactory seizure	1/101	0.10545473521199025	0.12265789284080139	0	0	9.465714285714286	21.292873143821897	FOS
Inflammatory Breast Carcinoma	1/102	0.10644372781945091	0.12344472251521757	0	0	9.371522866572372	20.9935120892893	PGR
Adult Acute Myeloblastic Leukemia	1/102	0.10644372781945091	0.12344472251521757	0	0	9.371522866572372	20.9935120892893	HIF1A
Cardiac conduction abnormality	1/102	0.10644372781945091	0.12344472251521757	0	0	9.371522866572372	20.9935120892893	CREBBP
Childhood Acute Myeloid Leukemia	1/102	0.10644372781945091	0.12344472251521757	0	0	9.371522866572372	20.9935120892893	CREBBP
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	1/102	0.10644372781945091	0.12344472251521757	0	0	9.371522866572372	20.9935120892893	HIF1A
Epileptic Seizures	1/103	0.10743167667166997	0.1243713724657375	0	0	9.279178338001868	20.7009208037458	FOS
Specific learning disability	1/103	0.10743167667166997	0.1243713724657375	0	0	9.279178338001868	20.7009208037458	SMAD4
Electrocardiogram abnormal	1/103	0.10743167667166997	0.1243713724657375	0	0	9.279178338001868	20.7009208037458	CREBBP
Respiratory distress	1/104	0.10841858279105103	0.1252202929896642	0	0	9.188626907073509	20.414884910795575	CREBBP
Tonic Seizures	1/104	0.10841858279105103	0.1252202929896642	0	0	9.188626907073509	20.414884910795575	FOS
Ischemia	1/104	0.10841858279105103	0.1252202929896642	0	0	9.188626907073509	20.414884910795575	HIF1A
Electrocardiographic changes	1/104	0.10841858279105103	0.1252202929896642	0	0	9.188626907073509	20.414884910795575	CREBBP
Premature Obstetric Labor	1/105	0.10940444726923505	0.12621132205417013	0	0	9.09981684981685	20.13519876202632	PGR
Ehlers-Danlos Syndrome	1/105	0.10940444726923505	0.12621132205417013	0	0	9.09981684981685	20.13519876202632	SMAD4
Cataract	2/519	0.11047057779272043	0.1273668366261663	0	0	3.7642166344294004	8.29259204851287	CREBBP;XRCC5
Dermatitis, Allergic Contact	1/107	0.11137305541261804	0.1281828580652218	0	0	8.92722371967655	19.594094214759313	MAPK1
Hairy Cell Leukemia	1/107	0.11137305541261804	0.1281828580652218	0	0	8.92722371967655	19.594094214759313	MAPK1
White Blood Cell Count procedure	1/107	0.11137305541261804	0.1281828580652218	0	0	8.92722371967655	19.594094214759313	CDK6
Carcinoma, Lewis Lung	1/108	0.11235580119112362	0.12893823785733247	0	0	8.84334668446818	19.332304412306982	MAPK1
Severe myopia	1/108	0.11235580119112362	0.12893823785733247	0	0	8.84334668446818	19.332304412306982	FOS
Vesico-Ureteral Reflux	1/108	0.11235580119112362	0.12893823785733247	0	0	8.84334668446818	19.332304412306982	CDK6
Malabsorption	1/108	0.11235580119112362	0.12893823785733247	0	0	8.84334668446818	19.332304412306982	CTNNB1
Congenital ocular coloboma (disorder)	1/108	0.11235580119112362	0.12893823785733247	0	0	8.84334668446818	19.332304412306982	CREBBP
Oligospermia	1/109	0.113337509489395	0.12991386026787877	0	0	8.761022927689595	19.07612080351189	PGR
Convulsive Seizures	1/109	0.113337509489395	0.12991386026787877	0	0	8.761022927689595	19.07612080351189	FOS
Undergrowth	2/529	0.11403053364113323	0.13050775037648213	0	0	3.6908918406072106	8.013992955173077	SMAD4;CREBBP
Hyperplastic Polyp	1/110	0.11431818134243751	0.13050775037648213	0	0	8.680209698558322	18.825375384313688	MAPK1
Aggressive reaction	1/110	0.11431818134243751	0.13050775037648213	0	0	8.680209698558322	18.825375384313688	MAPK3
Luminal A Breast Carcinoma	1/110	0.11431818134243751	0.13050775037648213	0	0	8.680209698558322	18.825375384313688	PGR
Borderline Personality Disorder	1/110	0.11431818134243751	0.13050775037648213	0	0	8.680209698558322	18.825375384313688	HDAC2
Neutrophil count (procedure)	1/110	0.11431818134243751	0.13050775037648213	0	0	8.680209698558322	18.825375384313688	CDK6
Dry skin	1/110	0.11431818134243751	0.13050775037648213	0	0	8.680209698558322	18.825375384313688	MAPK1
Kartagener Syndrome	1/111	0.11529781781493414	0.13147412828204094	0	0	8.600865800865801	18.579906625982126	CREBBP
Plasmacytoma	1/111	0.11529781781493414	0.13147412828204094	0	0	8.600865800865801	18.579906625982126	MAPK3
Skin Erosion	1/112	0.11627641991829156	0.1323607661894097	0	0	8.522951522951523	18.3395591765212	MAPK3
Uric acid measurement (procedure)	1/112	0.11627641991829156	0.1323607661894097	0	0	8.522951522951523	18.3395591765212	KAT5
Merkel cell carcinoma	1/112	0.11627641991829156	0.1323607661894097	0	0	8.522951522951523	18.3395591765212	SMAD4
Erythema	1/113	0.1172539887068551	0.13324316898506264	0	0	8.446428571428571	18.104183565431285	MAPK1
Lipodystrophy	1/113	0.1172539887068551	0.13324316898506264	0	0	8.446428571428571	18.104183565431285	HDAC3
Paresis	1/113	0.1172539887068551	0.13324316898506264	0	0	8.446428571428571	18.104183565431285	GSK3B
Failure to gain weight	2/539	0.11762140017124234	0.1335838213560688	0	0	3.620297951582868	7.748466815786868	SMAD4;CREBBP
Gingival Diseases	1/114	0.1182305252425444	0.13419844100806044	0	0	8.37126000842815	17.873635934356088	HIF1A
Pediatric failure to thrive	2/543	0.11906617199172595	0.13506932204690336	0	0	3.59279112754159	7.645732116188514	SMAD4;CREBBP
Epileptic drop attack	1/115	0.11920603053083924	0.1351503503435175	0	0	8.297410192147034	17.647777784279164	FOS
Acute Myeloid Leukemia, M1	1/116	0.12018050561999473	0.135943011798104	0	0	8.224844720496895	17.42647572499955	CDK6
Alzheimer Disease, Early Onset	1/116	0.12018050561999473	0.135943011798104	0	0	8.224844720496895	17.42647572499955	GSK3B
Ischemic cardiomyopathy	1/116	0.12018050561999473	0.135943011798104	0	0	8.224844720496895	17.42647572499955	HIF1A
Complex partial seizures	1/116	0.12018050561999473	0.135943011798104	0	0	8.224844720496895	17.42647572499955	FOS
Hypogonadism, Isolated Hypogonadotropic	1/117	0.1211539515583106	0.13680906479569094	0	0	8.153530377668309	17.209601247902125	CTNNB1
Teratoma	1/117	0.1211539515583106	0.13680906479569094	0	0	8.153530377668309	17.209601247902125	HIF1A
Joint stiffness	1/117	0.1211539515583106	0.13680906479569094	0	0	8.153530377668309	17.209601247902125	SMAD4
Erectile dysfunction	1/118	0.12212636934961266	0.13767099284559647	0	0	8.083435083435084	16.997030510778643	HDAC3
Anorexia	1/118	0.12212636934961266	0.13767099284559647	0	0	8.083435083435084	16.997030510778643	SMAD4
Convulsions	1/118	0.12212636934961266	0.13767099284559647	0	0	8.083435083435084	16.997030510778643	FOS
Retrognathia	1/119	0.12309776006553728	0.13844992945867662	0	0	8.01452784503632	16.788644123639525	CREBBP
Giant Cell Arteritis	1/119	0.12309776006553728	0.13844992945867662	0	0	8.01452784503632	16.788644123639525	MAPK8
Von Hippel-Lindau Syndrome	1/119	0.12309776006553728	0.13844992945867662	0	0	8.01452784503632	16.788644123639525	HIF1A
Premature Birth	1/119	0.12309776006553728	0.13844992945867662	0	0	8.01452784503632	16.788644123639525	MAPK1
Acute Myeloid Leukemia (AML-M2)	1/121	0.12503746434225704	0.14031192731588502	0	0	7.880158730158731	16.383967972675826	CDK6
Adult Acute Lymphocytic Leukemia	1/121	0.12503746434225704	0.14031192731588502	0	0	7.880158730158731	16.383967972675826	XRCC5
Juvenile Myelomonocytic Leukemia	1/121	0.12503746434225704	0.14031192731588502	0	0	7.880158730158731	16.383967972675826	MAPK1
Polyhydramnios	1/121	0.12503746434225704	0.14031192731588502	0	0	7.880158730158731	16.383967972675826	CREBBP
Hyperplasia	1/123	0.12697307262878257	0.14224153059662256	0	0	7.750195160031225	15.994699639424006	HIF1A
Absence Seizures	1/123	0.12697307262878257	0.14224153059662256	0	0	7.750195160031225	15.994699639424006	FOS
Peripheral T-Cell Lymphoma	1/123	0.12697307262878257	0.14224153059662256	0	0	7.750195160031225	15.994699639424006	CDK6
Encephalitis, St. Louis	1/124	0.1279393433544284	0.1431615881728023	0	0	7.686798296554394	15.805587027633496	MAPK1
Upward slant of palpebral fissure	1/124	0.1279393433544284	0.1431615881728023	0	0	7.686798296554394	15.805587027633496	CDK6
Familial M??ni??re disease	1/125	0.12890459317117553	0.14391552940252778	0	0	7.624423963133641	15.620025745756442	FOS
Tetralogy of Fallot	1/125	0.12890459317117553	0.14391552940252778	0	0	7.624423963133641	15.620025745756442	HIF1A
Congenital hypoplasia of lung	1/125	0.12890459317117553	0.14391552940252778	0	0	7.624423963133641	15.620025745756442	MAPK3
Peripheral Arterial Diseases	1/125	0.12890459317117553	0.14391552940252778	0	0	7.624423963133641	15.620025745756442	HIF1A
Generalized seizures	1/126	0.12986882309792863	0.1447465720194182	0	0	7.5630476190476195	15.437922649005321	FOS
Hypogonadotropic hypogonadism	1/126	0.12986882309792863	0.1447465720194182	0	0	7.5630476190476195	15.437922649005321	CTNNB1
Myocarditis	1/126	0.12986882309792863	0.1447465720194182	0	0	7.5630476190476195	15.437922649005321	MAPK3
Interstitial lung fibrosis	1/127	0.13083203417369998	0.14573788352682315	0	0	7.502645502645502	15.259187734338411	HIF1A
Seizures, Focal	1/129	0.13275540385552057	0.1477137592195229	0	0	7.384672619047619	14.911477387157237	FOS
liposarcoma	1/129	0.13275540385552057	0.1477137592195229	0	0	7.384672619047619	14.911477387157237	CDK6
Lyme Disease	1/130	0.13371556451170172	0.1486983332830016	0	0	7.327057954964932	14.742336530237585	MAPK1
Sleep Apnea, Obstructive	1/132	0.13563284259300215	0.1504914966972917	0	0	7.214467466375863	14.413090019979574	CREBBP
Mouth Neoplasms	1/132	0.13563284259300215	0.1504914966972917	0	0	7.214467466375863	14.413090019979574	CTNNB1
Cardiac Arrhythmia	1/132	0.13563284259300215	0.1504914966972917	0	0	7.214467466375863	14.413090019979574	CREBBP
Nausea and vomiting	1/132	0.13563284259300215	0.1504914966972917	0	0	7.214467466375863	14.413090019979574	CTNNB1
Thyroid Gland Follicular Adenoma	1/134	0.13754606977726383	0.1525286287535632	0	0	7.105263157894737	14.095395225480692	HIF1A
Flexion contractures of joints	1/135	0.13850116684009856	0.15324358796033313	0	0	7.051883439943142	13.940702854507963	CREBBP
Hirschsprung Disease	1/135	0.13850116684009856	0.15324358796033313	0	0	7.051883439943142	13.940702854507963	CREBBP
Hormone refractory prostate cancer	1/135	0.13850116684009856	0.15324358796033313	0	0	7.051883439943142	13.940702854507963	CREBBP
Mycoses	1/135	0.13850116684009856	0.15324358796033313	0	0	7.051883439943142	13.940702854507963	HIF1A
Flexion contracture	1/136	0.1394552542319498	0.15412654007168486	0	0	6.999294532627866	13.788690632752697	CREBBP
Follicular adenoma	1/136	0.1394552542319498	0.15412654007168486	0	0	6.999294532627866	13.788690632752697	CTNNB1
Periodontal Diseases	1/137	0.14040833300105676	0.15491980875814923	0	0	6.947478991596639	13.639293794381585	HIF1A
Prominent eyes	1/137	0.14040833300105676	0.15491980875814923	0	0	6.947478991596639	13.639293794381585	CREBBP
Protruding eyes	1/137	0.14040833300105676	0.15491980875814923	0	0	6.947478991596639	13.639293794381585	CREBBP
Tuberculosis	2/602	0.14089094786587608	0.1553655064405948	0	0	3.2296666666666667	6.329400960009658	MAPK8;MAPK1
Spontaneous abortion	1/138	0.14136040411810394	0.15562251846892713	0	0	6.896419881821342	13.492449590407194	PGR
Drug habituation	1/138	0.14136040411810394	0.15562251846892713	0	0	6.896419881821342	13.492449590407194	HIF1A
Psoriasis vulgaris	1/138	0.14136040411810394	0.15562251846892713	0	0	6.896419881821342	13.492449590407194	MAPK1
Differentiated Thyroid Gland Carcinoma	1/139	0.14231146861678823	0.15649507267157947	0	0	6.846100759144237	13.348097205226534	HIF1A
Prominent globes	1/139	0.14231146861678823	0.15649507267157947	0	0	6.846100759144237	13.348097205226534	CREBBP
Liver diseases	2/606	0.14240276638281668	0.15650832699280073	0	0	3.2076158940397352	6.251950838203861	MAPK8;CTNNB1
Cholangitis, Sclerosing	1/140	0.14326152753117857	0.15727710776769188	0	0	6.796505652620761	13.206177686801743	HIF1A
Contracture of joint	1/140	0.14326152753117857	0.15727710776769188	0	0	6.796505652620761	13.206177686801743	CREBBP
Pectus excavatum	1/141	0.14421058185091135	0.15814319775433086	0	0	6.747619047619048	13.066633878994942	CREBBP
Electroencephalogram abnormal	1/141	0.14421058185091135	0.15814319775433086	0	0	6.747619047619048	13.066633878994942	CREBBP
Exophthalmos	1/142	0.145158632579542	0.15891812602250302	0	0	6.6994258696386355	12.929410352051812	CREBBP
Vascular inflammations	1/142	0.145158632579542	0.15891812602250302	0	0	6.6994258696386355	12.929410352051812	MAPK1
Clear-cell metastatic renal cell carcinoma	1/142	0.145158632579542	0.15891812602250302	0	0	6.6994258696386355	12.929410352051812	HIF1A
Disease Exacerbation	1/144	0.14705172735166475	0.16081238179376406	0	0	6.605061605061605	12.661710673988173	CTNNB1
Encephalitis	1/144	0.14705172735166475	0.16081238179376406	0	0	6.605061605061605	12.661710673988173	XRCC5
Mild Mental Retardation	1/147	0.14988386791442312	0.1636377220182342	0	0	6.46836268754077	12.27626995994421	CDK6
Polydactyly	1/147	0.14988386791442312	0.1636377220182342	0	0	6.46836268754077	12.27626995994421	CREBBP
Depressive Symptoms	1/147	0.14988386791442312	0.1636377220182342	0	0	6.46836268754077	12.27626995994421	MAPK1
Chromophobe Renal Cell Carcinoma	1/149	0.15176697230360767	0.1656020830384669	0	0	6.38030888030888	12.029491858773522	HIF1A
Generalized hypotonia	2/633	0.1527028161346821	0.1665312323942557	0	0	3.0660855784469097	5.761976965490332	CREBBP;CTNNB1
Aneurysm	1/152	0.15458416499208327	0.1683969806174101	0	0	6.252601702932829	11.673711008372909	SMAD2
Pre-Eclampsia	1/152	0.15458416499208327	0.1683969806174101	0	0	6.252601702932829	11.673711008372909	HIF1A
Kidney Diseases	2/639	0.15501317283191865	0.16877123282416723	0	0	3.036263736263736	5.660340034511046	CREBBP;HIF1A
Cervical Squamous Cell Carcinoma	1/153	0.15552124285113708	0.16923110447988746	0	0	6.211152882205514	11.558787481713889	PGR
Breast Cancer, Familial	1/154	0.15645732919598102	0.17006231434345762	0	0	6.170245876128229	11.445633105492488	HIF1A
Icterus	1/154	0.15645732919598102	0.17006231434345762	0	0	6.170245876128229	11.445633105492488	SMAD4
Biliary cirrhosis	1/155	0.15739242505285433	0.17070293216880136	0	0	6.12987012987013	11.334209985174063	HIF1A
Monocyte count procedure	1/155	0.15739242505285433	0.17070293216880136	0	0	6.12987012987013	11.334209985174063	CDK6
Monocyte count result	1/155	0.15739242505285433	0.17070293216880136	0	0	6.12987012987013	11.334209985174063	CDK6
Other specified transient cerebral ischemias	1/155	0.15739242505285433	0.17070293216880136	0	0	6.12987012987013	11.334209985174063	HIF1A
Mucocutaneous Lymph Node Syndrome	1/156	0.15832653136454503	0.17152764643169305	0	0	6.090015360983103	11.224481273000661	HIF1A
Myoclonic Seizures	1/156	0.15832653136454503	0.17152764643169305	0	0	6.090015360983103	11.224481273000661	FOS
Small midface	1/158	0.16019177944615487	0.17316845342427797	0	0	6.0118289353958145	11.009964677714818	SMAD4
Hypotrophic midface	1/158	0.16019177944615487	0.17316845342427797	0	0	6.0118289353958145	11.009964677714818	SMAD4
Midface retrusion	1/158	0.16019177944615487	0.17316845342427797	0	0	6.0118289353958145	11.009964677714818	SMAD4
Decreased projection of midface	1/158	0.16019177944615487	0.17316845342427797	0	0	6.0118289353958145	11.009964677714818	SMAD4
Hypotrophic malar bone	1/160	0.16205308139546307	0.17498897526300686	0	0	5.935609463911351	10.801808091689047	SMAD4
Malar flattening	1/160	0.16205308139546307	0.17498897526300686	0	0	5.935609463911351	10.801808091689047	SMAD4
Weight decreased	1/161	0.16298225507955427	0.17589614960771568	0	0	5.898214285714285	10.700032807806542	SMAD4
Heartburn	1/162	0.16391044521953638	0.17680127215105643	0	0	5.86128364389234	10.599750873625513	MAPK8
Allergic rhinitis (disorder)	1/163	0.1648376527934836	0.1776074000366231	0	0	5.824808935920047	10.500931835185957	HIF1A
Neural Tube Defects	1/163	0.1648376527934836	0.1776074000366231	0	0	5.824808935920047	10.500931835185957	MAPK8
TARSAL-CARPAL COALITION SYNDROME	1/165	0.16668912423187263	0.1795043731504626	0	0	5.753193960511034	10.307564592903963	HIF1A
Acute GVH disease	1/166	0.16761339007915518	0.18010687998168198	0	0	5.7180375180375185	10.212959370400487	KAT5
Keratoconus	1/166	0.16761339007915518	0.18010687998168198	0	0	5.7180375180375185	10.212959370400487	SMAD2
Malignant neoplasm of brain	1/166	0.16761339007915518	0.18010687998168198	0	0	5.7180375180375185	10.212959370400487	CTNNB1
Contracture	1/166	0.16761339007915518	0.18010687998168198	0	0	5.7180375180375185	10.212959370400487	CREBBP
Retinal pigment epithelial abnormality	1/167	0.16853667734345493	0.18060767105443487	0	0	5.683304647160069	10.119702957431578	CTNNB1
Follicular thyroid carcinoma	1/167	0.16853667734345493	0.18060767105443487	0	0	5.683304647160069	10.119702957431578	MAPK3
Hereditary hemochromatosis	1/167	0.16853667734345493	0.18060767105443487	0	0	5.683304647160069	10.119702957431578	MAPK3
Abnormality of retinal pigmentation	1/167	0.16853667734345493	0.18060767105443487	0	0	5.683304647160069	10.119702957431578	CTNNB1
Irritable Bowel Syndrome	1/167	0.16853667734345493	0.18060767105443487	0	0	5.683304647160069	10.119702957431578	HIF1A
Tuberculosis, Pulmonary	1/169	0.17038031999161385	0.18238543738939691	0	0	5.615079365079365	9.937130406480772	MAPK1
Cyst	1/169	0.17038031999161385	0.18238543738939691	0	0	5.615079365079365	9.937130406480772	PGR
Dental caries	1/170	0.17130067736411486	0.183271309747631	0	0	5.581572273879966	9.847762867980924	SMAD4
Blood Coagulation Disorders	1/171	0.17222006006501586	0.1841551806325968	0	0	5.548459383753501	9.759641298689061	HIF1A
Tonic - clonic seizures	1/173	0.17405590544517727	0.1860175396397322	0	0	5.483388704318937	9.587040210264009	FOS
Increase in blood pressure	1/174	0.1749723700777881	0.1867948275154765	0	0	5.451417561244151	9.502514244791406	SMAD4
Prostatic Intraepithelial Neoplasias	1/174	0.1749723700777881	0.1867948275154765	0	0	5.451417561244151	9.502514244791406	HIF1A
Drug Dependence	1/175	0.17588786398787418	0.18767073548138924	0	0	5.419813902572523	9.419141318689299	MAPK1
Liver Failure	1/176	0.176802388136218	0.18854466337420656	0	0	5.388571428571429	9.336899610841375	FOS
Hemoglobin low	1/177	0.17771594351314726	0.18941661545518934	0	0	5.357683982683983	9.255767829821247	SMAD4
Cerebrovascular Disorders	1/178	0.17862853109752552	0.1900815457530242	0	0	5.32714554748453	9.175725199399695	SMAD4
Neutropenia	1/178	0.17862853109752552	0.1900815457530242	0	0	5.32714554748453	9.175725199399695	CTNNB1
Dyschezia	1/178	0.17862853109752552	0.1900815457530242	0	0	5.32714554748453	9.175725199399695	CREBBP
Penile hypospadias	1/180	0.18045080678616326	0.19191725546724417	0	0	5.267092311785049	9.018826769418473	CREBBP
Primary Myelofibrosis	1/182	0.18226922297134582	0.1937468866353111	0	0	5.208366219415943	8.866047844643044	NCOR2
Hepatitis, Chronic	1/183	0.18317698620999942	0.1945024450348112	0	0	5.17948717948718	8.791156309308382	SMAD2
Delayed bone age	1/183	0.18317698620999942	0.1945024450348112	0	0	5.17948717948718	8.791156309308382	CREBBP
Ulcer	1/184	0.18408378747180765	0.195360279557668	0	0	5.150923757481134	8.717239264525878	HIF1A
Hypoplasia of corpus callosum	1/187	0.18679842930266102	0.19802839391989024	0	0	5.067076292882745	8.501161392654433	CTNNB1
Childhood Glioblastoma	1/187	0.18679842930266102	0.19802839391989024	0	0	5.067076292882745	8.501161392654433	HIF1A
Acquired Immunodeficiency Syndrome	1/188	0.1877013924825559	0.1987722520927871	0	0	5.039724980901451	8.430970620202137	MAPK1
Dyspnea	1/188	0.1877013924825559	0.1987722520927871	0	0	5.039724980901451	8.430970620202137	CREBBP
Adult Glioblastoma	1/189	0.18860339854274408	0.1996204245026364	0	0	5.012664640324215	8.361670444603366	HIF1A
Long philtrum	1/190	0.1895044484736197	0.20046667688023506	0	0	4.985890652557319	8.293245218503335	CTNNB1
Cerebellar degeneration	1/193	0.19220187105514439	0.20310256572172827	0	0	4.907242063492063	8.093068009653642	UBE2I
Developmental delay (disorder)	1/193	0.19220187105514439	0.20310256572172827	0	0	4.907242063492063	8.093068009653642	CTNNB1
Mean Corpuscular Volume (result)	1/194	0.19309910605438618	0.20383256785537826	0	0	4.881569207994079	8.027993032435198	CDK6
Eclampsia	1/194	0.19309910605438618	0.20383256785537826	0	0	4.881569207994079	8.027993032435198	HIF1A
Hypospadias	1/195	0.19399538974041455	0.20466928137677284	0	0	4.856161021109474	7.9637198766521875	CREBBP
Tuberous Sclerosis	1/197	0.19578510698236704	0.20644718969042974	0	0	4.8061224489795915	7.83752465589223	MAPK1
Congenital clubfoot	1/198	0.19667854246153751	0.2072786133199235	0	0	4.781484167270969	7.77557614353097	NCOR2
Speech impairment	1/200	0.1984625719282345	0.20904724243107364	0	0	4.732950466618808	7.653913334056085	CREBBP
Eosinophil count procedure	1/201	0.1993531678153524	0.20964989693041583	0	0	4.709047619047619	7.594174268418155	CDK6
Eosinophil count result	1/201	0.1993531678153524	0.20964989693041583	0	0	4.709047619047619	7.594174268418155	CDK6
Arthritis, Psoriatic	1/201	0.1993531678153524	0.20964989693041583	0	0	4.709047619047619	7.594174268418155	KAT5
Muscular Dystrophy	1/203	0.2011315266869379	0.21140753869435996	0	0	4.661951909476662	7.476820865614278	SMAD4
Short neck	1/204	0.2020192915801868	0.2118895915405571	0	0	4.638752052545156	7.419183309087755	SMAD4
Brachydactyly	1/204	0.2020192915801868	0.2118895915405571	0	0	4.638752052545156	7.419183309087755	SMAD4
Papilloma	1/204	0.2020192915801868	0.2118895915405571	0	0	4.638752052545156	7.419183309087755	MAPK1
Dilated ventricles (finding)	1/204	0.2020192915801868	0.2118895915405571	0	0	4.638752052545156	7.419183309087755	CDK6
Cervical Intraepithelial Neoplasia	1/205	0.20290611470631448	0.212706781605611	0	0	4.6157796451914095	7.362223443639087	PGR
Language Delay	1/206	0.20379199704582684	0.2135221189206939	0	0	4.593031358885018	7.305930260288714	CREBBP
Ataxia	1/208	0.20556094309655468	0.21514725098870988	0	0	4.548194156889809	7.195301049847176	SMAD2
Neurodevelopmental Disorders	1/208	0.20556094309655468	0.21514725098870988	0	0	4.548194156889809	7.195301049847176	CTNNB1
Smoking Behaviors	1/209	0.2064440087145227	0.2157285276249642	0	0	4.5260989010989015	7.140944130218156	CDK6
Trisomy	1/209	0.2064440087145227	0.2157285276249642	0	0	4.5260989010989015	7.140944130218156	CTNNB1
Nonalcoholic Steatohepatitis	1/209	0.2064440087145227	0.2157285276249642	0	0	4.5260989010989015	7.140944130218156	HIF1A
Germ cell tumor	1/210	0.20732613732554697	0.2165357595018272	0	0	4.5042150831624514	7.08721209721306	SMAD4
Speech Delay	1/213	0.2099669105347157	0.21917793250849021	0	0	4.439802336028751	6.929667148276624	CREBBP
Craniosynostosis	1/214	0.2108453005712249	0.2199785888157259	0	0	4.418734630002236	6.878337481148603	MAPK8
Frontal bossing	1/216	0.2125992846937246	0.22157445238528026	0	0	4.37718715393134	6.77740099862115	CREBBP
Alopecia	1/216	0.2125992846937246	0.22157445238528026	0	0	4.37718715393134	6.77740099862115	PGR
Severe Combined Immunodeficiency	1/217	0.21347488070465043	0.22236966740067754	0	0	4.356701940035274	6.727776447659202	HIF1A
Neoplasm, Residual	1/220	0.2160960957179483	0.22486290255160585	0	0	4.296368775820831	6.582174803444699	MAPK1
Delayed speech and language development	1/220	0.2160960957179483	0.22486290255160585	0	0	4.296368775820831	6.582174803444699	CREBBP
Downward slant of palpebral fissure	1/222	0.21783893759598752	0.2265570835977227	0	0	4.257056668821375	6.487751415786585	CREBBP
Severe mental retardation (I.Q. 20-34)	1/224	0.21957808040349017	0.22812557011935458	0	0	4.218449711723254	6.39536967674684	CDK6
Blood basophil count (lab test)	1/224	0.21957808040349017	0.22812557011935458	0	0	4.218449711723254	6.39536967674684	CDK6
Exanthema	1/225	0.22044626701287534	0.22878685094610024	0	0	4.199404761904762	6.349925403096257	CREBBP
Malnutrition	1/225	0.22044626701287534	0.22878685094610024	0	0	4.199404761904762	6.349925403096257	HIF1A
Drug abuse	1/229	0.2239098029974443	0.2322593807352692	0	0	4.124895572263993	6.172955612952667	CREBBP
Feeding difficulties in infancy	1/233	0.22735864710625986	0.23546582487407614	0	0	4.052955665024631	6.003345598201084	CREBBP
Hamman-Rich syndrome	1/233	0.22735864710625986	0.23546582487407614	0	0	4.052955665024631	6.003345598201084	SMAD2
Chronic myeloproliferative disorder	1/233	0.22735864710625986	0.23546582487407614	0	0	4.052955665024631	6.003345598201084	CREBBP
Hepatoblastoma	1/235	0.2290775782557286	0.23712170705192034	0	0	4.0179080179080175	5.921169201114199	CTNNB1
Sarcoidosis	1/236	0.22993567434695458	0.237885257640249	0	0	4.000607902735562	5.880716333795229	FOS
Periodontitis	1/237	0.2307928586785011	0.23864706591101553	0	0	3.983454398708636	5.840679011190165	MAPK1
Hepatitis B, Chronic	1/238	0.2316491321720215	0.2392819226149281	0	0	3.9664456499899536	5.8010513627178115	MAPK8
Overweight	1/238	0.2316491321720215	0.2392819226149281	0	0	3.9664456499899536	5.8010513627178115	PGR
Allergic disposition	1/240	0.23335895035032136	0.24092207367584142	0	0	3.932855150428372	5.723002134593974	MAPK1
Leukopenia	1/246	0.23846664043392812	0.2460666744289488	0	0	3.835374149659864	5.498107991147254	CTNNB1
Immune System Diseases	1/250	0.24185370354342994	0.2494313652732502	0	0	3.7729967489003635	5.355475596595479	MAPK1
Alzheimer Disease, Late Onset	1/253	0.24438455895498995	0.25190997073909455	0	0	3.7275132275132274	5.252111736530547	GSK3B
Congenital Epicanthus	1/255	0.24606731342240737	0.25351222953012753	0	0	3.697787776527934	5.1848536806521	CREBBP
Adenoma of large intestine	1/258	0.24858473955154395	0.25583890600015596	0	0	3.6540670743005372	5.0863571802638035	HIF1A
Behcet Syndrome	1/258	0.24858473955154395	0.25583890600015596	0	0	3.6540670743005372	5.0863571802638035	MAPK3
Sjogren's Syndrome	1/260	0.25025856381351685	0.2574274289227582	0	0	3.6254826254826256	5.022238383315064	MAPK1
Renal Insufficiency	1/263	0.2527626285517419	0.25986787682961493	0	0	3.583424209378408	4.928299289107686	HIF1A
Trichohepatoenteric Syndrome	1/267	0.25608896550066074	0.26315073197908684	0	0	3.5288220551378444	4.807068585787497	CREBBP
Hypothyroidism	1/268	0.2569183385613277	0.2638656883300167	0	0	3.5154271446406278	4.77745491997216	NCOR2
Byzanthine arch palate	1/280	0.26680222266665754	0.2738744229556386	0	0	3.3621778460488136	4.442269524652676	CREBBP
Squamous cell carcinoma of lung	1/283	0.2692535140232305	0.27624711179006767	0	0	3.325903411009794	4.363924224303339	CREBBP
Neuropathy	1/284	0.2700688712946419	0.2769397823504246	0	0	3.313982836951035	4.3382629310744205	GSK3B
Kidney Failure	1/297	0.28058980595431654	0.28757906941347955	0	0	3.1663449163449164	4.023985664453448	HIF1A
Charcot-Marie-Tooth Disease	1/298	0.2813930846883027	0.2882527708814304	0	0	3.155523488856822	4.0012123330426554	PGR
Pancreatitis, Chronic	1/302	0.2845976462867806	0.2913843190338993	0	0	3.1129568106312293	3.9119870272536397	SMAD4
Serum total cholesterol measurement	1/307	0.2885841683456951	0.2951598821764619	0	0	3.061313414254591	3.8045038519563543	PGR
Arthrogryposis	1/307	0.2885841683456951	0.2951598821764619	0	0	3.061313414254591	3.8045038519563543	SMAD4
Peripheral Neuropathy	1/309	0.2901728323029976	0.29663113033044525	0	0	3.0411255411255413	3.762719430499663	MAPK1
Body Height	1/314	0.2941296902161569	0.30052050604082253	0	0	2.991784573254222	3.6611499561526704	CDK6
Cholestasis	1/315	0.2949185312002792	0.3011706820685375	0	0	2.9821049438883835	3.641317510723491	CTNNB1
Psychotic Disorders	1/317	0.2964936893879897	0.3026227579024701	0	0	2.9629294755877034	3.602120309019259	HDAC2
Hepatitis, Toxic	1/325	0.30276079716912285	0.3083819362604526	0	0	2.8885949441505	3.4513285770067132	CTNNB1
Chemical and Drug Induced Liver Injury	1/325	0.30276079716912285	0.3083819362604526	0	0	2.8885949441505	3.4513285770067132	CTNNB1
Chemically-Induced Liver Toxicity	1/325	0.30276079716912285	0.3083819362604526	0	0	2.8885949441505	3.4513285770067132	CTNNB1
Drug-Induced Acute Liver Injury	1/325	0.30276079716912285	0.3083819362604526	0	0	2.8885949441505	3.4513285770067132	CTNNB1
Hepatitis, Drug-Induced	1/329	0.3058743313401952	0.31139268267880693	0	0	2.852787456445993	3.3793576561268663	CTNNB1
Fatigue	1/330	0.30665063864860115	0.31186148884190895	0	0	2.8439716312056738	3.361705757900601	CTNNB1
Broad flat nasal bridge	1/330	0.30665063864860115	0.31186148884190895	0	0	2.8439716312056738	3.361705757900601	CREBBP
Nasal bridge wide	1/333	0.30897459117970066	0.3140632102830205	0	0	2.8178427997705104	3.3095457581866605	CREBBP
Lens Opacities	1/339	0.31360020961797236	0.31843723084601305	0	0	2.7669766131304594	3.2086865829359956	CREBBP
Muscle Weakness	1/339	0.31360020961797236	0.31843723084601305	0	0	2.7669766131304594	3.2086865829359956	GSK3B
Encephalomyelitis	1/348	0.3204832594677855	0.3252592175996281	0	0	2.693975572938109	3.065542791056162	MAPK1
Retinal Diseases	1/355	0.3257911414084491	0.3304763761076975	0	0	2.6397632499327415	2.960491247020972	HIF1A
Presenile dementia	1/362	0.3310594325759206	0.33564803867425214	0	0	2.5876533438860307	2.8605404473582037	GSK3B
Orbital separation excessive	1/368	0.33554381296854874	0.3400200259686423	0	0	2.5445698715453484	2.7786772744605917	SMAD4
Finding of body mass index	1/370	0.3370322190613252	0.34117818177658493	0	0	2.530520067105433	2.7521347845125743	CDK6
Body mass index	1/370	0.3370322190613252	0.34117818177658493	0	0	2.530520067105433	2.7521347845125743	CDK6
Drug-Induced Liver Disease	1/377	0.3422166177678263	0.3462488832435742	0	0	2.4825227963525838	2.662037388881101	CTNNB1
Chronic Kidney Diseases	1/380	0.34442663593705236	0.34830650587592343	0	0	2.462495288352808	2.624710119878101	HIF1A
Erythrocyte Mean Corpuscular Hemoglobin Test	1/387	0.34955581484215764	0.35313183340831783	0	0	2.4169750801875156	2.540463245764763	NCOR2
Finding of Mean Corpuscular Hemoglobin	1/387	0.34955581484215764	0.35313183340831783	0	0	2.4169750801875156	2.540463245764763	NCOR2
Chronic kidney disease stage 5	1/388	0.350285420142968	0.35368798813004176	0	0	2.4106066199089455	2.528743147909836	HIF1A
Ischemic stroke	1/394	0.3546466736920301	0.35790789562861347	0	0	2.3730764570459226	2.46001000882987	MAPK1
Retrusion of lower jaw	1/395	0.3553708270013727	0.35790789562861347	0	0	2.366932559825961	2.448812926778447	CREBBP
Hypoplastic mandible condyle	1/395	0.3553708270013727	0.35790789562861347	0	0	2.366932559825961	2.448812926778447	CREBBP
Decreased projection of lower jaw	1/395	0.3553708270013727	0.35790789562861347	0	0	2.366932559825961	2.448812926778447	CREBBP
Decreased projection of mandible	1/395	0.3553708270013727	0.35790789562861347	0	0	2.366932559825961	2.448812926778447	CREBBP
Aplasia/Hypoplasia of the mandible	1/397	0.3568168073607432	0.3591810369711865	0	0	2.354737854737855	2.426634532435711	CREBBP
Micrognathism	1/400	0.35897997413127575	0.36117445181317864	0	0	2.336675020885547	2.393897094683075	CREBBP
Curvature of spine	1/408	0.3647145202862169	0.3667572187195918	0	0	2.28980928980929	2.309594083875582	CREBBP
Attention deficit hyperactivity disorder	1/412	0.3675633974141809	0.3694339490549655	0	0	2.2670605955277487	2.2690090552993674	GSK3B
Myopathy	1/415	0.3696920480355629	0.3713844327925924	0	0	2.250287554635381	2.239227216921857	SMAD4
Acquired scoliosis	1/418	0.37181385867907224	0.37332606552677566	0	0	2.2337558524608885	2.209993000972616	CREBBP
Cardiomyopathy, Dilated	1/419	0.37251961253614174	0.37384463148317076	0	0	2.228298017771702	2.2003676200342257	MAPK3
Dementia	1/436	0.384402250815821	0.38557361369286264	0	0	2.139354132457581	2.0453632056823	GSK3B
Kidney Failure, Chronic	1/437	0.38509449816477764	0.38607189536824155	0	0	2.134338138925295	2.036727439078876	HIF1A
Muscle hypotonia	1/460	0.40081262205893686	0.40162604189061407	0	0	2.0250025936300444	1.8513813772826897	CREBBP
Epileptic encephalopathy	1/468	0.4061893314356561	0.40680726652404703	0	0	1.9894972978484755	1.7924095276320218	KAT5
Cerebellar Ataxia	1/565	0.4678247406891042	0.4682989674916273	0	0	1.6391421816953733	1.245193272237061	SMAD2
Autism Spectrum Disorders	1/572	0.47202796159664623	0.47226708417091	0	0	1.6184638478859144	1.215008412667896	MAPK1
Immunologic Deficiency Syndromes	1/641	0.5117989264519605	0.5117989264519605	0	0	1.4388392857142858	0.96376829845558	MAPK1
